Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.1.1.34 - lipoprotein lipase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Abetalipoproteinemia
Apoproteins of human serum high density lipoproteins. Isolation and characterization of the peptides of Sephadex fraction V from normal subjects and patients with abeta-lipoproteinemia.
Gene therapy for dyslipidemia: clinical prospects.
Lipoprotein lipase and hepatic lipase activity after heparin administration in abetalipoproteinemia and hypobetalipoproteinemia.
The molecular genetics of pediatric lipid disorders: recent progress and future research directions.
Abscess
Lipoprotein lipase deficiency presenting with neonatal perianal abscesses.
Acidosis
[Reduction of post-heparin lipoprotein lipase activity by acidotic blood pH]
[The human genome--chromosome 8]
Acidosis, Renal Tubular
[The human genome--chromosome 8]
Acne Vulgaris
Decreased eicosapentaenoic acid levels in acne vulgaris reveals the presence of a proinflammatory state.
Isotretinoin versus minocycline in cystic acne: a study of lipid metabolism.
Lipoprotein metabolism and lipoprotein lipase in severe cystic acne.
Acquired Immunodeficiency Syndrome
Effect of fasting on free fatty acid, glycerol and cholesterol concentrations in blood plasma and lipoprotein lipase activity in adipose tissue of cattle.
Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.
Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
Acromegaly
Decline of postheparin plasma lipoprotein lipase in acromegalic patients.
Effects of acromegaly treatment and growth hormone on adipose tissue lipoprotein lipase.
Acute Coronary Syndrome
[The relation of the activity of postheparin lipoprotein lipase with the CBC parameters in patients with acute coronary syndrome]
Acute Kidney Injury
Post-heparin lipolytic activity in acute renal failure.
Reduced kidney lipoprotein lipase and renal tubule triglyceride accumulation in cisplatin-mediated acute kidney injury.
Adenocarcinoma
[Relationship between chromosome 8 alterations and Gleason score in prostatic adenocarcinoma]
Adenocarcinoma of Lung
Expression of lipoprotein lipase associated with lung adenocarcinoma tissues.
Adiposis Dolorosa
Fat-cell heat production, adipose tissue fatty acids, lipoprotein lipase activity and plasma lipoproteins in adiposis dolorosa.
Albuminuria
Release of endothelium-associated proteins into blood by injection of heparin in normal subjects and in patients with Type 1 diabetes.
Alkalosis
[Reduction of post-heparin lipoprotein lipase activity by acidotic blood pH]
Alzheimer Disease
A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology.
Apolipoprotein E3Basel: new insights into a highly conserved protein region.
Genetic Variants of Lipoprotein Lipase and Regulatory Factors Associated with Alzheimer's Disease Risk.
Implication of lipid metabolism disturbance and Alzheimer's disease: focus on the lipoprotein lipase plays an important role in learning and memory function.
Intermittent Fasting Alleviates the Increase of Lipoprotein Lipase Expression in Brain of a Mouse Model of Alzheimer's Disease: Possibly Mediated by ?-hydroxybutyrate.
Lack of association of two lipoprotein lipase polymorphisms with Alzheimer's disease.
Lipoprotein lipase (LPL) is associated with neurite pathology and its levels are markedly reduced in the dentate gyrus in Alzheimer's disease brain.
Lipoprotein Lipase HindIII Intronic Polymorphism in a Subset of Iranian Patients with Late-Onset Alzheimer's Disease.
Lipoprotein lipase mutations and Alzheimer's disease.
Meta-analyses of four polymorphisms of lipoprotein lipase associated with the risk of Alzheimer's disease.
No association between the lipoprotein lipase S447X polymorphism and Alzheimer's disease.
Roles for lipoprotein lipase in Alzheimer's disease: an association study.
Structure-activity relationship of heparan sulphate.
The H+ allele of the lipoprotein lipase (LPL) HindIII intronic polymorphism and the risk for sporadic late-onset Alzheimer's disease.
Amyloidosis
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Anaphylaxis
Production of lipemia clearing factor during anaphylactoid shock.
Anemia
Erythropoietin supplement increases plasma lipoprotein lipase and hepatic triglyceride lipase levels in hemodialysis patients.
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Sex dimorphism in serum lecithin: cholesterol acyltransferase and lipoprotein lipase activities in adult sickle cell anaemia patients with proteinuria.
Anemia, Sickle Cell
Sex dimorphism in serum lecithin: cholesterol acyltransferase and lipoprotein lipase activities in adult sickle cell anaemia patients with proteinuria.
Aneurysm
Lipoprotein Lipase Deficiency (R243H) in a Type 2 Diabetes Patient with Multiple Arterial Aneurysms.
Angina Pectoris
Lipoprotein lipase activity is associated with severity of angina pectoris. REGRESS Study Group.
Angina, Stable
[Connection of HindIII-polymorphism in the lipoprotein lipase gene with myocardial infarct and life span in elderly ischemic heart disease patients]
Aortic Valve Stenosis
Lipoprotein lipase in aortic valve stenosis is associated with lipid retention and remodelling.
Arteriosclerosis
Influence of bilateral oophorectomy upon lipid metabolism.
Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
Mucopolysaccarides, clearing factor, age, and arteriosclerosis.
Relationship between a glycoprotein acting as lipoprotein lipase inhibitor and arteriosclerosis.
[Blood lipoprotein lipase activity in arteriosclerosis.]
[Clearing factor and heparin in the blood of patients with arteriosclerosis and the influence of iodine therapy on these indices.]
[Lipoprotein lipase and blood clotting in patients with arteriosclerosis]
Arthritis
Suppression of up-regulated LXR? by silybin ameliorates experimental rheumatoid arthritis and abnormal lipid metabolism.
Arthritis, Rheumatoid
Active-dimeric form of lipoprotein lipase increases in the adipose tissue of patients with rheumatoid arthritis treated with prednisolone.
Lipoprotein lipase in relation to inflammatory activity in rheumatoid arthritis.
Ascorbic Acid Deficiency
Hyperlipidemia in guinea-pigs induced by ascorbic acid deficiency. The effects of cholesterol, DL-ethionine and aflatoxin.
Wide variations of plasma triglyceride concentrations in guinea pigs.
Atherosclerosis
A 60-y-old chylomicronemia patient homozygous for missense mutation (G188E) in the lipoprotein lipase gene showed no accelerated atherosclerosis.
A critical role for the Sp1-binding sites in the transforming growth factor-beta-mediated inhibition of lipoprotein lipase gene expression in macrophages.
A lipoprotein lipase activator, NO-1886 prevents impaired endothelium-dependent relaxation of aorta caused by exercise in aged rats.
A lipoprotein lipase activator, NO-1886, improves endothelium-dependent relaxation of rat aorta associated with aging.
A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis.
A novel Lipoprotein lipase (LPL) agonist rescues the enzyme from inhibition by angiopoietin-like 4 (ANGPTL4).
A novel role of Sp1 and Sp3 in the interferon-gamma -mediated suppression of macrophage lipoprotein lipase gene transcription.
A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins.
Adeno-associated virus LPL(S447X) gene therapy in LDL receptor knockout mice.
Advanced glycation end products potentiate the stimulatory effect of glucose on macrophage lipoprotein lipase expression.
Altered lipid profile, postheparin lipolytic activity, and xanthoma of choroid plexus in vasectomized rabbits fed an atherogenic diet.
Analysis and lipoprotein lipase activation capacity of plasma lipoproteins isolated from atherosclerosis-susceptible White Carneau pigeon and atherosclerosis-resistant Show Racer pigeon.
Angiopoietin-like 4: A double-edged sword in atherosclerosis and ischemic stroke?
Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
Apelin-13 inhibits lipoprotein lipase expression via the APJ/PKC?/miR-361-5p signaling pathway in THP-1 macrophage-derived foam cells.
Artesunate inhibits atherosclerosis by upregulating vascular smooth muscle cells-derived LPL expression via the KLF2/NRF2/TCF7L2 pathway.
Ascorbic acid and atherosclerotic cardiovascular disease.
Assessment of lipoprotein lipase activity in patients with atherosclerosis and nonspecific pulmonary diseases.
Association of lipoprotein lipase Hind III and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians.
Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden.
Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivo.
C-reactive protein enhances macrophage lipoprotein lipase expression.
Can lipoprotein lipase be the culprit in cholesteryl ester accretion in smooth muscle cells in atheroma?
Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice.
Chronic Intermittent Hypoxia Induces Atherosclerosis via Activation of Adipose Angiopoietin-like 4.
Clearing factor inhibitor in human atherosclerosis.
Coiled-coil domain-containing 80 accelerates atherosclerosis development through decreasing lipoprotein lipase expression via ERK1/2 phosphorylation and TET2 expression.
Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes.
Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis.
COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity.
Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus.
Corrigendum to: "Krüppel-like factor 14 inhibits atherosclerosis via mir-27a-mediated down-regulation of lipoprotein lipase expression in vivo" [Atherosclerosis Volume 289, (October 2019), Pages 143-161].
Deficiencies in the lipoprotein lipase system in atherosclerosis.
Delayed metabolism of postprandial triglyceride-rich lipoproteins in subjects with echolucent carotid plaques.
Diet-induced atherosclerosis in the domestic cat.
Dietary cholesterol reduces lipoprotein lipase activity in the atherosclerosis-susceptible Bio F(1)B hamster.
Differential regulation of lipoprotein lipase in the macrophage J774.2 cell line by cytokines.
Effect of dietary sucrose and cholesterol on atherosclerosis, liver malate dehydrogenase and plasma lipoprotein lipase levels in pigeons.
Effect of the calcium channel antagonist nitrendipine on lipoprotein lipase and hepatic lipase in the normal rat.
Effects of a liquid high-fat meal on postprandial lipid metabolism in type 2 diabetic patients with abdominal obesity.
Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice.
Effects of NO-1886, a lipoprotein lipase promoting agent, on homozygous and heterozygous Watanabe heritable hyperlipidaemic rabbits.
EFFECTS OF ORAL CHONDROITIN SULFATE ON LIPID AND ANTIOXIDANT METABOLISMS IN RATS FED A HIGH-FAT DIET
Effects of platelet-derived growth factor on the synthesis of lipoprotein lipase in human monocyte-derived macrophages.
Effects of the lipoprotein lipase activator NO-1886 as a suppressor agent of atherosclerosis in aorta of mild diabetic rabbits.
Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase.
Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase.
Enhanced atherothrombotic formation after oxidative injury by FeCl3 to the common carotid artery in severe combined hyperlipidemic mice.
Enhanced lipoprotein lipase secretion and foam cell formation by macrophages of patients with growth hormone deficiency: possible contribution to increased risk of atherogenesis?
Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
Fibrinogen-coated chylomicrons in gastrointestinal lymph: a new rationale regarding the arterial deposition of postprandial lipids.
Folic acid and lipoprotein lipase from aorta and blood plasma of atherosclerotic rats.
Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
Haplotypes in the lipoprotein lipase gene influence fasting insulin and discovery of a new risk haplotype.
Haplotypes in the lipoprotein lipase gene influence high-density lipoprotein cholesterol response to statin therapy and progression of atherosclerosis in coronary artery bypass grafts.
HDL Cholesterol - Third Annual International Conference. Metabolic Pathways and Drug Development. 25-26 February 2002, Boston, MA, USA.
High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis.
High myocardial and low hepatic lipoprotein lipase activities responsible for the initiation of atherosclerosis.
High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis.
HindIII DNA polymorphism in the lipoprotein lipase gene and plasma lipid phenotypes and carotid artery atherosclerosis.
Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models.
Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice.
Involvement of both the tyrosine kinase and the phosphatidylinositol-3' kinase signal transduction pathways in the regulation of lipoprotein lipase expression in J774.2 macrophages by cytokines and lipopolysaccharide.
Isolation and characterization of glycosaminoglycans in human plasma.
Krüppel-like factor 14 inhibits atherosclerosis via mir-27a-mediated down-regulation of lipoprotein lipase expression in vivo.
Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C.
Lipoprotein lipase and atherosclerosis.
Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis.
Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia.
Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice.
Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study.
Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS).
Lipoprotein Lipase HindIII Intronic Polymorphism in a Subset of Iranian Patients with Late-Onset Alzheimer's Disease.
Lipoprotein lipase in atherosclerosis: its presence in smooth muscle cells and absence from macrophages.
Lipoprotein lipase in cultured pig aortic smooth muscle cells.
Lipoprotein lipase is expressed by glomerular mesangial cells.
Lipoprotein lipase locus and progression of atherosclerosis in coronary-artery bypass grafts.
Lipoprotein lipase secretion by human monocyte-derived macrophages.
Lipoprotein lipase secretion by human monocytes and rabbit alveolar macrophages in culture.
Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies.
Lipoprotein lipase: Biosynthesis, regulatory factors, and its role in atherosclerosis and other diseases.
Lipoprotein lipase: from gene to atherosclerosis.
Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis.
LPL polymorphism predicts stroke risk in men.
Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity.
Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice.
Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo.
Macrophage-derived lipoprotein lipase increases aortic atherosclerosis in cholesterol-fed Tg rabbits.
Macrophage-specific expression of human lipoprotein lipase accelerates atherosclerosis in transgenic apolipoprotein e knockout mice but not in C57BL/6 mice.
Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions.
Marked neointimal lipoprotein lipase increase in distinct models of proclivity to atherosclerosis: a feature independent of endothelial layer integrity.
Mechanisms of atherogenesis: endothelial hypoxia proposed as the major initiator.
MicroRNA-182 Promotes Lipoprotein Lipase Expression and Atherogenesisby Targeting Histone Deacetylase 9 in Apolipoprotein E-Knockout Mice.
MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
MicroRNA-590 attenuates lipid accumulation and pro-inflammatory cytokine secretion by targeting lipoprotein lipase gene in human THP-1 macrophages.
MicroRNA-590 Inhibits Lipoprotein Lipase Expression and Prevents Atherosclerosis in apoE Knockout Mice.
Mild oxidation of lipoproteins increases their affinity for surfaces covered by heparan sulfate and lipoprotein lipase.
MiR-27 alleviates myocardial cell damage induced by hypoxia/reoxygenation via targeting TGFBR1 and inhibiting NF-?B pathway.
New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis.
No evidence of accelerated atherosclerosis in a 66-yr-old chylomicronemia patient homozygous for the nonsense mutation (Tyr61-->stop) in the lipoprotein lipase gene.
Novel LPL mutation (L303F) found in a patient associated with coronary artery disease and severe systemic atherosclerosis.
On hepatic and extrahepatic postheparin serum lipase activities and the influence of experimental hypercortisolism and diabetes on these activities.
Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice.
Overexpression of lipoprotein lipase improves insulin resistance induced by a high-fat diet in transgenic rabbits.
Overexpression of lipoprotein lipase in transgenic rabbits inhibits diet-induced hypercholesterolemia and atherosclerosis.
Overexpression of lipoprotein lipase in transgenic rabbits leads to increased small dense LDL in plasma and promotes atherosclerosis.
Pathogenic factors in vascular dementia and Alzheimer's disease. Multiple actions of heparin that probably are beneficial.
PdPt nanoparticles anchored on the N-G with the integration of PANI nanohybrids as novel redox probe and catalyst for the detection of rs1801177.
Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis.
Polymorphisms of the lipoprotein lipase gene and premature atherosclerosis.
Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene.
Presence of lipoprotein lipase S447X stop codon affects the magnitude of interleukin 8 release after cardiac surgery with cardiopulmonary bypass.
Pseudocholinesterase and lipoprotein lipase in atherosclerosis.
Recent advances in factors that alter lipid metabolism in chronic renal failure.
Regulating intestinal function to reduce atherogenic lipoproteins.
Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase.
Role of hepatic and lipoprotein lipase in lipoprotein metabolism and atherosclerosis: studies in transgenic and knockout animal models and somatic gene transfer.
Role of lipoprotein lipase and apolipoprotein E secretion by macrophages in modulating lipoprotein uptake. Possible role in acceleration of atherosclerosis in diabetes.
Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis.
Secretion of lipoprotein lipase by macrophages in culture.
Stimulatory effect of glucose on macrophage lipoprotein lipase expression and production.
Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase.
Synergism between interferon gamma and tumour necrosis factor alpha in the regulation of lipoprotein lipase in the macrophage J774.2 cell line.
Synergism between lipopolysaccharide and interferon gamma in the regulation of lipoprotein lipase in macrophages.
The 3' untranslated region of the lipoprotein lipase gene: haplotype structure and association with post-heparin plasma lipase activity.
The clearing factor and atherosclerosis.
The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models.
The histochemistry of lipoprotein lipase in the normal organism and in atherosclerosis.
The Importance of Lipoprotein Lipase Regulation in Atherosclerosis.
The long non-coding RNA metastasis-associated lung adenocarcinoma transcript-1 regulates CCDC80 expression by targeting miR-141-3p/miR-200a-3p in vascular smooth muscle cells.
The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis.
The pivotal role of lipoprotein lipase in atherosclerosis.
The therapeutic role of very low-density lipoprotein receptor gene in hyperlipidemia in type 2 diabetic rats.
THP-1 macrophage cholesterol efflux is impaired by palmitoleate through Akt activation.
Tissue-specific expression of human lipoprotein lipase in the vascular system affects vascular reactivity in transgenic mice.
Transcriptomic Analysis of THP-1 Macrophages Exposed to Lipoprotein Hydrolysis Products Generated by Lipoprotein Lipase.
Transgenic rabbits expressing human lipoprotein lipase.
Transplant vascular disease: Role of lipids and proteoglycans.
Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: role of peripheral factors.
Very-low-density lipoprotein-induced triglyceride accumulation in human mesangial cells is mainly mediated by lipoprotein lipase.
Which is the Best Predictor for the Development of Atherosclerosis Among Circulating Lipoprotein Lipase, Hepatic Lipase, and Endothelial Lipase?
[Activity of lipoprotein lipase and other lipolytic enzymes in experimental atherosclerosis in rabbits]
[Age characteristics of lipoprotein lipase activity and cholesterol levels in various lipoprotein fractions]
[Blood lipoprotein lipase in normal rabbits and during the development of experimental atherosclerosis and the effect of zinc salts on lipase activity]
[Clearing factor of blood plasma after heparin in relation to atherosclerosis.]
[Effect of nicotinic acid on blood coagulation, blood heparin content and clearing factor in patients with atherosclerosis.]
[Fibrates]
[HEPARIN, LIPOPROTEIN LIPASE AND BLOOD FIBRINOLYTIC ACTIVITY IN PATIENTS WITH ATHEROSCLEROSIS DURING IODINE PREPARATION TREATMENT.]
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
[Lipoprotein lipase (LPL) in the pathogenesis of atherosclerosis]
[Lipoprotein lipase and atherosclerosis.]
[Lipoprotein lipase and atherosclerosis]
[Lipoprotein lipase enzyme activity in persons with atherosclerosis.]
[Lipoprotein lipase fractionation of very low density serum lipoproteins from healthy subjects and persons afflicted with atherosclerosis]
[Lipoprotein lipase gene polymorphism in non-insulin-dependent diabetics: preliminary study]
[Lipoprotein lipase in the blood in obliterating atherosclerosis.]
[On heparin in the blood and clearing factor in atherosclerosis.]
[ON SEMEIOLOGIC AND PHYSIOPATHOLOGIC SIGNIFICANCE OF TESTS OF HEPARIN STIMULATION OF THE CLEARING FACTOR IN ATHEROSCLEROSIS.]
[PREDICTORS OF ATHEROSCLEROSIS: NEW DEVELOPMENTS].
[The significance of proteoglycans in several diseases]
[Views on the pathogenesis of atherosclerosis in connection with the clearing factor in blood coagulation.]
Bacterial Infections
Antimicrobial peptides of an anti-lipopolysaccharide factor, epinecidin-1, and hepcidin reduce the lethality of Riemerella anatipestifer sepsis in ducks.
Bardet-Biedl Syndrome
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Biotinidase Deficiency
Hyperchylomicronaemia due to lipoprotein lipase deficiency as a cause of false-positive newborn screening for biotinidase deficiency.
Bone Resorption
Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats.
Leukemia inhibitory factor: a biological perspective.
Brachydactyly
Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II-receptor gene and the renin loci in man.
Brain Diseases
Severe Familial Hypertriglyceridemia: Successful Treatment With Insulin and a Modified Meal Plan.
Brain Infarction
Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population-based neuropathological study.
Brain Ischemia
Lipoprotein lipase and endothelial lipase expression in mouse brain: regional distribution and selective induction following kainic acid-induced lesion and focal cerebral ischemia.
Breast Neoplasms
Lipoprotein lipase hydrolysis products induce pro-inflammatory cytokine expression in triple-negative breast cancer cells.
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Spot 14: A marker of aggressive breast cancer and a potential therapeutic target.
Tamoxifen inhibits lipoprotein activity: in vivo and in vitro studies.
Bronchopneumonia
Lipoprotein lipase deficiency.
The involvement of polymorphonuclear leukocytes in the pathogenesis of bronchopneumonia in calves. VI. Superoxide dismutase and lipoprotein lipase activities.
Carcinogenesis
Lipoprotein lipase as a candidate target for cancer prevention/therapy.
Carcinoma
Existence of lipoprotein lipase in human sarcomas and carcinomas.
Lipoprotein lipase is frequently overexpressed or translocated in cervical squamous cell carcinoma and promotes invasiveness through the non-catalytic C terminus.
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Reduction of synthetic rate of lipoprotein lipase in adipose tissues of patients with carcinoma.
The biochemical alterations following administration of Kalpaamruthaa and Semecarpus anacardium in mammary carcinoma.
[Elective induction in mice of solid and ascitic carcinoma of the exocrine pancreas by the repeated doses of antibodies against a lipoprotein lipase fraction]
Carcinoma 256, Walker
Low-density lipoproteins and lipoprotein lipase activity in tissues from rats bearing Walker carcinosarcoma 256.
Properties of lipoprotein lipase extracted from livers of normal rats and livers and tumors of rats bearing Walker carcinosarcoma 256.
Carcinoma, Ehrlich Tumor
Changes in lipoprotein lipase activity (LPLA) in tumor cells and tissues in mice bearing Ehrlich ascites tumor.
Release of lipoprotein lipase from Ehrlich ascites tumor produced by an association with a rapid increase in cyclic AMP content.
Stimulatory release of lipoprotein lipase activity with activation of protein tyrosine kinase produced by low molecular weight dextran sulfate in Ehrlich ascites tumor cells.
Carcinoma, Hepatocellular
alpha-Adrenergic receptors may contribute to the hypertriglyceridemia associated with tumour growth.
Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model.
Comparison of the changes in lipid metabolism between hepatoma-bearing and lipopolysaccharide-treated rats.
Effects of sulfur amino acids, L: -methionine, L: -cystine and L: -cysteine on lipoprotein lipase and hormone-sensitive lipase in differentiated mouse 3T3-L1 adipocytes.
Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells.
Lipoprotein lipase expression in undifferentiated hepatoma cells is regulated by progesterone and protein kinase A.
Sequential changes in lipoprotein lipase activity and lipaemia induced by the Yoshida AH-130 ascites hepatoma in rats.
The binding of human lipoprotein lipase treated VLDL by the human hepatoma cell line HepG2.
Carcinoma, Non-Small-Cell Lung
Increased Fatty Acid Synthase Activity in Non-small Cell Lung Cancer Tissue Is a Weaker Predictor of Shorter Patient Survival than Increased Lipoprotein Lipase Activity.
Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival.
Lipoprotein lipase in non-small cell lung cancer tissue is highly expressed in a subpopulation of tumor-associated macrophages.
Reply: Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival.
Carcinoma, Squamous Cell
Lipoprotein lipase is frequently overexpressed or translocated in cervical squamous cell carcinoma and promotes invasiveness through the non-catalytic C terminus.
Carcinosarcoma
Low-density lipoproteins and lipoprotein lipase activity in tissues from rats bearing Walker carcinosarcoma 256.
Properties of lipoprotein lipase extracted from livers of normal rats and livers and tumors of rats bearing Walker carcinosarcoma 256.
Cardiomegaly
Cold acclimation induces physiological cardiac hypertrophy and increases assimilation of triacylglycerol metabolism through lipoprotein lipase.
Endothelial Lipase Modulates Pressure Overload-Induced Heart Failure Through Alternative Pathway for Fatty Acid Uptake.
Ketamine-induced changes in metabolic and endocrine parameters of normal and 2-kidney 1-clip rats.
Cardiomyopathies
Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse.
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy.
Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy.
Perfusion of hearts with triglyceride-rich particles reproduces the metabolic abnormalities in lipotoxic cardiomyopathy.
Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy.
Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.
Cardiomyopathy, Dilated
Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse.
Cardiovascular Diseases
A common mutation in the lipoprotein lipase gene (N291S) alters the lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolemia.
Angiopoietin-like Protein 4 Inhibition of Lipoprotein Lipase: EVIDENCE FOR REVERSIBLE COMPLEX FORMATION.
ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins.
Association between lipoprotein lipase gene polymorphisms and cardiovascular disease risk factors in European adolescents: The Healthy Lifestyle in Europe by Nutrition in Adolescence study.
Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels.
Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene.
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance.
Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics.
DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene.
Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases.
Ethanol consumption affects lipoprotein lipase gene expression in C57BL/6 mice.
Functional variants in the lipoprotein lipase gene and risk cardiovascular disease.
Genetic polymorphisms and lipoprotein responses to diets.
Interaction Effects of Lipoprotein Lipase Polymorphisms with Lifestyle on Lipid Levels in a Korean Population: A Cross-sectional Study.
Lipoprotein lipase 1595 c/g and hepatic lipase -480 c/t polymorphisms--impact on lipid profile in incident dialysis patients.
Lipoprotein lipase and atherosclerosis.
Lipoprotein lipase deficiency--rare or common?
Lipoprotein lipase gene variants and the effect of environmental factors on cardiovascular disease risk.
Lipoprotein lipase: A bioinformatics criterion for assessment of mutations as a risk factor for cardiovascular disease.
Orlistat response to missense mutations in lipoprotein lipase.
Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia.
Pitavastatin versus Atorvastatin: Potential Differences in their Effects on Serum Lipoprotein Lipase and Cardiovascular Disease.
Simple and rapid real-time monitoring of LPL activity in vitro.
Triglyceride-lowering LPL alleles combined with LDL-C-lowering alleles are associated with an additively improved lipoprotein profile.
Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease.
[Lipoprotein lipase gene mutations and the risk of cardiovascular diseases in children with obesity.]
[Lipoprotein lipase gene polymorphism in non-insulin-dependent diabetics: preliminary study]
Carotid Artery Diseases
Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis.
Carotid Stenosis
Association between well-characterized lipoprotein-related genetic variants and carotid intimal medial thickness and stenosis: The Framingham Heart Study.
Lipoprotein lipase (LPL) gene variation and progression of carotid artery plaque.
Lipoprotein lipase gene polymorphisms in ischaemic stroke and carotid stenosis.
[Associations between Ser447Ter gene polymorphism of lipoprotein lipase and atherosclerotic cerebral infarction]
Cataract
Suppression of hyperlipidemia-associated cataracts in diabetic rats with the lipoprotein lipase activator NO-1886.
Cerebral Hemorrhage
Lipoprotein lipase gene Hind III polymorphism was associated with hemorrhagic stroke.
Relationship between lipoprotein lipase gene polymorphism and hemorrhagic stroke in a Chinese population.
Cerebral Infarction
Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese.
Polymorphisms of the lipoprotein lipase gene are associated with atherosclerotic cerebral infarction in the Chinese.
The D9N, N291S, and T495G Polymorphisms of the Lipoprotein Lipase Gene Are Not Associated with Cerebral Infarction.
[Associations between Ser447Ter gene polymorphism of lipoprotein lipase and atherosclerotic cerebral infarction]
[Effect of intravenous glucose load on post-heparin lipoprotein lipase and hepatic lipase activities in the plasma of patients with cerebral infarction]
Cerebrovascular Disorders
A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovascular disease in women but not in men.
Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population-based neuropathological study.
Cholesteryl ester transfer protein TaqI B and lipoprotein lipase Ser447Ter gene polymorphisms are not associated with ischaemic stroke in Greek patients.
Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism.
Lipoprotein lipase genetic variation and gender-specific ischemic cerebrovascular disease risk.
The D9N, N291S, and T495G Polymorphisms of the Lipoprotein Lipase Gene Are Not Associated with Cerebral Infarction.
Chagas Disease
Lipoprotein lipase in the fat body of Triatoma brasiliensis.
[Activity of lipoprotein lipase in vivo in the chronic form of Chagas' disease]
[Study of plasma lipoprotein lipase activity in chronic Chagas' disease]
Chemical and Drug Induced Liver Injury
[THE BLOOD CLEARING FACTOR IN ACUTE EXPERIMENTAL TOXIC HEPATITIS.]
Cholelithiasis
[Cholelithiasis & the clearing factor.]
Cholera
Cold-induced beta-adrenergic recruitment of lipoprotein lipase in brown fat is due to increased transcription.
Effect of cholera toxin on triacylglycerol lipase activity and triacylglycerol content of rat heart.
Effects of cholera toxin on gene expression in brown preadipocytes differentiating in culture.
Lipoprotein lipase activity in cultured macrophage cell line J774(2) and its increase in variants deficient in adenylate cyclase and cyclic AMP-dependent protein kinase.
Modulation of lipoprotein lipase activity in cultured rat mesenchymal heart cells and preadipocytes by dibutyryl cyclic AMP, cholera toxin and 3-isobutyl-1-methylxanthine.
Modulation of lipoprotein lipase in the intact rat by cholera toxin--an irreversible agonist of cyclic AMP.
Regulation of lipoprotein lipase activity in the sand rat: effect of nutritional state and cAMP modulation.
Regulation of lipoprotein lipase by dibutyryl cAMP, cholera toxin, Hepes and heparin in F1 heart-cell cultures.
Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.
Cholestasis
Depletion of high-density lipoprotein and appearance of triglyceride-rich low-density lipoprotein in a Japanese patient with FIC1 deficiency manifesting benign recurrent intrahepatic cholestasis.
Cholestasis, Intrahepatic
Lipoprotein lipase and lipid profiles in plasma and placenta from normal pregnancies compared with patients with intrahepatic cholestasis of pregnancy.
Cholesterol Ester Storage Disease
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Choline Deficiency
Factors influencing lipoprotein lipase activity in choline deficiency.
Chronic Urticaria
Acquired lipoprotein lipase deficiency associated with chronic urticaria. A new etiology for type I hyperlipoproteinemia.
Chylothorax
Lipoprotein Lipase Deficiency.
Chylous Ascites
Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota.
Coinfection
Generation of a recombinant apolipoprotein E variant with improved biological functions: hydrophobic residues (LEU-261, TRP-264, PHE-265, LEU-268, VAL-269) of apoE can account for the apoE-induced hypertriglyceridemia.
Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
Colitis, Ulcerative
Impact of lipoprotein lipase gene polymorphisms on ulcerative colitis.
Colonic Neoplasms
Changes in activity of lipoprotein lipase, plasma free fatty acids and triglycerides with weight loss in a cachexia model.
Colorectal Neoplasms
A significant role of lipogenic enzymes in colorectal cancer.
Communicable Diseases
Lipoproteins and acute phase response during acute infection. Interrelationships between C-reactive protein and serum amyloid-A protein and lipoproteins.
Congenital Abnormalities
[Congenital defects of post-heparin lipoprotein lipase. Diagnosis of familial combined lipoproteinemia]
Contracture
The genotypic and phenotypic spectrum of PIGA deficiency.
Coronary Artery Disease
Activity and concentration of lipoprotein lipase in post-heparin plasma and the extent of coronary artery disease.
Analysis of gene-environment interaction in coronary artery disease: lipoprotein lipase and smoking as examples.
Analysis of lipoprotein lipase haplotypes reveals associations not apparent from analysis of the constituent loci.
Association between HindIII (rs320) variant in the lipoprotein lipase gene and the presence of coronary artery disease and stroke among the Saudi population.
Association of lipoprotein lipase gene polymorphisms with coronary artery disease among Filipinos.
Association of lipoprotein lipase gene polymorphisms with coronary artery disease.
Association of lipoprotein lipase Hind III and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians.
Association of PvuII polymorphism in the lipoprotein lipase gene with the coronary artery disease in Macedonian population.
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.
Association of Three Lipoprotein Lipase Polymorphisms with Coronary Artery Disease in Chinese and Asian Indians.
Association of two genetic variations of lipoprotein lipase, S447X and Hind III, with coronary artery disease and hypertriglyceridemia.
Associations between
Associations for lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene and coronary artery disease in an Indian population.
Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
Associations of lipoprotein lipase S447X and apolipoprotein E genotypes with low-density lipoprotein subfractions in Turkish patients with coronary artery disease.
Associations of three lipoprotein lipase gene polymorphisms, lipid profiles and coronary artery disease.
Cholesterol ester transfer protein, apolipoprotein E and lipoprotein lipase genotypes in patients with coronary artery disease in the Turkish population.
Circulating lipoprotein profiles are modulated differently by lipoprotein lipase in obese humans.
Clinical significance of preheparin serum lipoprotein lipase mass in coronary vasospasm.
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes.
Common genetic variants of lipoprotein lipase and apolipoproteins AI-CIII that relate to coronary artery disease: a study in Chinese and European subjects.
Common genetic variants of lipoprotein lipase that relate to lipid transport in patients with premature coronary artery disease.
Common variants in the lipoprotein lipase gene in Brazil: association with lipids and angiographically assessed coronary atherosclerosis.
Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels.
Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation.
Detection of missense mutations in the genes for lipoprotein lipase and hepatic triglyceride lipase in patients with dyslipidemia undergoing coronary angiography.
Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans.
Diet and the role of lipoproteins, lipases, and thyroid hormones in coronary lesion growth.
DNA polymorphisms of the lipoprotein lipase gene and their association with coronary artery disease in the saudi population.
Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients.
Enhanced bridging function and augmented monocyte adhesion by lipoprotein lipase N9: insights into increased risk of coronary artery disease in N9 carriers.
Essential role of post-heparin lipoprotein lipase activity and of plasma testosterone in coronary artery disease.
Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease.
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes.
Genetic markers in coronary artery disease in a Russian population.
Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
Genetic variants at the APOE, lipoprotein lipase (LpL), cholesteryl ester transfer protein (CETP), and endothelial nitric oxide (eNOS) genes and coronary artery disease (CAD): CETP Taq1 B2B2 associates with lower risk of CAD in Asian Indians.
Genetic variation at the lipoprotein lipase gene associates with coronary arteriosclerosis.
Genetics, Dyslipidemia, and Cardiovascular Disease: New Insights.
Human lipoprotein lipase HindIII polymorphism in young patients with myocardial infarction.
Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa heart study.
Lack of association of lipoprotein lipase gene polymorphisms with coronary artery disease in the Saudi Arab population.
Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis.
Lipoprotein Lipase (LPL) Polymorphism and the Risk of Coronary Artery Disease: A Meta-Analysis.
Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins.
Lipoprotein lipase and premature coronary artery disease.
Lipoprotein lipase gene mutations in coronary artery disease.
Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study.
Lipoprotein lipase gene polymorphism and lipid profile in coronary artery disease.
Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population.
Lipoprotein lipase gene polymorphisms and blood pressure levels in the Northern Chinese Han population.
Lipoprotein lipase gene polymorphisms in Croatian patients with coronary artery disease.
Lipoprotein lipase gene PvuII polymorphism serum lipids and risk for coronary artery disease: meta-analysis.
Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS).
Lipoprotein Lipase HindIII Intronic Polymorphism in a Subset of Iranian Patients with Late-Onset Alzheimer's Disease.
Lipoprotein lipase HindIII polymorphism influences HDL-cholesterol levels in statin-treated patients with coronary artery disease.
Lipoprotein lipase: gene variants and coronary atherosclerosis.
Metabolism of chylomicron-like emulsions in carriers of the S447X lipoprotein lipase polymorphism.
Plasma concentrations of LPL and LCAT are in putative association with females and alcohol use which are independent negative risk factors for coronary atherosclerosis among Japanese.
Polymorphisms of the lipoprotein lipase gene and premature atherosclerosis.
Potentially protective effects of the Ser447-Ter mutation of the lipoprotein lipase gene against the development of coronary artery disease in Japanese subjects via a beneficial lipid profile.
Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis.
Progression and regression of human coronary atherosclerosis. The role of lipoproteins, lipases and thyroid hormones in coronary lesion growth.
Recent advances in factors that alter lipid metabolism in chronic renal failure.
Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease.
Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians.
Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study.
Serum Triglyceride Lipase Concentrations are Independent Risk Factors for Coronary Artery Disease and In-Stent Restenosis.
Single-nucleotide polymorphisms in the lipoprotein lipase gene associated with coronary heart disease in Chinese.
Synergistic Effect Between Lipoprotein Lipase and Apolipoprotein C3 Genes in Determining the Severity of Coronary Artery Disease.
The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study Group.
The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study.
The Association of Lipoprotein Lipase Genes, HindIII and S447X Polymorphisms With Coronary Artery Disease in Shiraz City.
The common mutations in the lipoprotein lipase gene in Italy: effects on plasma lipids and angiographically assessed coronary atherosclerosis.
The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease.
The S447X variant of lipoprotein lipase gene is inversely associated with severity of coronary artery disease.
The Ser447-Ter mutation of the lipoprotein lipase gene relates to variability of serum lipid and lipoprotein levels in monozygotic twins.
Triglyceride content in remnant lipoproteins is significantly increased after food intake and is associated with plasma lipoprotein lipase.
[Changes in lipoprotein lipase activity in patients with coronary atherosclerosis under the action of therapy with small doses of heparin]
[Clearing factor deficiency in coronary atherosclerosis.]
[Clinical significance of preheparin serum lipoprotein lipase mass in normocholesterolemic patients with coronary artery disease]
[Effect of carbohydrates on the vascular wall, heparin levels and the activity of blood lipoprotein lipase in patients with coronary atherosclerosis]
[STUDY OF THE LIPOPROTEIN LIPASE ACTIVITY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS.]
Coronary Disease
A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study.
A Lipoprotein Lipase Gene Polymorphism Interacts with Consumption of Alcohol and Unsaturated Fat to Modulate Serum HDL-Cholesterol Concentrations.
A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases.
Application of statistical and functional methodologies for the investigation of genetic determinants of coronary heart disease biomarkers: lipoprotein lipase genotype and plasma triglycerides as an exemplar.
Association of lipoprotein lipase gene with coronary heart disease in Sudanese population.
Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population-based neuropathological study.
Associations between lipoprotein lipase gene polymorphisms and insulin resistance in coronary heart disease.
Common genetic determinants of dyslipidemia: the hypertriglyceridemia/low-high-density lipoprotein syndrome.
Detection of missense mutations in the genes for lipoprotein lipase and hepatic triglyceride lipase in patients with dyslipidemia undergoing coronary angiography.
Equivalent binding of wild-type lipoprotein lipase (LPL) and S447X-LPL to GPIHBP1, the endothelial cell LPL transporter.
Functional variants in the lipoprotein lipase gene and risk cardiovascular disease.
Genetic screening of the LPL gene in hypertriglyceridaemic patients.
Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease.
High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
Identification of a common variant in the lipoprotein lipase gene in a large Utah kindred ascertained for coronary heart disease: the -93G/D9N variant predisposes to low HDL-C/high triglycerides.
Kinetics of lipolysis of very low density lipoproteins by lipoprotein lipase. Importance of particle number and noncompetitive inhibition by particles with low triglyceride content.
Lipoprotein lipase activity in patients with combined hyperlipidaemia.
Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids.
Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention.
Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde.
Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies.
Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins.
Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
Meta-analysis of genetic association studies under different inheritance models using data reported as merged genotypes.
Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease: the Veterans Affairs HDL Intervention Trial.
Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men.
Polymorphisms of the human lipoprotein lipase gene: possible association with lipid levels in patients with coronary heart disease in Beijing area.
Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking.
Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiency.
Relationship between a novel polymorphism of lipoprotein lipase gene and coronary heart disease.
Role of candidate genes in the lipid responses to intensified treatment in Type 2 diabetes.
S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies.
Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis.
Single-nucleotide polymorphisms in the lipoprotein lipase gene associated with coronary heart disease in Chinese.
Study of common variants of the apolipoprotein E and lipoprotein lipase genes in patients with coronary heart disease and variable body mass index.
The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.
The S447X polymorphism of lipoprotein lipase: effect on the incidence of premature coronary disease and on plasma lipids.
[Association between variants of lipoprotein lipase and coronary heart disease in a Tunisian population.]
[ESTIMATING THE EFFECTIVENESS OF HYPOLIPIDEMIC THERAPY WITH ROSUVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE DEPENDING ON THE GENOTYPE OF LIPOPROTEIN LIPASE].
[Lipoprotein lipase--physiological and pathophysiological roles of this gene variant in Croatian population]
[Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease]
[Peculiarities of postprandial activity of lipoprotein lipase in coronary heart disease]
Coronary Stenosis
Six lipoprotein lipase gene polymorphisms, lipid profile and coronary stenosis in a Tunisian population.
Coronary Vasospasm
Clinical significance of preheparin serum lipoprotein lipase mass in coronary vasospasm.
Craniopharyngioma
Elevated adipose tissue lipoprotein lipase activity in craniopharyngioma patients.
Cushing Syndrome
Blockade of the glucocorticoid receptor with RU 486: effects in vitro and in vivo on human adipose tissue lipoprotein lipase activity.
Muscle and adipose tissue morphology and metabolism in Cushing's syndrome.
Synthesis of active high mannose-type lipoprotein lipase in human adipose tissues.
[Lipolytic and lipoprotein lipase activity of subcutaneous and visceral adipose tissue in Cushing's syndrome]
Cystic Fibrosis
Association Analyses of Genetic Polymorphisms of GSTM1, GSTT1, NQO1, NAT2, LPL, PRSS1, PSTI, and CFTR With Chronic Alcoholic Pancreatitis in Japan.
Lipoprotein lipase in cystic fibrosis of the pancreas.
Studies on mechanism for decreased lipoprotein lipase in cystic fibrosis of the pancrease.
Deafness
Maternally inherited diabetes and deafness coexists with lipoprotein lipase gene mutation-associated severe hyperlipidemia that was resistant to fenofibrate and atorvastatin, but sensitive to bezafibrate: A case report.
Dementia
Genetic markers to predict polygenic disease.
Genetic markers to predict polygenic disease: a new problem for social genetics.
Potential genetic markers of sporadic Alzheimer's dementia.
Demyelinating Diseases
Lipoprotein Lipase Is a Feature of Alternatively-Activated Microglia and May Facilitate Lipid Uptake in the CNS During Demyelination.
Diabetes Mellitus
A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases.
Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
Association of lipoprotein lipase (LPL) single nucleotide polymorphisms with type 2 diabetes mellitus.
Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families.
Atorvastatin and pravastatin elevated pre-heparin lipoprotein lipase mass of type 2 diabetes with hypercholesterolemia.
Cardiomyocyte VEGF Regulates Endothelial Cell GPIHBP1 to Relocate Lipoprotein Lipase to the Coronary Lumen During Diabetes Mellitus.
Clearing factor, fibrinolysis and blood lipids in diabetes mellitus.
Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus.
Diabetes Mellitus Severity and a Switch From Using Lipoprotein Lipase to Adipose-Derived Fatty Acid Results in a Cardiac Metabolic Signature That Embraces Cell Death.
DNA polymorphism of Pvu II site in the lipoprotein lipase gene in patients with non-insulin dependent diabetes mellitus.
DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus.
Effect of acarbose, an alpha-glucosidase inhibitor, on serum lipoprotein lipase mass levels and common carotid artery intima-media thickness in type 2 diabetes mellitus treated by sulfonylurea.
Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients.
Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus.
Endothelial Heparanase Regulates Heart Metabolism by Stimulating Lipoprotein Lipase Secretion From Cardiomyocytes.
Enhancement of serum lipoprotein lipase mass levels by intensive insulin therapy.
Erythrocyte membrane alterations and plasma lipids in patients with chylomicronemia and in Tangier disease.
Hyperglycemia-induced secretion of endothelial heparanase stimulates a vascular endothelial growth factor autocrine network in cardiomyocytes that promotes recruitment of lipoprotein lipase.
Impact of 1,25(OH) 2 D 3 on TG content in liver of rats with type 2 diabetes.
In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus.
Increased frequency of the lipoprotein lipase 9N allele in adults with Type I (insulin-dependent) diabetes mellitus.
Lipoprotein lipase activity in patients with diabetes mellitus, with and without hyperlipemia.
Lipoprotein lipase activity is stimulated by insulin and dexamethasone in cardiomyocytes from diabetic rats.
Lipoprotein lipase deficiency and transient diabetes mellitus in a neonate.
Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy.
Mutations at the lipoprotein lipase gene locus in subjects with diabetes mellitus, obesity and lipaemia.
Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia.
Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
Potential role of insulin in the clearance of remnant lipoproteins in dysbetalipoproteinaemia.
Regulation of lipoprotein lipase in the diabetic rat.
Response to pioglitazone treatment is associated with the lipoprotein lipase S447X variant in subjects with type 2 diabetes mellitus.
Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes).
Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
Severe hypertriglyceridaemia in diabetic ketoacidosis: clinical and genetic study.
Streptozotocin-induced diabetes decreases mammary gland lipoprotein lipase activity and messenger ribonucleic acid in pregnant and nonpregnant rats.
The HindIII polymorphism in the lipoprotein lipase gene predicts type 2 diabetes risk among Chinese adults.
The relationship between the basal lipolytic and lipoprotein lipase activities in human adipose tissue.
The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome.
[DNA polymorphism of Pvu II site in the lipoprotein lipase gene in patients with type 2 diabetes mellitus]
[Dyslipidemia in diabetes mellitus: significance, diagnosis and treatment]
[Heparin and insulin in the treatment of acute hypertriglyceridemia-induced pancreatitis]
[Lipoprotein lipase, diabetes mellitus and hypertriglyceridemia]
[Reduction of post-heparin lipoprotein lipase activity by acidotic blood pH]
[Serum lipoprotein lipase activity in diabetes mellitus. I. Activity in primary pancreatic diabetes mellitus and diabetes mellitus of contra-regulation]
[Serum lipoprotein lipase activity in diabetes mellitus. II. Hypertriglyceridemia and lipoprotein lipase activity]
Diabetes Mellitus, Type 1
Decreased activity of plasma cholesteryl ester transfer protein in children and adolescents with insulin-dependent diabetes mellitus.
Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM.
Effects of omega-3 fish oils on plasma lipids, lipoprotein composition, and postheparin lipoprotein lipase in women with IDDM.
Elevated Lipoprotein Lipase Activity Does Not Account for the Association Between Adiponectin and HDL in Type 1 Diabetes.
Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus.
Lipoprotein lipase activity is stimulated by insulin and dexamethasone in cardiomyocytes from diabetic rats.
Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II).
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study.
Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy.
Regulation of apolipoprotein A-I-containing lipoproteins in IDDM.
Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes.
Serum lipids and postheparin plasma lipase activity in Japanese children with ketosis-prone diabetes mellitus.
Severe hypertriglyceridaemia in diabetic ketoacidosis: clinical and genetic study.
Severe hypertriglyceridemia, large lipoproteins and protection against atherosclerosis.
The effects of gender and type of diabetes on HDL-cholesterol.
Very low density lipoprotein subfraction abnormalities in IDDM patients: any effect of blood glucose control?
Diabetes Mellitus, Type 2
A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases.
Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.
Alteration in lipoprotein lipase activity bound to triglyceride-rich lipoproteins in the postprandial state in type 2 diabetes.
Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase.
Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Association of high density lipoprotein cholesterol with plasma lipolytic activity and C-peptide concentration in type 2 diabetes.
Association of lipoprotein lipase (LPL) single nucleotide polymorphisms with type 2 diabetes mellitus.
Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes The genetics, outcomes, and lipids in type 2 diabetes (GOLD) study.
Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population.
Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families.
Atherogenic factors in diabetes: the role of lipoprotein metabolism.
Atorvastatin and pravastatin elevated pre-heparin lipoprotein lipase mass of type 2 diabetes with hypercholesterolemia.
C-reactive protein enhances macrophage lipoprotein lipase expression.
Change in skeletal muscle lipoprotein lipase activity in response to insulin/glucose in non-insulin-dependent diabetes mellitus.
Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus.
Decreased release of lipoprotein lipase is associated with vascular endothelial damage in NIDDM patients with microalbuminuria.
Diabetes and plasma lipoproteins in Native Americans. Studies of the Pima Indians.
DNA polymorphism of Pvu II site in the lipoprotein lipase gene in patients with non-insulin dependent diabetes mellitus.
DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus.
Effect of acarbose, an alpha-glucosidase inhibitor, on serum lipoprotein lipase mass levels and common carotid artery intima-media thickness in type 2 diabetes mellitus treated by sulfonylurea.
Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients.
Effects of clofibrate treatment on plasma triglyceride concentration, plasma post-heparin clearing factor lipase (lipoprotein lipase) activity and serum clearing factor lipase activating ability in maturity-onset diabetes.
Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus.
Effects of monounsaturated vs. saturated fat on postprandial lipemia and adipose tissue lipases in type 2 diabetes.
Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM.
Enhancement of serum lipoprotein lipase mass levels by intensive insulin therapy.
Fasting and postprandial adipose tissue LPL and HSL in obesity and type 2 diabetes.
Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance.
Gender differences in the effect of type 2 diabetes on serum lipids, pre-heparin plasma lipoprotein lipase mass and other metabolic parameters in Japanese population.
Glycohemoglobin levels relate to the response of adipose tissue lipoprotein lipase to insulin/glucose in obese non-insulin-dependent diabetes mellitus.
High fat diet modifies the association of lipoprotein lipase gene polymorphism with high density lipoprotein cholesterol in an Asian Indian population.
Impact of 1,25(OH) 2 D 3 on TG content in liver of rats with type 2 diabetes.
Increased VLDL-TG Fatty Acid Storage in Skeletal Muscle in Men With Type 2 Diabetes.
Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone.
Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C.
Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity.
Lipoprotein Lipase Deficiency (R243H) in a Type 2 Diabetes Patient with Multiple Arterial Aneurysms.
Lipoprotein lipase gene variants and progression of nephropathy in hypercholesterolaemic patients with type 2 diabetes.
Lipoprotein lipase links vitamin D, insulin resistance, and type 2 diabetes: a cross-sectional epidemiological study.
Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy.
Micro R-410 Binding Site Single Nucleotide Polymorphism rs13702 in Lipoprotein Lipase Gene is Effective to Increase Susceptibility to Type 2 Diabetes in Iranian Population.
Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families.
Pathogenic mutations of the lipoprotein lipase gene in Chinese patients with hypertriglyceridemic type 2 diabetes.
Pathophysiology of hyperlipidemia in diabetes mellitus.
Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
Postprandial regulation of blood lipids and adipose tissue lipoprotein lipase in type 2 diabetes patients and healthy control subjects.
Pre-heparin lipoprotein lipase mass as a potential mediator in the association between adiponectin and HDL-cholesterol in type 2 diabetes.
Rarity of the Asn291Ser mutation of lipoprotein lipase gene in Japanese NIDDM patients.
Regulation of Mitochondrial Biogenesis by Lipoprotein Lipase in Muscle of Insulin-Resistant Offspring of Parents With Type 2 Diabetes.
Relationship among urinary albumin excretion rate, lipoprotein lipase PvuII polymorphism and plasma fibrinogen in type 2 diabetic patients.
Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes.
Response to pioglitazone treatment is associated with the lipoprotein lipase S447X variant in subjects with type 2 diabetes mellitus.
Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes.
The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
The association of the R219K polymorphism in the ATP-binding cassette transporter 1 ( ABCA1) gene with coronary heart disease and hyperlipidaemia.
The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1? signalling pathway.
The effect of insulin sensitizer, troglitazone, on lipoprotein lipase mass in preheparin serum.
The effects of gender and type of diabetes on HDL-cholesterol.
The HindIII polymorphism in the lipoprotein lipase gene predicts type 2 diabetes risk among Chinese adults.
The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes.
UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study.
Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: role of peripheral factors.
Why do low-fat high-carbohydrate diets accentuate postprandial lipemia in patients with NIDDM?
[Association of Hind RFLP in lipoprotein lipase gene with type 2 diabetes]
[DNA polymorphism of Pvu II site in the lipoprotein lipase gene in patients with type 2 diabetes mellitus]
[Mutation-function analysis in the lipoprotein lipase gene of Chinese patients with hypertriglyceridemic type 2 diabetes]
[The role of gut microbiota in the pathogenesis of obesity].
Diabetes, Gestational
Decreased concentrations of the lipoprotein lipase inhibitor angiopoietin-like protein 4 and increased serum triacylglycerol are associated with increased neonatal fat mass in pregnant women with gestational diabetes mellitus.
Placental lipoprotein lipase DNA methylation alterations are associated with gestational diabetes and body composition at 5 years of age.
Placental lipoprotein lipase DNA methylation levels are associated with gestational diabetes mellitus and maternal and cord blood lipid profiles.
Relationship between a lipoprotein lipase gene polymorphism in placental tissue and insulin resistance in patients with gestational diabetes mellitus.
[TOTAL PARENTERAL NUTRITION IN A PREGNANT PATIENT WITH ACUTE PANCREATITIS AND LIPOPROTEIN LIPASE DEFICIENCY].
Diabetic Cardiomyopathies
Lipoprotein lipase mediated fatty acid delivery and its impact in diabetic cardiomyopathy.
Diabetic Nephropathies
Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to diabetic nephropathy.
High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy.
Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genétique de la Nephropathie Diabétique Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Résistance Study Group.
Diabetic Neuropathies
Insulin-induced upregulation of lipoprotein lipase in Schwann cells during diabetic peripheral neuropathy.
Dwarfism
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Dyslipidemias
A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases.
Abnormality of hepatic triglyceride metabolism in ApcMin/+ mice with colon cancer cachexia.
Acute dyslipoproteinemia induced by interleukin-2: lecithin:cholesteryl acyltransferase, lipoprotein lipase, and hepatic lipase deficiencies.
Acute lipoprotein lipase deletion in adult mice leads to dyslipidemia and cardiac dysfunction.
Angelica acutiloba Root Attenuates Insulin Resistance Induced by High-Fructose Diet in Rats.
Angiopoietin-like proteins in atherosclerosis.
Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Association between the lipoprotein lipase rs1534649 gene polymorphism in intron one with Body Mass Index and High Density Lipoprotein-Cholesterol.
Association of lipoprotein lipase Hind III and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians.
Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene.
Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families.
Association of the lipoprotein lipase gene T+495G polymorphism with central obesity and serum lipids in a twin study.
Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivo.
Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia.
Common genetic determinants of dyslipidemia: the hypertriglyceridemia/low-high-density lipoprotein syndrome.
Contribution of ApoCIII to Diabetic Dyslipidemia and Treatment With Volanesorsen.
Detection of missense mutations in the genes for lipoprotein lipase and hepatic triglyceride lipase in patients with dyslipidemia undergoing coronary angiography.
Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism.
Dyslipidemias associated with heterozygous lipoprotein lipase mutations in the French-Canadian population.
Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome.
Effects of Weight Loss on Lipid Transfer Proteins in Morbidly Obese Women.
Efficient adenovirus-mediated ectopic gene expression of human lipoprotein lipase in human hepatic (HepG2) cells.
Endothelial lipase and the metabolic syndrome.
Gender-related relation between metabolic syndrome and S447X and HindIII polymorphisms of lipoprotein lipase gene in northern Iran.
Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesity.
Human lipoprotein lipase deficiency: does chronic dyslipidemia lead to increased oxidative stress and mitochondrial DNA damage in blood cells?
Identification of a common variant in the lipoprotein lipase gene in a large Utah kindred ascertained for coronary heart disease: the -93G/D9N variant predisposes to low HDL-C/high triglycerides.
Incidence of lipoprotein lipase genotype for premature termination codon (Ser447-Ter) in Japanese, and association with dyslipoproteinemia.
Inflammation increases plasma angiopoietin-like protein 4 in patients with the metabolic syndrome and type 2 diabetes.
Lipoprotein lipase as a therapeutic target for dyslipidemia.
Lipoprotein Lipase Deficiency Arising in Type V Dyslipidemia.
Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population.
Lipoprotein lipase gene polymorphisms and risks of childhood obesity in Chinese preschool children.
Malnutrition causing neonatal dyslipidemia.
Maternally inherited diabetes and deafness coexists with lipoprotein lipase gene mutation-associated severe hyperlipidemia that was resistant to fenofibrate and atorvastatin, but sensitive to bezafibrate: A case report.
Mechanisms of dyslipoproteinemias in systemic lupus erythematosus.
Medicinal plants in treatment of hypertriglyceridemia: A review based on their mechanisms and effectiveness.
Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4.
New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk.
Novel aspects of PCSK9 and lipoprotein receptors in renal disease-related dyslipidemia.
Pathogenesis of dyslipoproteinemia in renal insufficiency: the role of lipoprotein lipase and hepatic lipase.
Preventive effect of diabegon, a polyherbal preparation, during progression of diabetes induced by high-fructose feeding in rats.
Preventive effect of small-leaved Kuding tea (Ligustrum robustum) on high-diet-induced obesity in C57BL/6J mice.
Progress of research on dyslipidemia accompanied by nephrotic syndrome.
Suppression of up-regulated LXR? by silybin ameliorates experimental rheumatoid arthritis and abnormal lipid metabolism.
The common mutations in the lipoprotein lipase gene in Italy: effects on plasma lipids and angiographically assessed coronary atherosclerosis.
The genotypic and phenotypic spectrum of PIGA deficiency.
The Ser447-Ter mutation of the lipoprotein lipase gene relates to variability of serum lipid and lipoprotein levels in monozygotic twins.
The structure of helical lipoprotein lipase reveals an unexpected twist in lipase storage.
The translational regulation of lipoprotein lipase in diabetic rats involves the 3'-untranslated region of the lipoprotein lipase mRNA.
Vitamin D deficiency serves as a precursor to stunted growth and central adiposity in zebrafish.
Water-Based Aerobic Training Successfully Improves Lipid Profile of Dyslipidemic Women: A Randomized Controlled Trial.
[Association between serum lipoprotein lipase level and dyslipidemia in patients with obstructive sleep apnea syndrome].
[Dyslipidemia in diabetes mellitus: significance, diagnosis and treatment]
[Dyslipoproteinemias in Quebec: primary deficit in lipoprotein lipase and familial hypercholesterolemia]
[Polymorphisms of lipoprotein lipase gene and their participation in metabolic processes].
[PREDICTORS OF ATHEROSCLEROSIS: NEW DEVELOPMENTS].
[The association of S447X and Hind III polymorphism in the lipoprotein lipase gene with dyslipidemia of the metabolic syndrome in patients with essential hypertension]
Encephalomalacia
[Lipoprotein lipase activity in serum of patients with encephalomalacia]
Endometrial Neoplasms
Effects of high dose progestin on serum lipids and lipid metabolizing enzymes in patients with endometrial cancer.
Endotoxemia
Nonalcoholic Fatty Liver Disease and the Gut Microbiome.
Epilepsy
LncRNAs expression signatures of human brain arteriovenous malformation revealed by microarray.
[Lipoprotein lipase expression in the hippocampus and its effects on vitamin E levels in rats with epilepsy]
Erectile Dysfunction
Downregulated lncRNA-MIAT confers protection against erectile dysfunction by downregulating lipoprotein lipase via activation of miR-328a-5p in diabetic rats.
Essential Hypertension
A study of lipoprotein lipase gene intron 8 polymorphisms in Chinese Han race essential hypertension patients.
Linkage analysis of five candidate genes and essential hypertension in 106 Chinese nuclear families.
Lipoprotein lipase gene is in linkage with blood pressure phenotypes in Chinese pedigrees.
The S447X polymorphism of the lipoprotein lipase gene is associated with lipoprotein lipid and blood pressure levels in Chinese patients with essential hypertension.
[The association of S447X and Hind III polymorphism in the lipoprotein lipase gene with dyslipidemia of the metabolic syndrome in patients with essential hypertension]
[The behavior of lipoprotein lipase in essential hypertension.]
Fatty Liver
A case of non-alcoholic steatohepatitis complicated with severe acute pancreatitis induced by decreased lipoprotein lipase and hepatic triglyceride lipase activity levels in a young Japanese woman.
Angiopoietin-like protein 4 deficiency augments liver fibrosis in liver diseases such as nonalcoholic steatohepatitis in mice through enhanced free cholesterol accumulation in hepatic stellate cells.
Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease.
Chrysanthemum morifolium extract attenuates high-fat milk-induced fatty liver through peroxisome proliferator-activated receptor ?-mediated mechanism in mice.
Dietary chitosan improves hypercholesterolemia in rats fed high-fat diets.
Effects of long-term high-sucrose and dexamethasone on fat depots, liver fat, and lipid fuel fluxes through the retroperitoneal adipose tissue and splanchnic area in rats.
Effects of total parenteral nutrition on lipid metabolism in rats.
Fatty liver in dairy cows post partum is associated with decreased concentration of plasma triacylglycerols and decreased activity of lipoprotein lipase in adipocytes.
Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis.
Lipoprotein lipase activator NO-1886 improves fatty liver caused by high-fat feeding in streptozotocin-induced diabetic rats.
Lipoprotein Lipase Expression in Livers of Morbidly Obese Patients Could be Responsible for Liver Steatosis.
Loss of the lipoprotein lipase activating ability of rat serum after administration of some fatty liver inducing drugs.
Molecular Mechanism of Age-Specific Hepatic Lipid Accumulation in PPARalpha (+/-):LDLR (+/-) Mice, an Obese Mouse Model.
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
On the mechanism of protective action of cold acclimatization against carbon tetrachloride- and ethionine-induced fatty liver.
Prevention Mechanism of 2,3,5,4'-Tetrahydroxy-stilbene-2-O-?-D-glucoside on Lipid Accumulation in Steatosis Hepatic L-02 Cell.
Pyrazinamide alleviates rifampin-induced steatohepatitis in mice by regulating the activities of cholesterol-activated 7?-hydroxylase and lipoprotein lipase.
The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities.
Fatty Liver, Alcoholic
Hepatic lipogenesis and mobilization of peripheral fats in the formation of alcoholic fatty liver.
Fetal Death
Potential of essential fatty acid deficiency with extremely low fat diet in lipoprotein lipase deficiency during pregnancy: A case report.
Fibrosarcoma
Effect of intralipid infusion on serum high- and low-density lipoprotein cholesterol, lecithin:cholesterol acyltransferase, and lipoprotein lipase in tumor-bearing rats.
Friedreich Ataxia
Plasma lipoprotein lipase and hepatic lipase activities in Friedreich's ataxia.
Gallstones
[Changes of lipoprotein lipase and hepatic lipase and their significance in gallstone formation in rabbit model]
[Relationship of gallstone formation after radical gastrectomy with the polymorphisms of apolipoprotein B Xba I and lipoprotein lipase Hind III gene]
Gastrointestinal Neoplasms
Tumor-associated metabolic alterations in patients with gastric and esophageal cancer.
Genetic Diseases, Inborn
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.
Cell therapy could be a potential way to improve lipoprotein lipase deficiency.
Cognitive impairment and polidistrectual atherosclerotic disease in chylomicronemia syndrome: A case report.
Development of a direct DNA sequencing method for detecting heterozygous mutations of the human lipoprotein lipase gene.
Encephalopathy in type I hyperlipidemia.
Familial chylomicronemia syndrome.
Familial lipoprotein lipase deficiency: a case of compound heterozygosity of a novel duplication (R44Kfs*4) and a common mutation (N291S) in the lipoprotein lipase gene.
JCL Roundtable: Hypertriglyceridemia due to defects in lipoprotein lipase function.
Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis.
Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.
Prevalence, geographical distribution and genealogical investigations of mutation 188 of lipoprotein lipase gene in the French Canadian population of Québec.
Serum HDL-C values: An extremely useful marker for differentiating homozygous lipoprotein lipase deficiency from severe hypertriglyceridemia with other causes in Japan: A meta-analysis based on literatures on Japanese homozygous lipoprotein lipase deficiency.
Severe hypertriglyceridemia in Japan: Differences in causes and therapeutic responses.
Targeting APOC3 in the familial chylomicronemia syndrome.
The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study.
The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study.
The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.
[Chylomicronemia syndrome]
Glioma
Lipoprotein lipase and phospholipid transfer protein overexpression in human glioma cells and their effect on cell growth, apoptosis, and migration.
Glomerulonephritis
Tissue lipoprotein lipase, serum, and urinary lipids and lipoproteins in experimental glomerulonephritis of rats (Heymann's nephritis).
[Lipoprotein lipase activity of the blood in chronic glomerulonephritis patients]
Glomerulosclerosis, Focal Segmental
Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis.
Protein restriction and AST-120 improve lipoprotein lipase and VLDL receptor in focal glomerulosclerosis.
Glucose Intolerance
Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal.
Comparison of the effect of bezafibrate on improvement of atherogenic lipoproteins in Japanese familial combined hyperlipidemic patients with or without impaired glucose tolerance.
Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
Familial dyslipidaemic hypertension and other multiple metabolic syndromes.
Studies of lipids, lipoproteins, and apolipoproteins in Menkes' disease.
Glycogen Storage Disease
A Novel Lipoprotein Lipase Mutation in an Infant With Glycogen Storage Disease Type-Ib and Severe Hypertriglyceridemia.
Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I.
In vitro remodelling of plasma lipoproteins in whole plasma by lipoprotein lipase in primary and secondary hypertriglyceridaemia.
The activity of hepatic lipase and lipoprotein lipase in glycogen storage disease: evidence for a circulating inhibitor of postheparin lipolytic activity.
Glycogen Storage Disease Type I
Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I.
In vitro remodelling of plasma lipoproteins in whole plasma by lipoprotein lipase in primary and secondary hypertriglyceridaemia.
Goiter
[On the behavior of the clearing factor in patients of hyperfunctioning goiters before and after surgical intervention.]
Gout
Decreased activities of lipoprotein lipase and hepatic triglyceride lipase in patients with gout.
Postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities in gout.
Postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities in patients with primary asymptomatic gout.
Study on lipoprotein lipase and hepatic triglyceride lipase activities in patients with gout.
Hearing Loss, Mixed Conductive-Sensorineural
The genotypic and phenotypic spectrum of PIGA deficiency.
Heart Defects, Congenital
[Lipid metabolism in congenital heart diseases. 2. Lipase activity of the feces, lipoprotein lipase activity in the blood and various serum lipid fractions]
Heart Diseases
A preliminary study of single nucleotide polymorphisms of lipoprotein lipase gene in coronary atherosclerotic heart disease.
Cardiac lipoprotein lipase: metabolic basis for diabetic heart disease.
Lipoprotein lipase and angiopoietin-like 4 - Cardiomyocyte secretory proteins that regulate metabolism during diabetic heart disease.
PLASMA LIPOPROTEIN LIPASE ACTIVITY IN ISCHAEMIC HEART DISEASE.
Post heparin lipoprotein lipase activity in patients of ischaemic heart disease and in controls.
Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers.
The lipoprotein lipase gene HindIII polymorphism is associated with lipid levels in early-onset type 2 diabetic patients.
[Frequent mutation doubles the risk of ischemic heart disease in women]
[Some peculiarities of the activity of postheparin lipoprotein lipase and parameters of lipid metabolism at ischaemic heart disease]
Heart Failure
Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy.
Myocardial lipoprotein lipase levels in hamsters with congestive heart failure.
Hematologic Diseases
[Behavior of the clearing factor in some blood diseases.]
Hemophilia B
Developing immunologically inert adeno-associated virus (AAV) vectors for gene therapy: possibilities and limitations.
Hemorrhagic Stroke
Lipoprotein lipase gene Hind III polymorphism was associated with hemorrhagic stroke.
Relationship between lipoprotein lipase gene polymorphism and hemorrhagic stroke in a Chinese population.
Hepatitis
Lipoprotein lipase and hepatic lipase deficiencies associated with impaired chylomicron clearance in D-(+) galactosamine hepatitis.
The effect of lipoprotein lipase and hepatic lipase on the electrophoretic mobility of lipoprotein-X.
Triglyceride lipases in acute hepatitis.
Hepatitis A
[Blood clearing factor in infectious hepatitis]
Hepatitis C
Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins.
Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry.
Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.
Virolytic action of lipoprotein lipase on hepatitis C virus in human sera.
Hepatitis C, Chronic
Effects of interferon-beta on plasma lipid and lipoprotein composition and post-heparin lipase activities in patients with chronic hepatitis C.
The Correlation between miR-122 and Lipoprotein Lipase Expression in Chronic Hepatitis C Patients.
Hepatitis, Chronic
The effect of lipoprotein lipase and hepatic lipase on the electrophoretic mobility of lipoprotein-X.
[On lipoprotein lipase activity, serum lipids and the effect of heparin on the blood sugar level in atrophic liver cirrhosis and chronic hepatitis]
Hepatomegaly
Lipoprotein Lipase Deficiency in an Infant With Chylomicronemia, Hepatomegaly, and Lipemia Retinalis.
HIV-Associated Lipodystrophy Syndrome
Effect of extended-release niacin on hormone-sensitive lipase and lipoprotein lipase in patients with HIV-associated lipodystrophy syndrome.
Homozygous Familial Hypercholesterolemia
Gene therapy for dyslipidemia: clinical prospects.
Gene-based therapies in lipidology: current status and future challenges.
Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia.
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
hormone-sensitive lipase deficiency
Hormone-sensitive lipase deficiency in mice changes the plasma lipid profile by affecting the tissue-specific expression pattern of lipoprotein lipase in adipose tissue and muscle.
Hyperaldosteronism
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
Hypercholesterolemia
Atorvastatin and pravastatin elevated pre-heparin lipoprotein lipase mass of type 2 diabetes with hypercholesterolemia.
Decreased Efficiency of Very-Low-Density Lipoprotein Lipolysis Is Linked to Both Hypertriglyceridemia and Hypercholesterolemia, but It Can Be Counteracted by High-Density Lipoprotein.
Dyslipidemia and cardiovascular health in childhood nephrotic syndrome.
Effects of dietary methionine and cystine on lipid metabolism in hepatoma-bearing rats with hyperlipidemia.
Effects of probucol and pravastatin on plasma lipids, activities of postheparin lipoprotein lipase, and lecithin cholesterol acyltransferase and apo A-I containing lipoproteins with and without apo A-II in patients with moderate hypercholesterolemia.
Exercise Increases Lipoprotein Lipase in the Porcine Heart, Even During Hypercholesterolemia: 66: 1:10 PM-1:35 PM.
Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease.
Inhibition of miR-27b Regulates Lipid Metabolism in Skeletal Muscle of Obese Rats During Hypoxic Exercise by Increasing PPAR? Expression.
Mutations in the gene for lipoprotein lipase. A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia.
Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia.
Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia.
Overexpression of lipoprotein lipase in transgenic rabbits inhibits diet-induced hypercholesterolemia and atherosclerosis.
Postheparin plasma lipoprotein lipase in copper-deficient rats.
Progress of research on dyslipidemia accompanied by nephrotic syndrome.
Severe hypercholesterolemia in a double heterozygote for lipoprotein lipase deficiency (LPL(Arita)) and apolipoprotein epsilon4: a report of a family with LPL(Arita).
Whole exome sequencing for non-selective pediatric patients with hyperlipidemia.
[Lipids profile in a group of hypothyroid patients vs. treated hypothyroid patients]
[The mechanism of formation of spectrum of nonesterified fatty acids in biological fluids of rabbits with alimentary hypercholesterolemia]
Hyperglycemia
Abnormal lipoprotein metabolism in diabetic nephropathy.
Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886.
Defining the Regulated Secreted Proteome of Rodent Adipocytes upon the Induction of Insulin Resistance.
Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity.
Diabetic hypertriglyceridemia.
Hyperglycemia downregulates total lipoprotein lipase activity in humans.
Hyperglycemia, lipoprotein glycation, and vascular disease.
Ibrolipim attenuates early-stage nephropathy in diet-induced diabetic minipigs: Focus on oxidative stress and fibrogenesis.
Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity.
Pathogenetic mechanisms of the endogenous hypertriglyceridemia in a nonobese rat model.
Hyperinsulinism
A family-based study of hyperinsulinemia and hypertriglyceridemia in heterozygous lipoprotein lipase deficiency.
Alterations in cholesteryl ester transfer, lipoprotein lipase, and lipoprotein composition after combined pancreas-kidney transplantation.
Association of polymorphism genes LPL , ADRB2 , AGT and AGTR1 with risk of hyperinsulinism and insulin resistance in the Kazakh population.
Comparative responsiveness to prolonged hyperinsulinemia between adipose-tissue and mammary-gland lipoprotein lipase activities in pregnant rats.
Contribution of hyperinsulinemia to modulation of lipoprotein lipase activity in the obese Zucker rat.
Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886.
Decreased activity of plasma cholesteryl ester transfer protein in children and adolescents with insulin-dependent diabetes mellitus.
Development of pancreatic and plasma insulin in prenatal and suckling Zucker rats.
Eating behavior disorders in uremia: a question of balance in appetite regulation.
Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus.
Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
Enzymatic and metabolic responses to affluent diet of two diabetes-prone species of spiny mice: Acomys cahirinus and Acomys russatus.
Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.
Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia.
Hyperglycemia downregulates total lipoprotein lipase activity in humans.
Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency.
Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications.
In vivo regulation of adipose tissue lipoprotein lipase in normal rats made hyperinsulinemic and in hyperinsulinemic genetically-obese (fa/fa) rats.
Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus.
Lipoproteins, lipases, and the metabolic cardiovascular syndrome.
Long-term weight cycling in female Wistar rats: effects on metabolism.
Pancreas transplantation modulates reverse cholesterol transport.
Pathogenetic mechanisms of the endogenous hypertriglyceridemia in a nonobese rat model.
Postheparin plasma lipoprotein and hepatic lipase activities in hyperinsulinemic infants of diabetic mothers and in large-for-date infants at birth.
Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery.
Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia.
Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia.
Relationship between common lipoprotein lipase gene sequence variants, hyperinsulinemia, and risk of ischemic heart disease: A population-based study.
Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency. Islet LPL regulates insulin secretion.
The effect of growth hormone administration on lipids and lipoproteins in growth hormone-deficient patients.
Hyperlipidemia, Familial Combined
A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia.
A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.
A non-integrated iPSC line (SDQLCHi042-A) from a boy suffering from familial combined hyperlipidemia with compound heterozygous mutations of lipoprotein lipase gene.
Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome.
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Characterization of apoprotein metabolism and atherogenic lipoproteins during oral isotretinoin treatment.
Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia.
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.
Familial combined hyperlipidemia and abnormal lipoprotein lipase.
Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia.
Higher triglycerides, lower high-density lipoprotein cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes. A preliminary report.
In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies.
Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia.
Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity).
Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia.
Postprandial triglyceride levels in familial combined hyperlipidemia. The role of apolipoprotein E and lipoprotein lipase polymorphisms.
Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease.
Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene.
Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity.
[Management of hypertriglyceridemia in children].
[Progress in the diagnosis of endocrine and metabolic disorders: hyperlipidemia]
[Studies on the heredity and pathogenesis of familial combined hyperlipidemia ("multiple lipoprotein type" hyperlipidemia)]
Hyperlipidemias
A case report of an adult with severe hyperlipidemia during acute lymphocytic leukemia induction therapy successfully treated with plasmapheresis.
A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects.
A compound heterozygote for lipoprotein lipase deficiency, Val69-->Leu and Gly188-->Glu: correlation between in vitro LPL activity and clinical expression.
A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia.
A heterozygous mutation (the codon for Ser447----a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia.
A missense mutation (Ala334-->Thr) in exon 7 of the lipoprotein lipase gene in a case with type I hyperlipidemia.
A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.
A non-integrated iPSC line (SDQLCHi042-A) from a boy suffering from familial combined hyperlipidemia with compound heterozygous mutations of lipoprotein lipase gene.
A novel frameshift mutation in exon 6 (the site of Asn 291) of the lipoprotein lipase gene in type I hyperlipidemia.
Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.
Abnormality of hepatic triglyceride metabolism in ApcMin/+ mice with colon cancer cachexia.
Absence of lipemia clearing factor lipase in human adipose tissue.
Activation of coagulation factor VII during alimentary lipemia.
Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome.
Adrenal and liver in normal and cld/cld mice synthesize and secrete hepatic lipase, but the lipase is inactive in cld/cld mice.
An Infant with Milky Serum and a Rare Mutation.
APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency.
Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Associations of the ABCA1 and LPL Gene Polymorphisms With Lipid Levels in a Hyperlipidemic Population.
Capecitabine-induced severe hypertriglyceridemia: report of two cases.
Characterization of apoprotein metabolism and atherogenic lipoproteins during oral isotretinoin treatment.
Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test.
Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics.
Circulating lipoprotein profiles are modulated differently by lipoprotein lipase in obese humans.
Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia.
Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice.
Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice.
Congenital lipoprotein lipase deficiency and hyperlipemia in the young puppy.
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.
Corn oil, palm oil and butterfat fractions affect postprandial lipemia and lipoprotein lipase in meal-fed rats.
Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886.
Decreased cardiac lipoprotein lipase activity in rats treated chronically with adriamycin.
Decreased expression of murine PPARgamma in adipose tissue during endotoxemia.
Deficiency of the very low-density lipoprotein (VLDL) receptors in streptozotocin-induced diabetic rats: insulin dependency of the VLDL receptor.
Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol.
Diagnostic evaluation of acute pancreatitis in two patients with hypertriglyceridemia.
Dietary fat and postprandial lipids.
Dietary lipemia and the clearing factor.
Differential expression of lipoprotein lipase gene in tissues of the rat model with visceral obesity and postprandial hyperlipidemia.
Distribution of lipoprotein lipase and hepatic lipase between plasma and tissues: effect of hypertriglyceridemia.
Diurnal changes in plasma and liver lipids and lipoprotein lipase activity in heart and adipose tissue in rats fed a high and low fat diet.
Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia.
Effect of eggplant (Solanum melongena) on the metabolic syndrome: A review.
Effect of individual dietary fatty acids on postprandial activation of blood coagulation factor VII and fibrinolysis in healthy young men.
Effect of pancreas transplantation on lipoprotein lipase, postprandial lipemia, and HDL cholesterol.
Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia.
Effects of a liquid high-fat meal on postprandial lipid metabolism in type 2 diabetic patients with abdominal obesity.
Effects of acute hypoxia on human adipose tissue lipoprotein lipase activity and lipolysis.
Effects of hydrochlorothiazide and propranolol treatment on chylomicron metabolism in hypertensive objects.
Effects of low and moderate exercise intensity on postprandial lipemia and postheparin plasma lipoprotein lipase activity in physically active men.
Effects of monounsaturated vs. saturated fat on postprandial lipemia and adipose tissue lipases in type 2 diabetes.
Effects of Spirulina platensis on plasma lipoprotein lipase activity in fructose-induced hyperlipidemic rats.
Effects of sulfur amino acids, L: -methionine, L: -cystine and L: -cysteine on lipoprotein lipase and hormone-sensitive lipase in differentiated mouse 3T3-L1 adipocytes.
Enhancement of cholesteryl ester transfer in plasma by hormone-replacement therapy.
Enhancement of preheparin serum lipoprotein lipase mass by bezafibrate administration.
Factors regulating blood levels of free fatty acids during alimentary lipemia.
Familial combined hyperlipidemia and abnormal lipoprotein lipase.
Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus.
Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia.
Generation of a recombinant apolipoprotein E variant with improved biological functions: hydrophobic residues (LEU-261, TRP-264, PHE-265, LEU-268, VAL-269) of apoE can account for the apoE-induced hypertriglyceridemia.
Gestational hyperlipidemia and acute pancreatitis with underlying partial lipoprotein lipase deficiency and apolipoprotein E3/E2 genotype.
Glucocorticoids and triglyceride transport: effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat.
Heparininduced lipemia clearing factor in rats: role of the pancreas in its production.
Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.
High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.
High density lipoproteins in postprandial lipemia. Relation to sex and lipoprotein lipase activity.
High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase.
Higher triglycerides, lower high-density lipoprotein cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes. A preliminary report.
Human endogenous lipemia clearing factor (active factor).
Human plasma lipoproteins and total parenteral nutrition with intravenous fat emulsion.
Hyperglycemia, lipoprotein glycation, and vascular disease.
HYPERLIPEMIA AND LIPOPROTEIN LIPASE ACTIVITY.
Hyperlipemia in acute pancreatitis. Metabolic studies in a patient and demonstration of abnormal lipoprotein-triglyceride complexes resistant to the action of lipoprotein lipase.
Hyperlipidemia and pancreatitis during pregnancy in two sisters with a mutation in the lipoprotein lipase gene.
Hyperlipidemia in acute lymphoblastic leukemia.
Hyperlipidemia in guinea-pigs induced by ascorbic acid deficiency. The effects of cholesterol, DL-ethionine and aflatoxin.
Hyperlipidemia in renal failure: studies of plasma lipoproteins, hepatic triglyceride production, and tissue lipoprotein lipase in a chronically uremic rat moedl.
Hyperlipidemia of chronic renal failure.
Hyperlipidemia Resulting in Abnormal Density and Signal Intensity of Blood in a Neonate with Lipoprotein Lipase Deficiency.
Hypocholesterolemia and dysregulated production of angiopoietin-like proteins in sickle cell anemia patients.
Hypolipidemic and antioxidant activities of polysaccharides from Rosae Laevigatae Fructus in rats
Hypolipidemic and antioxidant activities of polysaccharides from Rosae Laevigatae Fructus in rats.
Ibrolipim attenuates early-stage nephropathy in diet-induced diabetic minipigs: Focus on oxidative stress and fibrogenesis.
Improved visual function with dietary intervention in a child with lipemia retinalis.
In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
Inhibition of lipoprotein lipase activity by a monoclonal immunoglobulin in autoimmune hyperlipidemia.
Iron deficiency hyperlipidemia in 18-day-old rat pups: effects of milk lipids, lipoprotein lipase, and triglyceride synthesis.
Lipid Nephrotoxicity: New Concept for an Old Disease.
Lipid profiles and lipase activities in children and adolescents with chronic renal failure treated conservatively or with hemodialysis or transplantation.
Lipid-lowering effects of Zanthoxylum schinifolium Siebold & Zucc. seed oil (ZSO) in hyperlipidemic rats and lipolytic effects in 3T3-L1 adipocytes.
Lipoprotein lipase activation by red ginseng saponins in hyperlipidemia model animals.
Lipoprotein lipase activity in patients with diabetes mellitus, with and without hyperlipemia.
Lipoprotein lipase activity of human adipose tissue in health and in some diseases with hyperlipidemia as a common feature.
Lipoprotein lipase activity of huuman adipose tissue in different types of hyperlipidemia.
Lipoprotein Lipase Deficiency in an Infant With Chylomicronemia, Hepatomegaly, and Lipemia Retinalis.
Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies.
Lipoprotein lipase in fat-induced hyperlipemia.
LIPOPROTEIN LIPASE INHIBITION IN THE HYPERLIPEMIA OF ACUTE ALCOHOLIC PANCREATITIS.
Lipoprotein lipase is expressed by glomerular mesangial cells.
Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia.
Lipoprotein metabolism in diabetics treated with diet, oral hypoglycemic drug and insulin.
Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia.
Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
Major involvement of mTOR in the PPAR?-induced stimulation of adipose tissue lipid uptake and fat accretion.
Maternally inherited diabetes and deafness coexists with lipoprotein lipase gene mutation-associated severe hyperlipidemia that was resistant to fenofibrate and atorvastatin, but sensitive to bezafibrate: A case report.
Medicinal plants in treatment of hypertriglyceridemia: A review based on their mechanisms and effectiveness.
Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity).
Metabolism of liver triacylglycerols in rats tube-fed a threonine-devoid diet.
Mitigation of alimentary lipemia by postprandial exercise--phenomena and mechanisms.
Moderate exercise, postprandial lipemia, and skeletal muscle lipoprotein lipase activity.
Neonatal hyperlipidemia with pancreatitis: Novel gene mutation of lipoprotein lipase.
Origin and pattern of glucocorticoid-induced hyperlipidemia in rats. Dose-dependent bimodal changes in serum lipids and lipoproteins in relation to hepatic lipogenesis and tissue lipoprotein lipase activity.
Origin of endocrine-metabolic changes in the weanling rat ventromedial syndrome.
Overexpression of lipoprotein lipase in transgenic Watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity.
Pancreas transplantation modulates reverse cholesterol transport.
Pancreatitis in a child with lipemia due to novel lipoprotein lipase mutations.
Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells.
Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats.
Physical activity and postprandial lipidemia: are energy expenditure and lipoprotein lipase activity the real modulators of the positive effect?
Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats.
Platycodi radix beverage ameliorates postprandial lipemia response through lipid clearance of triglyceride-rich lipoprotein: A randomized controlled study in healthy subjects with a high-fat load.
Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia.
Postprandial lipemia and lipoprotein lipase in the rabbit are modified by olive and coconut oil.
Postprandial triglyceride levels in familial combined hyperlipidemia. The role of apolipoprotein E and lipoprotein lipase polymorphisms.
Postprandial triglyceridemia after single dose of alcohol in healthy young men.
PPAR-gamma activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion.
Preheparin serum lipoprotein lipase mass level: the effects of age, gender, and types of hyperlipidemias.
Production of lipemia clearing factor during anaphylactoid shock.
Properties of heparin-produced lipemia clearing factor.
Protective role of L-carnitine and vitamin E on the testis of atherosclerotic rats.
Proteinuria and lipoprotein lipase activity in Miniature Schnauzer dogs with and without hypertriglyceridemia.
Rare variants in the lipoprotein lipase (LPL) gene are common in hypertriglyceridemia but rare in Type III hyperlipidemia.
Reduced adipose tissue lipoprotein lipase responses, postprandial lipemia, and low high-density lipoprotein-2 subspecies levels in older athletes with silent myocardial ischemia.
Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease.
Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia.
Relation of endocrines and clearing factor inhibitors to hyperlipemia in fasted animals.
Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia.
Relationships of lipoprotein lipase and hyperlipemia in pancreatitis.
Severe hyperlipidemia in apolipoprotein E2 homozygotes due to a combined effect of hyperinsulinemia and an SstI polymorphism.
Severe hypertriglyceridemia with plasma inhibitory factor(s) on lipoprotein lipase activity in a patient with a common Ser(447)-Ter LPL mutation.
Sex differences in environmental and genetic factors for hypertension.
Sex-dependent variables in the modulation of postalimentary lipemia.
Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene.
Studies on heparin and lipemia clearing factor; inhibition towards clearing in plasma from normal and atherosclerotic individuals.
Studies on heparin and the lipemia clearing factor. I.
Suppression of hyperlipidemia-associated cataracts in diabetic rats with the lipoprotein lipase activator NO-1886.
The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III hyperlipidemia.
The effect of pancreatectomy in lipoprotein lipase activity: an experimental study in pancreatectomized rats.
The effects of medications used for the management of dyslipidemia on postprandial lipemia.
The environmental and genetic evidence for the association of hyperlipidemia and hypertension.
The impact of the leucine 7 to proline 7 polymorphism of the neuropeptide Y gene on postprandial lipemia and on the response of serum total and lipoprotein lipids to a reduced fat diet.
The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion.
The modulating effect of Persea americana fruit extract on the level of expression of fatty acid synthase complex, lipoprotein lipase, fibroblast growth factor-21 and leptin--A biochemical study in rats subjected to experimental hyperlipidemia and obesity.
The role of cachectin/TNF in the pathogenesis of tuberculosis.
Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity.
Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity.
Vascular and metabolic effects of treatment of combined hyperlipidemia: focus on statins and fibrates.
[ACTIVITY OF LIPOPROTEIN LIPASE AND POSTHEPARIN ESTERASE IN IDIOPATHIC HYPERLIPEMIA.]
[Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome]
[Alimentary lipemia and post-heparin lipoprotein lipase activity (PHLA) in children with dysthyroidism]
[Alimentary lipemia and postheparin activity of lipoprotein lipase in children with malabsorption syndrome]
[Apolipoprotein C-II and C-III anomalies in normolipemic and hyperlipemic patients with chronic kidney failure]
[Determination of total plasma lipoprotein lipase in patients with vascular diseases and hyperlipemia]
[Diagnosis of Secondary Hyperlipidemia due to Diabetes].
[EFFECT OF ALIMENTARY LIPEMIA ON ACTIVATION OF LIPOPROTEIN LIPASE AND POSTHEPARIN ESTERASE.]
[Effect of Astragalus Angelica Mixture on lipoprotein lipase and lecithin cholesterol acyltransferase of nephrotic rats]
[ESTIMATING THE EFFECTIVENESS OF HYPOLIPIDEMIC THERAPY WITH ROSUVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE DEPENDING ON THE GENOTYPE OF LIPOPROTEIN LIPASE].
[HEPARIN CLEARING FACTOR AND NEPHROTIC HYPERLIPEMIA.]
[Heparin-dependency of lipoprotein lipase in idiopathic hyperlipidemia]
[Hyperlipemia and diabetes]
[Hyperlipemia and lipoprotein lipase activity in plasma]
[Hyperlipemia and tumors : post heparin lipase activity of the hamster bearing a malignant lymphoma]
[In vitro inhibition of lipoprotein lipase by a monoclonal immunoglobulin in a case of nephrotic syndrome with hyperlipemia caused by auto-antibodies]
[In vivo effects of triton WR 1339 on plasma lipoproteins and the postheparin activity of lipoprotein lipase and liver triglyceride lipase (triton hyperlipidemia in rabbits)]
[Inhibition of the clearing factor and of pancreatic lipase by the serum of patients with idiopathic hyperlipemia.]
[Lipoproteins, post-heparin lipoprotein lipase and hepatic triglyceride lipase in patients with and without severe hyperlipemia caused by alcoholism]
[Management of hypertriglyceridemia in children].
[Molecular mechanism of wendan tang in prevention of lipid metabolism disorder in adult rats]
[Neonatal hyperlipemia due to lipoprotein lipase deficiency]
[Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease]
[Possibility of New Circulating Atherosclerosis-Related Lipid Markers Measurement in Medical and Complete Medical Checkups: Small Dense Low-Density Lipoprotein Cholesterol and Lipoprotein Lipase].
[Post-heparin lipolytic activity. (III). Lipoprotein lipase and monoglyceride hydrolase activities on hyperlipemia and the organs responsible for their biosynthesis]
[PREDICTORS OF ATHEROSCLEROSIS: NEW DEVELOPMENTS].
[Progress in the diagnosis of endocrine and metabolic disorders: hyperlipidemia]
[Relations of lipoprotein lipase gene polymorphism at Pvu II locus and dietary intervention predisposition in hyperlipidemia population]
[Studies on the heredity and pathogenesis of familial combined hyperlipidemia ("multiple lipoprotein type" hyperlipidemia)]
[The role of lipoprotein lipase in alimentary lipemia.]
Hyperlipoproteinemia Type I
11-year Follow-up in Biliopancreatic Diversion for Recurrent Pancreatitis Due to Lipoprotein Lipase Deficiency.
A 19 year follow-up of a woman with lipoprotein lipase deficiency treated with biliopancreatic diversion.
A 4 basepair deletion in exon 4 of the human lipoprotein lipase gene results in type I hyperlipoproteinemia.
A case of severe acquired hypertriglyceridemia in a 7-year-old girl.
A Chinese patient with recurrent pancreatitis during pregnancy induced by hypertriglyceridemia associated with compound heterozygosity (Glu242Lys and Leu252VaL) in the lipoprotein lipase gene.
A compound heterozygote for lipoprotein lipase deficiency, Val69-->Leu and Gly188-->Glu: correlation between in vitro LPL activity and clinical expression.
A Comprehensive Update on the Chylomicronemia Syndrome.
A family-based study of hyperinsulinemia and hypertriglyceridemia in heterozygous lipoprotein lipase deficiency.
A G----C change at the donor splice site of intron 1 causes lipoprotein lipase deficiency in a southern-Italian family.
A Japanese patient with lipoprotein lipase deficiency homozygous for the Gly188Glu mutation prevalent worldwide.
A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency.
A missense (Asp250----Asn) mutation in the lipoprotein lipase gene in two unrelated families with familial lipoprotein lipase deficiency.
A missense mutation (Trp86----Arg) in exon 3 of the lipoprotein lipase gene: a cause of familial chylomicronemia.
A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries.
A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians.
A mutation in the lipoprotein lipase gene associated with hyperlipoproteinemia type I in mink: studies on lipid and lipase levels in heterozygotes.
A new Italian case of lipoprotein lipase deficiency: a Leu365- > Val change resulting in loss of enzyme activity.
A new mutation in the human lipoprotein lipase gene causing familial hyperchylomicronaemia.
A newly identified lipoprotein lipase (LPL) gene mutation (F270L) in a Japanese patient with familial LPL deficiency.
A newly identified null allelic mutation in the human lipoprotein lipase (LPL) gene of a compound heterozygote with familial LPL deficiency.
A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency.
A novel frameshift mutation in the lipoprotein lipase gene is rescued by alternative messenger RNA splicing.
A novel missense (E163G) mutation in the catalytic subunit of lipoprotein lipase causes familial chylomicronemia.
A novel missense mutation in the C-terminal domain of lipoprotein lipase (Glu410-->Val) leads to enzyme inactivation and familial chylomicronemia.
A novel missense mutation in the gene for lipoprotein lipase resulting in a highly conservative amino acid substitution (Asp180-->Glu) causes familial chylomicronemia (type I hyperlipoproteinemia).
A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome.
A novel substitution at the translation initiator codon (ATG-->ATC) of the lipoprotein lipase gene is mainly responsible for lipoprotein lipase deficiency in a patient with severe hypertriglyceridemia and recurrent pancreatitis.
A pathophysiologic approach to managing hyperlipemia.
A sweet heart: Increased cardiac glucose uptake in patients with lipoprotein lipase deficiency.
Absence of serum-stimulated lipase activity and altered lipid content in milk from a patient with type I hyperlipoproteinaemia.
Accumulation of large VLDL in cyclophosphamide treated rabbits. Relationship with lipoprotein lipase deficiency.
Acquired lipoprotein lipase deficiency associated with chronic urticaria. A new etiology for type I hyperlipoproteinemia.
Acute and chronic pancreatitis in patients with inborn errors of metabolism.
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.
Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity.
Adipose cell size and distribution in familial lipoprotein lipase deficiency.
Adipose Specific Lipoprotein Lipase Deficiency More Profoundly Affects Brown Than White Fat Biology.
Adipose tissue fatty acid composition in humans with lipoprotein lipase deficiency.
Alipogene tiparvovec for the treatment of lipoprotein lipase deficiency.
Alipogene tiparvovec, an adeno-associated virus encoding the Ser(447)X variant of the human lipoprotein lipase gene for the treatment of patients with lipoprotein lipase deficiency.
Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency.
Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency.
Alterations in erythrocyte membrane lipid composition and fluidity in primary lipoprotein lipase deficiency.
Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency.
Amino acid substitution (Ile194----Thr) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands. Support for a multicentric origin.
An essential receptor for adeno-associated virus infection.
An incomplete form of familial lipoprotein lipase deficiency presenting with type I hyperlipoproteinemia.
ApoE enhances lipid uptake by macrophages in lipoprotein lipase deficiency during pregnancy.
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Apolipoprotein C-II deficiency. The role of apolipoprotein C-II in the hydrolysis of triacylglycerol-rich lipoproteins.
Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiency.
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.
Bio F1B hamster: a unique animal model with reduced lipoprotein lipase activity to investigate nutrient mediated regulation of lipoprotein metabolism.
Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro.
C-II anapolipoproteinemia and severe hypertriglyceridemia. Report of a rare case with absence of C-II apolipoprotein isoforms and review of the literature.
Capecitabine-induced severe hypertriglyceridemia: report of two cases.
Cardiovascular Gene Therapy: Past, Present, and Future.
Case series of type III hyperlipoproteinemia in children.
Catalytic triad residue mutation (Asp156----Gly) causing familial lipoprotein lipase deficiency. Co-inheritance with a nonsense mutation (Ser447----Ter) in a Turkish family.
Cell therapy could be a potential way to improve lipoprotein lipase deficiency.
Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study.
Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias.
Clearance defects in primary chylomicronemia: a study of tissue lipoprotein lipase activities.
Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene.
Cognitive impairment and polidistrectual atherosclerotic disease in chylomicronemia syndrome: A case report.
Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia.
Comparison of plasmapheresis with medical apheresis in terms of efficacy and cost in the acute treatment of hypertriglyceridemia in children with lipoprotein lipase deficiency.
Complete paternal isodisomy for chromosome 8 unmasked by lipoprotein lipase deficiency.
Compound heterozygosity for a known (D250N) and a novel (E410K) missense mutation in the C-terminal domain of lipoprotein lipase causes familial chylomicronemia.
Compound heterozygosity for a new (S259G) and a previously described (G188E) mutation in lipoprotein lipase (LpL) as a cause of chylomicronemia. Mutations in brief no. 183. Online.
Compound heterozygosity of Leu252Val and Leu252Arg causing lipoprotein lipase deficiency in a chinese patient with hypertriglyceridemia.
Compound heterozygote for lipoprotein lipase deficiency: Ser----Thr244 and transition in 3' splice site of intron 2 (AG----AA) in the lipoprotein lipase gene.
Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph.
Congenital lipoprotein lipase deficiency and hyperlipemia in the young puppy.
Congenital lipoprotein lipase deficiency in hyperlipemic kitten siblings.
Correction of Feline Lipoprotein Lipase Deficiency with Adeno-Associated Virus Serotype 1-Mediated Gene Transfer of the Lipoprotein Lipase S447X Beneficial Mutation.
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation.
Cost-Effectiveness Analysis of Glybera for The Treatment of Lipoprotein Lipase Deficiency.
Critical review of non-statin treatments for dyslipoproteinemia.
Deceptive hyperbilirubinaemia in a newborn with familial lipoprotein lipase deficiency.
Defective enzyme protein in lipoprotein lipase deficiency.
Demystifying the management of hypertriglyceridaemia.
Detailed analysis of lipolytic enzymes in a Japanese woman of familial lipoprotein lipase deficiency - Effects of pemafibrate treatment.
Detection and characterization of the heterozygote state for lipoprotein lipase deficiency.
Detection of a new compound heterozygote (del G916/G1401A) for lipoprotein lipase deficiency and a comparative haplotype analysis of the mutant lipoprotein lipase gene from Japanese patients.
Detection of mutations in the apolipoprotein CII gene by denaturing gradient gel electrophoresis. Identification of the splice site variant apolipoprotein CII-Hamburg in a patient with severe hypertriglyceridemia.
Developing immunologically inert adeno-associated virus (AAV) vectors for gene therapy: possibilities and limitations.
Development and Optimization of AAV hFIX Particles by Transient Transfection in an iCELLis(®) Fixed-Bed Bioreactor.
Diagnosis and management of type I and type V hyperlipoproteinemia.
Diet-induced atherosclerosis in the domestic cat.
Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome.
Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism.
Dissociation between plasma triglyceride concentration and tissue lipoprotein lipase deficiency in insulin-deficient rats.
Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome.
Effects of exercise and fat ingestion on high density lipoprotein production by peripheral tissues.
Effects of heparin infusion on plasma lipoproteins in subjects with lipoprotein lipase deficiency. Evidence for a role of hepatic endothelial lipase in the metabolism of high-density lipoprotein subfractions in man.
Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice.
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL(S447X)) gene therapy for lipoprotein lipase deficiency: an open-label trial.
Encephalopathy in type I hyperlipidemia.
Eruptive Xanthomas in Lipoprotein Lipase Deficiency.
Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
Evaluation of an HPLC method for LDL-cholesterol determination in patients with various lipoprotein abnormalities in comparison with beta-quantification.
Exchange transfusions for extreme hypertriglyceridemia in a 7-week-old infant with multi-organ failure.
Extreme hypertriglyceridemia, pseudohyponatremia, and pseudoacidosis in a neonate with lipoprotein lipase deficiency due to segmental uniparental disomy.
Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene.
Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity.
Familial chylomicronemia in a nine months old infant.
Familial chylomicronemia syndrome.
Familial chylomicronemia syndrome: a case report.
Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.
Familial dyslipidaemic hypertension and other multiple metabolic syndromes.
Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives.
Familial lipoprotein lipase deficiency caused by known (G188E) and novel (W394X) LPL gene mutations.
Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study.
Familial lipoprotein lipase deficiency: a case of compound heterozygosity of a novel duplication (R44Kfs*4) and a common mutation (N291S) in the lipoprotein lipase gene.
Familial lipoprotein lipase deficiency: abnormal lipoproteins and defective metabolism of low density lipoproteins in cultured human skin fibroblasts.
Frameshift mutation in exon 3 of the lipoprotein lipase gene causes a premature stop codon and lipoprotein lipase deficiency.
Gene polymorphism identified by PvuII in familial lipoprotein lipase deficiency.
Gene therapy for dyslipidemia: clinical prospects.
Gene therapy for genetic lipid disorders: lipoprotein lipase deficiency as a paradigm.
Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice.
Gene therapy for lipoprotein lipase deficiency.
Gene Therapy for Lipoprotein Lipase Deficiency: Working Toward Clinical Application.
Gene therapy for lipoprotein lipase deficiency: working toward clinical application.
Gene Therapy in Lipoprotein Lipase Deficiency: Case Report on the First Patient Treated with Alipogene Tiparvovec Under Daily Practice Conditions.
Gene therapy on demand: site specific regulation of gene therapy.
Gene-based therapies in lipidology: current status and future challenges.
Genealogy and regional distribution of lipoprotein lipase deficiency in French-Canadians of Quebec.
Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies.
Generation of analytic plasma lipoprotein profiles using two prepacked superose 6B columns.
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
Genetic epidemiology of lipoprotein lipase deficiency in Saguenay-Lac-St-Jean (Québec, Canada).
Geographic distribution and genealogy of mutation 207 of the lipoprotein lipase gene in the French Canadian population of Québec.
Gestational hyperlipidemia and acute pancreatitis with underlying partial lipoprotein lipase deficiency and apolipoprotein E3/E2 genotype.
Glucose-stimulated insulin response in non-diabetic patients with lipoprotein lipase deficiency and hypertriglyceridemia.
HDL metabolic activities in a boy with lipoprotein lipase deficiency and his family.
Hemolysis in primary lipoprotein lipase deficiency.
Heterogeneity of primary lipoprotein lipase deficiency.
Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency.
Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.
Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease.
High frequency of lipoprotein lipase deficiency in the Quebec population.
Homozygosity for two point mutations in the lipoprotein lipase (LPL) gene in a patient with familial LPL deficiency: LPL(Asp9-->Asn, Tyr262-->His).
Homozygous deletion of exon 9 causes lipoprotein lipase deficiency: possible intron-Alu recombination.
Homozygous LPL p.Gly188Glu Mutation in a Mexican Girl With Lipoprotein Lipase Deficiency.
Human lipoprotein lipase deficiency: does chronic dyslipidemia lead to increased oxidative stress and mitochondrial DNA damage in blood cells?
Hyperchylomicronaemia due to lipoprotein lipase deficiency as a cause of false-positive newborn screening for biotinidase deficiency.
Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency.
Hyperlipidemia Resulting in Abnormal Density and Signal Intensity of Blood in a Neonate with Lipoprotein Lipase Deficiency.
Hyperlipoproteinemia and multifocal neurologic dysfunction in systemic lupus erythematosus.
Hyperlipoproteinemia type I in a patient with active lipoprotein lipase in adipose tissue and indications of defective transport of the enzyme.
Hyperlipoproteinemias: Part I. Lipoprotein classification and abnormalities.
Hypertriglyceridemia and insulin resistance.
Hypertriglyceridemia associated with thrombocytopenia and lipoprotein lipase deficiency.
Hypertriglyceridemia-induced pancreatitis created by oral estrogen and in vitro fertilization ovulation induction.
Identification of lipoprotein lipase immunoreactive protein in pre- and postheparin plasma from normal subjects and patients with type I hyperlipoproteinemia.
Identification of two separate allelic mutations in the lipoprotein lipase gene of a patient with the familial hyperchylomicronemia syndrome.
IDL, VLDL, chylomicrons and atherosclerosis.
Ile225Thr loop mutation in the lipoprotein lipase (LPL) gene is a de novo event.
Immune Responses to Intramuscular Administration of Alipogene Tiparvovec (AAV1-LPL(S447X)) in a Phase II Clinical Trial of Lipoprotein Lipase Deficiency Gene Therapy.
Improved visual function with dietary intervention in a child with lipemia retinalis.
In vitro remodelling of plasma lipoproteins in whole plasma by lipoprotein lipase in primary and secondary hypertriglyceridaemia.
Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis.
Initial diagnosis of lipoprotein lipase deficiency in a 75-year-old man.
Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency.
Irradiation-induced free cholesterol accumulation in very-low-density lipoproteins. Role of lipoprotein lipase deficiency.
Issues Affecting Quality of Life and Disease Burden in Lipoprotein Lipase Deficiency (Lpld) - First Step Towards a Pro Measure in Lpld.
Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency.
Lipaemia in lipoprotein lipase deficiency.
Lipaemia retinalis in a 29-day-old infant with type 1 hyperlipoproteinaemia.
Lipase deficiencies.
Lipemia retinalis: case report and review of the literature.
Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency.
Lipid and lipoprotein analysis of cats with lipoprotein lipase deficiency.
Lipid-lowering agents.
Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat.
Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations: 75 % are clustered in exons 5 and 6.
Lipoprotein lipase and atherosclerosis.
Lipoprotein Lipase Deficiency (R243H) in a Type 2 Diabetes Patient with Multiple Arterial Aneurysms.
Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice.
Lipoprotein lipase deficiency and transient diabetes mellitus in a neonate.
Lipoprotein Lipase Deficiency Arising in Type V Dyslipidemia.
Lipoprotein lipase deficiency due to a 3' splice site mutation in intron 6 of the lipoprotein lipase gene.
Lipoprotein lipase deficiency due to long-term heparinization presenting as severe hypertriglyceridaemia in pregnancy.
Lipoprotein Lipase Deficiency Impairs Bone Marrow Myelopoiesis and Reduces Circulating Monocyte Levels.
Lipoprotein Lipase Deficiency in an Infant With Chylomicronemia, Hepatomegaly, and Lipemia Retinalis.
Lipoprotein lipase deficiency in an infant.
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.
Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein (ASP) plasma levels.
Lipoprotein lipase deficiency leads to ?-synuclein aggregation and ubiquitin C-terminal hydrolase L1 reduction.
Lipoprotein lipase deficiency presenting with neonatal perianal abscesses.
Lipoprotein lipase deficiency resulting from a nonsense mutation in exon 3 of the lipoprotein lipase gene.
Lipoprotein lipase deficiency with pancreatitis in mink: biochemical characterization and pathology.
Lipoprotein lipase deficiency with visceral xanthomas.
Lipoprotein lipase deficiency.
Lipoprotein Lipase Deficiency.
Lipoprotein lipase deficiency: benefits and limitations of a novel therapeutic surgical approach.
Lipoprotein lipase deficiency: clinical, biochemical and molecular characteristics in three patients with novel mutations in the LPL gene.
Lipoprotein Lipase Deficiency: Diet is the Key!
Lipoprotein lipase secretion by human monocyte-derived macrophages.
Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation.
Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis.
Management of patients with severe hypertriglyceridaemia during pregnancy: report of two cases with familial lipoprotein lipase deficiency.
Management of severe hypertriglyceridemia due to lipoprotein lipase deficiency in children
Management strategy and novel ophthalmological findings in neonatal severe hypertriglyceridemia: a case report and literature review.
Marked changes of lipid levels during puberty in a patient with lipoprotein lipase deficiency.
Maternal expression of functional lipoprotein lipase and effects on body fat mass and body condition scores of mature cats with lipoprotein lipase deficiency.
Mechanisms of atherogenesis: endothelial hypoxia proposed as the major initiator.
Medium- and long-chain triglycerides labeled with 13C: a comparison of oxidation after oral or parenteral administration in humans.
Metabolic surgery for the treatment of hypertriglyceridemia-related pancreatitis due to familial lipoprotein lipase deficiency.
Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia.
Milk and plasma lipid composition in a lactating patient with type I hyperlipoproteinemia.
Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.
Molecular and functional characterization of familial chylomicronemia syndrome.
Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes.
Molecular basis of lipoprotein lipase deficiency in two Austrian families with type I hyperlipoproteinemia.
Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society.
Molecular genetics of apoC-II and lipoprotein lipase deficiency.
Molecular genetics of human lipoprotein lipase deficiency.
Molecular studies on primary lipoprotein lipase (LPL) deficiency. One base deletion (G916) in exon 5 of LPL gene causes no detectable LPL protein due to the absence of LPL mRNA transcript.
Neonatal pancreatitis associated with familial lipoprotein lipase deficiency.
Neuronal Lipoprotein Lipase Deficiency Alters Neuronal Function and Hepatic Metabolism.
New lipid-lowering drugs: an update.
Novel compound heterozygous mutations for lipoprotein lipase deficiency. A G-to-T transversion at the first position of exon 5 causing G154V missense mutation and a 5' splice site mutation of intron 8.
Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review.
Novel therapeutics in hypertriglyceridemia.
Occurrence of idiopathic, familial hyperchylomicronaemia in a cat.
Occurrence of multiple aberrantly spliced mRNAs upon a donor splice site mutation that causes familial lipoprotein lipase deficiency.
Pancreatitis in Hyperlipemic Mink (Mustela Vison).
Partial gene duplication involving exon-Alu interchange results in lipoprotein lipase deficiency.
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.
Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transfer.
Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.
Phenotypic heterogeneity in the extended pedigree of a proband with lipoprotein lipase deficiency.
Phospholipid and cholesteryl ester transfer are increased in lipoprotein lipase deficiency.
Plasma apolipoprotein CII levels in hypertriglyceridemia.
Postheparin plasma lipoprotein lipase activity in heterozygotes of familial lipoprotein lipase deficiency.
Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia.
Potential of AAV vectors in the treatment of metabolic disease.
Potential of essential fatty acid deficiency with extremely low fat diet in lipoprotein lipase deficiency during pregnancy: A case report.
Pregnancy-induced hyperlipoproteinemia: review of the literature.
Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene.
Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent.
Prevalence, geographical distribution and genealogical investigations of mutation 188 of lipoprotein lipase gene in the French Canadian population of Québec.
Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiency.
Prevention of recurrent pancreatitis in familial lipoprotein lipase deficiency with high-dose antioxidant therapy.
Primary hypertriglyceridemia in children and adolescents.
Primary lipoprotein lipase deficiency.
Primary type 1 hyperlipoproteinemia: significance of lipoprotein lipase and hepatic triglyceride lipase activity in heterozygotes of patients with familial lipoprotein lipase deficiency.
Primary type I hyperlipoproteinemia with normal lipoprotein lipase activity.
Progress and challenges in viral vector manufacturing.
Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.
Quantification and genotyping of lipoprotein lipase in patients with diabetic lipaemia.
Recurrent acute and chronic pancreatitis in two brothers with familial chylomicronemia syndrome.
Recurrent missense mutations at the first and second base of codon Arg243 in human lipoprotein lipase in patients of different ancestries.
Reduced cholesteryl ester transfer in plasma of patients with lipoprotein lipase deficiency.
Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency.
Risk factors for coronary artery disease: a study comparing hypercholesterolaemia and hypertriglyceridaemia in angiographically characterized patients.
Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera®).
Scientifically-based strategies for nutrition of the high-risk low birth weight infant.
Serum HDL-C values: An extremely useful marker for differentiating homozygous lipoprotein lipase deficiency from severe hypertriglyceridemia with other causes in Japan: A meta-analysis based on literatures on Japanese homozygous lipoprotein lipase deficiency.
Severe acute necrotizing pancreatitis associated with lipoprotein lipase deficiency in childhood.
Severe hypercholesterolemia in a double heterozygote for lipoprotein lipase deficiency (LPL(Arita)) and apolipoprotein epsilon4: a report of a family with LPL(Arita).
Severe hypertriglyceridaemia and pancreatitis in a patient with lipoprotein lipase deficiency based on mutations in lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) genes.
Severe hypertriglyceridaemia as a result of familial chylomicronaemia: the Cape Town experience.
Severe hypertriglyceridemia associated with pancytopenia and lipoprotein lipase deficiency.
Severe Hypertriglyceridemia in a Newborn with Monogenic Lipoprotein Lipase Deficiency: An Unconventional Therapeutic Approach with Exchange Transfusion.
Severe hypertriglyceridemia in Japan: Differences in causes and therapeutic responses.
Severe hypertriglyceridemia, large lipoproteins and protection against atherosclerosis.
Severe hypertriglyceridemia-related acute pancreatitis.
Severe, gestational, non-familial, non-genetic hypertriglyceridemia.
Siblings with hepatosplenomegaly and lipoprotein lipase deficiency.
Striated muscle gene therapy for the treatment of lipoprotein lipase deficiency.
Successful management of acute pancreatitis due to apolipoprotein C-II deficiency in a 37-day-old infant.
Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase.
Support for founder effect for two lipoprotein lipase (LPL) gene mutations in French Canadians by analysis of GT microsatellites flanking the LPL gene.
Targeting APOC3 in the familial chylomicronemia syndrome.
The burden of familial chylomicronemia syndrome in Canadian patients.
The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study.
The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study.
The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.
The effect of gestational age on intralipid tolerance in newborn infants.
The genotypic and phenotypic spectrum of PIGA deficiency.
The impact of lipoprotein lipase deficiency on health-related quality of life: a detailed, structured, qualitative study.
The molecular defects in lipoprotein lipase deficient patients.
The molecular genetics of pediatric lipid disorders: recent progress and future research directions.
The pathology of an inherited hyperlipoproteinaemia of cats.
The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
The rapidly evolving state of gene therapy.
The role of lecithin: cholesterol acyltransferase in high density lipoprotein3/high density lipoprotein2 interconversion.
The role of patient registries for rare genetic lipid disorders.
The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency.
The ultrastructural pathology of five lipoprotein lipase-deficient cats.
Tocopherol content of adipose tissue from vitamin E-deficient humans.
Transient lipoprotein lipase deficiency with hyperchylomicronemia.
Treatment of primary hypertriglyceridemia states--General approach and the role of extracorporeal methods.
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
Type I hyperlipidaemia caused by lipoprotein lipase deficiency in a nurseling: the role of the clinical laboratory in processing biological samples and contributing to the diagnosis and therapeutic follow-up of patients.
Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride.
Type I hyperlipoproteinemia due to a novel loss of function mutation of lipoprotein lipase, Cys(239)-->Trp, associated with recurrent severe pancreatitis.
Use of plasma lipoprotein lipase activity without heparin injection for detection of homozygous and heterozygous lipoprotein lipase deficiency.
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.
Volanesorsen for treatment of patients with familial chylomicronemia syndrome.
Whole exome sequencing for non-selective pediatric patients with hyperlipidemia.
Xanthoma of bone associated with lipoprotein lipase deficiency.
[A case of neonatal lipoprotein lipase deficiency caused by novel compound heterozygous variants of LPL gene].
[A gene analysis of familial lipoprotein lipase deficiency in China]
[Chylomicronemia syndrome in 45 years old man]
[Chylomicronemia syndrome]
[Familial hyperchylomicronemia with a new mutation of the lipoprotein lipase gene]
[Familial lipoprotein lipase deficiency]
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
[Lipoprotein lipase deficiencies]
[Lipoprotein lipase deficiency due to lipoprotein lipase gene mutations (current overview)]
[Lipoprotein lipase deficiency in 2 young patients (hyperlipoproteinemia type I)]
[Lipoprotein lipase deficiency, familial]
[Lipoprotein lipase deficiency. A familial study]
[Lipoprotein lipase deficiency. Apropos of 2 cases]
[Lipoprotein lipase: a multifunctional enzyme in lipoprotein metabolism]
[Management of hypertriglyceridemia in children].
[Molecular genetics and lipoprotein lipase deficiency]
[Neonatal hyperlipemia due to lipoprotein lipase deficiency]
[Oral contraceptive-induced pancreatitis in the hyperchylomicronemia syndrome]
[Primary hyperchylomicronemia].
[Primary lipoprotein lipase deficiency. Study in Quebec]
[Primary lipoprotein lipase deficiency: clinical and genetic aspects]
Hyperlipoproteinemia Type II
A common mutation in the lipoprotein lipase gene (N291S) alters the lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolemia.
A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemia.
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy.
Generation of analytic plasma lipoprotein profiles using two prepacked superose 6B columns.
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
High density lipoprotein, apoproteins A-I and A-II and postheparin plasma lipolytic enzymes after ileal bypass.
Kinetics of lipolysis of very low density lipoproteins by lipoprotein lipase. Importance of particle number and noncompetitive inhibition by particles with low triglyceride content.
Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.
Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
Macrophage lipoprotein lipase expression is increased in patients with heterozygous familial hypercholesterolemia.
Mutations in the gene for lipoprotein lipase. A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia.
Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiency.
Selective deficiency of hepatic triglyceride lipase in uremic patients.
The effect of etophylline clofibrate on HDL subfractions.
The molecular genetics of pediatric lipid disorders: recent progress and future research directions.
[A study of low density lipoprotein in a patient with hyper-high density lipoprotein cholesterolemia with normal cholesterolester transfer protein]
[Dyslipoproteinemias in Quebec: primary deficit in lipoprotein lipase and familial hypercholesterolemia]
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
[Progress in the diagnosis of endocrine and metabolic disorders: hyperlipidemia]
Hyperlipoproteinemia Type III
Adipose tissue lipoprotein lipase activity in type III hyperlipoproteinemia.
Cholesterol in the plasma very low density lipoprotein fraction in patients with type III hyperlipoproteinemia: analysis of factors which modulate its concentration.
Diagnosis and management of familial dyslipoproteinemia in children and adolescents.
Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.
Generation of analytic plasma lipoprotein profiles using two prepacked superose 6B columns.
Impaired very low density lipoprotein and triglyceride removal in broad beta disease: comparison with endogenous hypertriglyceridemia.
Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-beta-disease) a cause or an effect of increased apolipoprotein E levels?
Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia.
Pregnancy-induced hyperlipoproteinemia: review of the literature.
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
Hyperlipoproteinemia Type IV
A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia.
A newly identified heterozygous lipoprotein lipase gene mutation (Cys239-->stop/TGC972-->TGA; LPLobama) in a patient with primary type IV hyperlipoproteinemia.
Characterization of apoprotein metabolism and atherogenic lipoproteins during oral isotretinoin treatment.
Development of a direct DNA sequencing method for detecting heterozygous mutations of the human lipoprotein lipase gene.
Generation of the induced pluripotent stem cell(iPSC) line (AHQUi001-A) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene.
Higher triglycerides, lower high-density lipoprotein cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes. A preliminary report.
Hyperlipoproteinemias: Part I. Lipoprotein classification and abnormalities.
In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity).
Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families.
No evidence for linkage between familial hypertriglyceridemia and apolipoprotein B, apolipoprotein C-III or lipoprotein lipase genes.
Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.
Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia.
Severe Familial Hypertriglyceridemia: Successful Treatment With Insulin and a Modified Meal Plan.
Severe hypertriglyceridemia-related acute pancreatitis.
Severe, gestational, non-familial, non-genetic hypertriglyceridemia.
The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia.
Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis.
Update on dyslipidemia.
[Alcohol-induced hypertriglyceridemia in subjects with decreased lipoprotein lipase--improvement after cessation of alcohol intake]
[Hyperchylomicronemia and hyperprebetalipoproteinemia. Study of the lipoprotein lipase system]
Hyperlipoproteinemia Type V
Activation of adipose tissue lipoprotein lipase by lipoprotein fractions from normals and patients with type v hyperlipoproteinemia.
APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency.
Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.
Autoimmune severe hypertriglyceridemia induced by anti-apolipoprotein C-II antibody.
Diagnosis and management of familial dyslipoproteinemia in children and adolescents.
Diagnosis and management of type I and type V hyperlipoproteinemia.
Diagnostic evaluation of acute pancreatitis in two patients with hypertriglyceridemia.
Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia.
[Possibility of New Circulating Atherosclerosis-Related Lipid Markers Measurement in Medical and Complete Medical Checkups: Small Dense Low-Density Lipoprotein Cholesterol and Lipoprotein Lipase].
[Primary hyperchylomicronemia].
Hyperlipoproteinemias
A 4 basepair deletion in exon 4 of the human lipoprotein lipase gene results in type I hyperlipoproteinemia.
A case of adolescent hyperlipoproteinemia with xanthoma and acute pancreatitis, associated with decreased activities of lipoprotein lipase and hepatic triglyceride lipase.
A case of severe acquired hypertriglyceridemia in a 7-year-old girl.
A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia.
A mutation in the lipoprotein lipase gene associated with hyperlipoproteinemia type I in mink: studies on lipid and lipase levels in heterozygotes.
A newly identified heterozygous lipoprotein lipase gene mutation (Cys239-->stop/TGC972-->TGA; LPLobama) in a patient with primary type IV hyperlipoproteinemia.
A novel frameshift mutation in the lipoprotein lipase gene is rescued by alternative messenger RNA splicing.
Acquired lipoprotein lipase deficiency associated with chronic urticaria. A new etiology for type I hyperlipoproteinemia.
Activation of adipose tissue lipoprotein lipase by lipoprotein fractions from normals and patients with type v hyperlipoproteinemia.
Adipose tissue lipoprotein lipase activity in type III hyperlipoproteinemia.
An incomplete form of familial lipoprotein lipase deficiency presenting with type I hyperlipoproteinemia.
Autoimmune severe hypertriglyceridemia induced by anti-apolipoprotein C-II antibody.
Catalytic triad residue mutation (Asp156----Gly) causing familial lipoprotein lipase deficiency. Co-inheritance with a nonsense mutation (Ser447----Ter) in a Turkish family.
Cholesterol in the plasma very low density lipoprotein fraction in patients with type III hyperlipoproteinemia: analysis of factors which modulate its concentration.
Clearance defects in primary chylomicronemia: a study of tissue lipoprotein lipase activities.
Congenital lipoprotein lipase deficiency in hyperlipemic kitten siblings.
Correlations between the apoprotein C composition of very-low-density lipoproteins and triglyceridemia in subjects with type IV hyperlipoproteinemia.
Development of a direct DNA sequencing method for detecting heterozygous mutations of the human lipoprotein lipase gene.
Diagnosis and management of familial dyslipoproteinemia in children and adolescents.
Diagnosis and management of type I and type V hyperlipoproteinemia.
Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
Effect of clofibrate on postheparin plasma triglyceride lipase activities in patients with hypertriglyceridemia.
Effect of oral mesoglycan on plasma lipoprotein concentration and on lipoprotein lipase activity in primary hyperlipoproteinemia.
Effect of the apolipoprotein C-II/C-III1 ratio on the capacity of purified milk lipoprotein lipase to hydrolyse triglycerides in monolayer vesicles.
Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.
Heparin-released blood plasma lipoprotein lipase activity in patients with hyperlipoproteinemia.
Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
Hyperlipoproteinemia type I in a patient with active lipoprotein lipase in adipose tissue and indications of defective transport of the enzyme.
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia.
Identification of lipoprotein lipase immunoreactive protein in pre- and postheparin plasma from normal subjects and patients with type I hyperlipoproteinemia.
Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-beta-disease) a cause or an effect of increased apolipoprotein E levels?
Kinetics of lipolysis of very low density lipoproteins by lipoprotein lipase. Importance of particle number and noncompetitive inhibition by particles with low triglyceride content.
Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.
Lipolytic enzymes, metablic syndrome and atherosclerosis (revisiting and revising a 40 years old study).
Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia.
Milk and plasma lipid composition in a lactating patient with type I hyperlipoproteinemia.
Molecular basis of lipoprotein lipase deficiency in two Austrian families with type I hyperlipoproteinemia.
Pancreatitis in Hyperlipemic Mink (Mustela Vison).
Phenotypic heterogeneity in the extended pedigree of a proband with lipoprotein lipase deficiency.
Polymorphism of the gene encoding lipoprotein lipase in thai primary hyperlipoproteinemias.
Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent.
Primary type 1 hyperlipoproteinemia: significance of lipoprotein lipase and hepatic triglyceride lipase activity in heterozygotes of patients with familial lipoprotein lipase deficiency.
Primary type I hyperlipoproteinemia with normal lipoprotein lipase activity.
Purified postheparin plasma lipoprotein lipase in primary hyperlipoproteinemias.
Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis.
Selective deficiency of hepatic triglyceride lipase in uremic patients.
The effect of etophylline clofibrate on HDL subfractions.
The effect of treatment with clofibrate on hepatic triglyceride and lipoprotein lipase activities of post heparin plasma in male patients with hyperlipoproteinemia.
Transient lipoprotein lipase deficiency with hyperchylomicronemia.
Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjogren's syndrome.
Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene.
Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride.
Type I hyperlipoproteinemia due to a novel loss of function mutation of lipoprotein lipase, Cys(239)-->Trp, associated with recurrent severe pancreatitis.
[Alcohol-induced hypertriglyceridemia in subjects with decreased lipoprotein lipase--improvement after cessation of alcohol intake]
[Lipoprotein lipase activity of adipose tissue in various types of primary familial hyperlipoproteinemias]
[Lipoprotein lipase activity of ischemic heart disease patients with different types of hyperlipoproteinemia on the basis of fat loading]
[Lipoprotein lipase and post-heparin esterase activity in primary type IV and V hyperlipoproteinemia]
[Primary hyperchylomicronemia].
[Study on lipoprotein lipase gene Hind III polymorphism in Chinese type IIb hyperlipoproteinemia]
[Type ? hyperlipoproteinemia caused by lipoprotein lipase gene mutation in three Chinese children].
Hyperparathyroidism
Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspects.
Hyperparathyroidism, Secondary
Hyperlipidemia of chronic renal failure.
Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure.
Hyperprolactinemia
Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery.
Hypertension
Analysis of candidate genes in Polish families with obesity.
Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families.
Association of the lipoprotein lipase gene Ser447Ter polymorphism with hypertension and blood pressure variation: evidence from an updated meta-analysis.
Cardiac lipoprotein lipase in the spontaneously hypertensive rat.
Cardiac metabolic compensation to hypertension requires lipoprotein lipase.
Dyslipoproteinemic changes in borderline hypertension.
Effects of long-term therapy with labetalol on lipoprotein metabolism in patients with mild hypertension.
Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
Genetic polymorphism of S447X lipoprotein lipase (LPL) and the susceptibility to hypertension.
Incorporating covariates into multipoint association mapping in the case-parent design.
Investigation of lipoprotein lipase (LPL) as a candidate gene for dyslipidaemic hypertension.
Lipoprotein lipase gene is linked and associated with hypertension in Taiwan young-onset hypertension genetic study.
Lipoprotein lipase gene polymorphisms and blood pressure levels in the Northern Chinese Han population.
Lipoprotein lipase variants associated with an endophenotype of hypertension: hypertension combined with elevated triglycerides.
Meta-based association of the lipoprotein lipase gene S447X variant with hypertension and blood pressure variation.
Multigenic human hypertension: evidence for subtypes and hope for haplotypes.
No association between alpha-adducin 460 polymorphism and essential hypertension in a Japanese population.
No linkage of the lipoprotein lipase locus to hypertension in Caucasians.
Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II-receptor gene and the renin loci in man.
Sex differences in environmental and genetic factors for hypertension.
The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
The environmental and genetic evidence for the association of hyperlipidemia and hypertension.
Variation near the region of the lipoprotein lipase gene and hypertension or blood pressure levels in Chinese.
[Lipoprotein lipase activity and blood lipid fractions in hypertension]
[The role of gut microbiota in the pathogenesis of obesity].
Hyperthyroidism
Adrenergic binding sites and enzyme activities in the heart of hyperthyroid rats.
Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: roles of hepatic lipase and cholesteryl ester transfer protein.
EFFECTS OF HYPERTHYROIDISM, EPINEPHRINE, AND DIET ON HEART LIPOPROTEIN LIPASE ACTIVITY.
Experimental hyperthyroidism in man: effects on plasma lipoproteins, lipoprotein lipase and hepatic lipase.
High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction--effects of treatment.
Lipoprotein lipase in rat lung. Effect of dexamethasone.
Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations.
Tissue lipoprotein lipase in the hyperthyroid rat. Effect of growth and aging.
Treatment of hyperthyroidism: effects on hepatic lipase, lipoprotein lipase, LCAT and plasma lipoproteins.
Hypertriglyceridemia
A Chinese patient with recurrent pancreatitis during pregnancy induced by hypertriglyceridemia associated with compound heterozygosity (Glu242Lys and Leu252VaL) in the lipoprotein lipase gene.
A family-based study of hyperinsulinemia and hypertriglyceridemia in heterozygous lipoprotein lipase deficiency.
A newly identified heterozygous lipoprotein lipase gene mutation (Cys239-->stop/TGC972-->TGA; LPLobama) in a patient with primary type IV hyperlipoproteinemia.
A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.
A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency.
A novel frameshift mutation in the lipoprotein lipase gene is rescued by alternative messenger RNA splicing.
A novel lipoprotein lipase gene missense mutation in Chinese patients with severe hypertriglyceridemia and pancreatitis.
A Novel Lipoprotein Lipase Mutation in an Infant With Glycogen Storage Disease Type-Ib and Severe Hypertriglyceridemia.
A novel nonsense mutation in exon 1 and a transition in intron 3 of the lipoprotein lipase gene.
A novel nonsense mutation in the LPL gene in a Chinese neonate with hypertriglyceridemia.
A novel substitution at the translation initiator codon (ATG-->ATC) of the lipoprotein lipase gene is mainly responsible for lipoprotein lipase deficiency in a patient with severe hypertriglyceridemia and recurrent pancreatitis.
A practical approach to the laboratory diagnosis of dyslipidemia.
A variant primary structure of apolipoprotein C-II in individuals of African descent.
Ability of exercise to inhibit carbohydrate-induced hypertriglyceridemia in rats.
Abnormal lipoprotein lipase in familial exogenous hypertriglyceridemia.
Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents.
Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
Acute lipoprotein lipase deletion in adult mice leads to dyslipidemia and cardiac dysfunction.
Adipose tissue lipoprotein lipase in chronic hemodialysis: role in plasma triglyceride metabolism.
Alcoholic hypertriglyceridemia with decreased activity of lipoprotein lipase and hepatic triglyceride lipase.
Alpha-adrenergic receptors mediate the hypertriglyceridemia induced by endotoxin, but not tumor necrosis factor, in rats.
Alteration of negatively charged residues in the 89 to 99 domain of apoA-I affects lipid homeostasis and maturation of HDL.
An ELISA for quantifying GPIHBP1 autoantibodies and making a diagnosis of the GPIHBP1 autoantibody syndrome.
Anti-TNF treatment does not reverse the abnormalities in lipid metabolism of the obese Zucker rat.
ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen.
ApoE enhances lipid uptake by macrophages in lipoprotein lipase deficiency during pregnancy.
Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.
Apolipoprotein C-II Deficiency with No Rare Variant in the APOC2 Gene.
Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice.
Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin.
Apolipoprotein CIII and diabetes. Is there a link?
Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism.
Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.
Artemisia Iwayomogi Extract Attenuates High-Fat Diet-Induced Hypertriglyceridemia in Mice: Potential Involvement of the Adiponectin-AMPK Pathway and Very Low Density Lipoprotein Assembly in the Liver.
Association of lipoprotein lipase Hind III and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians.
Association of two genetic variations of lipoprotein lipase, S447X and Hind III, with coronary artery disease and hypertriglyceridemia.
Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
Carbohydrate-lipid interactions during gestation and their control by insulin.
Catalytically inactive lipoprotein lipase overexpression increases insulin sensitivity in mice.
Causes of dysregulation of lipid metabolism in chronic renal failure.
Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.
Cell therapy could be a potential way to improve lipoprotein lipase deficiency.
Cellular Glycolysis and The Differential Survival of Lung Fibroblast and Lung Carcinoma Cell Lines.
Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne.
Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation.
Charge-based heterogeneity of human plasma lipoproteins at hypertriglyceridemia: capillary isotachophoresis study.
Cholesterol homeostatic mechanisms in transgenic mice with altered expression of apoproteins A-I, A-II and A-IV.
Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias.
Chylomicron and very low-density lipoprotein apolipoprotein B metabolism: mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia.
Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test.
Chylomicronemia caused by lipoprotein lipase gene mutation related to a hyper-response of insulin secretion to glucose.
Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia.
Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome.
Clinical factors affecting lipid metabolism and optimal dose of heparin in preterm infants on parenteral nutrition.
Combination of apolipoprotein E2 and lipoprotein lipase heterozygosity causes severe hypertriglyceridemia during pregnancy.
Combined (n-3 and n-6) essential fatty deficiency is a potent modulator of plasma lipids, lipoprotein composition, and lipolytic enzymes.
Combined lipase deficiency in the mouse. Evidence of impaired lipase processing and secretion.
Common mutations of the lipoprotein lipase gene and their clinical significance.
Common sequence variant in lipoprotein lipase gene conferring triglyceride response to fibrate treatment.
Comparison of assay methods for selective measurement of plasma lipase. The effect of clofibrate on hepatic and lipoprotein lipase in normals and patients with hypertriglyceridemia.
Comparison of plasmapheresis with medical apheresis in terms of efficacy and cost in the acute treatment of hypertriglyceridemia in children with lipoprotein lipase deficiency.
Compound but non-linked heterozygous p.W14X and p.L279 V LPL gene mutations in a Chinese patient with long-term severe hypertriglyceridemia and recurrent acute pancreatitis.
Compound heterozygosity of Leu252Val and Leu252Arg causing lipoprotein lipase deficiency in a chinese patient with hypertriglyceridemia.
Correction of hypertriglyceridemia and impaired fat tolerance in lipoprotein lipase-deficient mice by adenovirus-mediated expression of human lipoprotein lipase.
Decline of postheparin plasma lipoprotein lipase in acromegalic patients.
Decreased Efficiency of Very-Low-Density Lipoprotein Lipolysis Is Linked to Both Hypertriglyceridemia and Hypercholesterolemia, but It Can Be Counteracted by High-Density Lipoprotein.
Decreased lipoprotein lipase as a risk factor for atypical neuroleptic-induced hypertriglyceridemia.
Decreased release of lipoprotein lipase is associated with vascular endothelial damage in NIDDM patients with microalbuminuria.
Determinants of fasting hypertriglyceridemia in ventromedial hypothalamic obesity in rats.
Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity.
Development of a sensitive ELISA to quantify apolipoprotein CIII in non-human primate serum.
Developmental and pharmacological regulation of apolipoprotein C-II gene expression. Comparison with apo C-I and apo C-III gene regulation.
Diabetic hypertriglyceridemia.
Diagnosis and management of familial dyslipoproteinemia in children and adolescents.
Diagnosis and treatment of severe hypertriglyceridemia.
Diagnostic evaluation of acute pancreatitis in two patients with hypertriglyceridemia.
Diethylaminoethoxyhexestrol causes hypertriglyceridemia in guinea pigs.
Differential modulation of intracellular energetics in A549 and MRC-5 cells.
Distribution of lipoprotein lipase and hepatic lipase between plasma and tissues: effect of hypertriglyceridemia.
Dyslipidemia and cardiovascular health in childhood nephrotic syndrome.
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.
Dysregulation of hepatic fatty acid metabolism in chronic kidney disease.
Effect of improved diabetes control on the expression of lipoprotein lipase in human adipose tissue.
Effect of oxandrolone treatment on the activity of lipoprotein lipase, hepatic lipase and phospholipase A1 of human postheparin plasma.
Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome.
Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridemia.
Effects of dietary methionine and cystine on lipid metabolism in hepatoma-bearing rats with hyperlipidemia.
Effects of intralipid-induced hypertriglyceridemia on plasma high-density lipoprotein metabolism in the cynomolgus monkey.
Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.
Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding.
Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
Effects of two therapeutic dietary regimens on primary chylomicronemia in paediatric age: a retrospective data analysis.
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL(S447X)) gene therapy for lipoprotein lipase deficiency: an open-label trial.
Efficient adenovirus-mediated ectopic gene expression of human lipoprotein lipase in human hepatic (HepG2) cells.
Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level.
Enhanced atherothrombotic formation after oxidative injury by FeCl3 to the common carotid artery in severe combined hyperlipidemic mice.
Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer.
Enhanced lipoprotein lipase secretion from human monocyte-derived macrophages caused by hypertriglyceridemic very low density lipoproteins.
Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertriglyceridemia in renal failure.
Excessive hypertriglyceridemia and pancreatitis in pregnancy. Association with deficiency of lipoprotein lipase.
Exchange transfusions for extreme hypertriglyceridemia in a 7-week-old infant with multi-organ failure.
Extreme hypertriglyceridemia, pseudohyponatremia, and pseudoacidosis in a neonate with lipoprotein lipase deficiency due to segmental uniparental disomy.
Failure of the nonselective beta-blocker propranolol to affect lipoprotein lipase gene expression in the rat.
Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.
Functional importance of apolipoprotein A5 185G in the activation of lipoprotein lipase.
Functional variants of the lipoprotein lipase gene and the risk of preeclampsia among non-Hispanic Caucasian women.
Gene polymorphisms in the Quebec population: a risk to develop hypertriglyceridemia.
Gene Therapy for Lipoprotein Lipase Deficiency: Working Toward Clinical Application.
Gene therapy for lipoprotein lipase deficiency: working toward clinical application.
Genetic markers to predict polygenic disease.
Genetic screening of the lipoprotein lipase gene for mutations in Chinese subjects with or without hypertriglyceridemia.
Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis.
Glucocorticoids and triglyceride transport: effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat.
Glucose-stimulated insulin response in non-diabetic patients with lipoprotein lipase deficiency and hypertriglyceridemia.
Hemorheological abnormalities in lipoprotein lipase deficient mice with severe hypertriglyceridemia.
Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia.
Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease.
Homozygosity for two point mutations in the lipoprotein lipase (LPL) gene in a patient with familial LPL deficiency: LPL(Asp9-->Asn, Tyr262-->His).
Homozygous deletion of exon 9 causes lipoprotein lipase deficiency: possible intron-Alu recombination.
Human apolipoprotein A-II associates with triglyceride-rich lipoproteins in plasma and impairs their catabolism.
Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency.
Hyperlipoproteinemias: Part I. Lipoprotein classification and abnormalities.
Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII.
Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic, Escherichia coli bacteremic, and polymicrobial septic rats.
Hypertriglyceridemia and lipoprotein lipase activity in experimental uremia.
Hypertriglyceridemia associated with thrombocytopenia and lipoprotein lipase deficiency.
Hypertriglyceridemia associated with tumor necrosis factor-alpha in hamster cheek-pouch carcinogenesis.
Hypertriglyceridemia characterized by low-density lipoprotein phenotype and lipoprotein lipase gene mutation.
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia.
Impaired metabolism of high density lipoprotein in uremic patients.
Impaired triacylglycerol catabolism in hypertriglyceridemia of the diabetic, cholesterol-fed rabbit: a possible mechanism for protection from atherosclerosis.
Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.
Increased lipase inhibition in uremia: identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma.
Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.
Inflammation associated with the postprandial lipolysis of triglyceride-rich lipoproteins by lipoprotein lipase.
Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients.
Influence of glucose on production and N-sulfation of heparan sulfate in cultured adipocyte cells.
Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia.
Inhibition of purified human postheparin lipoprotein lipase by beta-adrenergic blockers in vitro.
Initial diagnosis of lipoprotein lipase deficiency in a 75-year-old man.
Insulin action in uremia.
Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese.
Intricacies of the endothelin system in human obesity: role in the development of complications and potential as a therapeutic target.
Iron loading impairs lipoprotein lipase activity and promotes hypertriglyceridemia.
Is the glucocorticoid-induced hypertriglyceridemia in uremic rats caused by decreased tissue lipoprotein lipase activity?
Is the hypertriglyceridemia associated with insulin deficiency caused by decreased lipoprotein lipase activity?
JCL Roundtable: Hypertriglyceridemia due to defects in lipoprotein lipase function.
Leu452His Mutation in Lipoprotein Lipase Gene Transfer Associated with Hypertriglyceridemia in Mice in vivo.
Lipid abnormalities, renal failure, and parathyroid hormone.
Lipid metabolism in pregnancy.
Lipid metabolism in renal failure.
Lipoprotein lipase activity and common gene variants in severely hypertriglyceridemic patients with and without diabetes.
Lipoprotein lipase activity and hypertriglyceridemia in alloxan diabetic rabbits.
Lipoprotein lipase activity in surgical patients: influence of trauma and infection.
Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy.
Lipoprotein lipase and hepatic lipase activity in post-heparin plasma of patients with hypertriglyceridemia.
Lipoprotein lipase and hypertriglyceridemias.
Lipoprotein Lipase Deficiency (R243H) in a Type 2 Diabetes Patient with Multiple Arterial Aneurysms.
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.
Lipoprotein lipase gene polymorphism and lipid profile in patients with hypertriglyceridemia.
Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people.
Lipoprotein Lipase Inhibitor, Nordihydroguaiaretic Acid, Aggravates Metabolic Phenotypes and Alters HDL Particle Size in the Western Diet-Fed db/db Mice.
Lipoprotein lipase mass and activity in severe hypertriglyceridemia.
Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases.
Lipoprotein metabolism in normal and uremic patients.
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation.
Long-term weight cycling in female Wistar rats: effects on metabolism.
LPL gene Pvu II polymorphism and hypertriglyceridemia: a meta-analysis involving 1,640 subjects.
Lpl-C310R mutation is associated with impaired glucose tolerance and endoplasmic reticulum stress in skeletal muscle.
Lycopene amends LPS induced oxidative stress and hypertriglyceridemia via modulating PCSK-9 expression and Apo-CIII mediated lipoprotein lipase activity.
Management of severe hypertriglyceridemia due to lipoprotein lipase deficiency in children
Mechanism of hypertriglyceridemia in Dahl rats.
Medicinal plants in treatment of hypertriglyceridemia: A review based on their mechanisms and effectiveness.
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity.
Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.
Molecular and functional characterization of familial chylomicronemia syndrome.
Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families.
Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes.
Mutations in the lipoprotein lipase gene as a cause of hypertriglyceridemia and pancreatitis in Taiwan.
Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
Newly identified missense mutation reduces lipoprotein lipase activity in Taiwanese patients with hypertriglyceridemia.
Nitric oxide mediates endotoxin-induced hypertriglyceridemia through its action on skeletal muscle lipoprotein lipase.
Novel Combined GPIHBP1 Mutations in a Patient with Hypertriglyceridemia Associated with CAD.
Novel mutations of the lipoprotein lipase gene associated with hypertriglyceridemia in members of type 2 diabetic pedigrees.
On a rabbit hyperlipemia induced by a fungic galactomannane peptide.
Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia.
Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia.
Pathogenetic mechanisms of the endogenous hypertriglyceridemia in a nonobese rat model.
Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency.
Pathophysiology of hyperlipidemia in diabetes mellitus.
Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.
Plasma lipoproteins and lipoprotein lipase in young diabetics with and without ketonuria.
Postheparin plasma lipoprotein lipase in copper-deficient rats.
Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia.
Postprandial lipemia and lipoprotein lipase in the rabbit are modified by olive and coconut oil.
Potential of essential fatty acid deficiency with extremely low fat diet in lipoprotein lipase deficiency during pregnancy: A case report.
Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity.
Progress of research on dyslipidemia accompanied by nephrotic syndrome.
Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.
Proteinuria and lipoprotein lipase activity in Miniature Schnauzer dogs with and without hypertriglyceridemia.
Rare and common variants in LPL and APOA5 in Thai subjects with severe hypertriglyceridemia: A resequencing approach.
Rare LPL gene missense mutation in an infant with hypertriglyceridemia.
Rare novel LPL mutations are associated with neonatal onset lipoprotein lipase (LPL) deficiency in two cases.
Rare variants in the lipoprotein lipase (LPL) gene are common in hypertriglyceridemia but rare in Type III hyperlipidemia.
Recent advances in factors that alter lipid metabolism in chronic renal failure.
Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients.
Recommendations for Severe Hypertriglyceridemia Treatment, are There New Strategies?
Reduced hepatic triglyceride secretion in rats fed docosahexaenoic acid-rich fish oil suppresses postprandial hypertriglyceridemia.
Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids.
Regulation of lipoprotein lipase by glucose in primary cultures of isolated human adipocytes. Relevance to hypertriglyceridemia of diabetes.
Regulation of lipoprotein lipase in the diabetic rat.
Regulation of secretion and enzymatic activity of lipoprotein lipase by C-mannosylation.
Relation of lipoprotein lipase activity in adipose tissue to adipocyte volume and its influence in hypertriglyceridemia pathogenesis.
Relationship of organ lipoprotein lipase activity and ketonuria to hypertriglyceridemia in starved and streptozocin-induced diabetic rats.
Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia.
Resequencing the untranslated regions of the lipoprotein lipase (LPL) gene reveals that variants in microRNA target sequences are associated with triglyceride levels.
Retinoid X receptor gamma-deficient mice have increased skeletal muscle lipoprotein lipase activity and less weight gain when fed a high-fat diet.
Reversal of decreased human adipose tissue lipoprotein lipase and hypertriglyceridemia after treatment of hypothyroidism.
Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes).
RNA Interference Targeting Liver Angiopoietin-Like Protein 3 Protects from Nephrotic Syndrome in a Rat Model Via Amelioration of Pathologic Hypertriglyceridemia.
Role of apolipoproteins, ABCA1 and LCAT in the biogenesis of normal and aberrant high density lipoproteins.
Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy.
Role of protein kinase C in the translational regulation of lipoprotein lipase in adipocytes.
Selective deficiency of hepatic triglyceride lipase in uremic patients.
Sepsis-induced regulation of lipoprotein lipase expression in rat adipose tissue and soleus muscle.
Sequencing of Lipoprotein Lipase Gene in 11 Cases of Chinese Patients with Severe Endogenous Hypertriglyceridemia.
Sequential alterations in tissue lipoprotein lipase, triglyceride secretion rates, and serum tumor necrosis factor alpha during Escherichia coli bacteremic sepsis in relation to the development of hypertriglyceridemia.
Sequential changes in the activities of lipoprotein lipase and lipogenic enzymes during tumor growth in rats.
Serum HDL-C values: An extremely useful marker for differentiating homozygous lipoprotein lipase deficiency from severe hypertriglyceridemia with other causes in Japan: A meta-analysis based on literatures on Japanese homozygous lipoprotein lipase deficiency.
Severe hypertriglyceridemia associated with pancytopenia and lipoprotein lipase deficiency.
Severe Hypertriglyceridemia due to a novel p.Q240H mutation in the Lipoprotein Lipase gene.
Severe hypertriglyceridemia due to two novel loss-of-function lipoprotein lipase gene mutations (C310R/E396V) in a Chinese family associated with recurrent acute pancreatitis.
Severe Hypertriglyceridemia in a Newborn with Monogenic Lipoprotein Lipase Deficiency: An Unconventional Therapeutic Approach with Exchange Transfusion.
Severe hypertriglyceridemia in a patient heterozygous for a lipoprotein lipase gene allele with two novel missense variants.
Severe hypertriglyceridemia with plasma inhibitory factor(s) on lipoprotein lipase activity in a patient with a common Ser(447)-Ter LPL mutation.
Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
Severe hypertriglyceridemia-related acute pancreatitis.
Severe, gestational, non-familial, non-genetic hypertriglyceridemia.
Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients.
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia.
Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet.
Strain differences in susceptibility to streptozotocin-induced diabetes: effects on hypertriglyceridemia and cardiomyopathy.
Streptozotocin-induced diabetes decreases mammary gland lipoprotein lipase activity and messenger ribonucleic acid in pregnant and nonpregnant rats.
Striated muscle gene therapy for the treatment of lipoprotein lipase deficiency.
Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
Tamoxifen might influence the affinity of LPL for heparin-sepharose.
Targeting APOC3 in the familial chylomicronemia syndrome.
The burden of familial chylomicronemia syndrome in Canadian patients.
The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study.
The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.
The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.
The recovery of dysfunctional lipoprotein lipase (Asp204-Glu) activity by modification of substrate.
The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency.
The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism.
Therapeutic response to medium-chain triglycerides and omega-3 fatty acids in a patient with the familial chylomicronemia syndrome.
Tissue lipoprotein lipase in normal individuals and in individuals with exogenous hypertriglyceridemia and the relationship of this enzyme to assimilation of fat.
Tumor necrosis factor mediates hypertriglyceridemia during thermal injury in mice genetically susceptible to lipopolysaccharides.
Tumor necrosis factor, cytokines, and the hyperlipidemia of infection.
Tumor-induced alterations in tissue lipoprotein lipase activity and mRNA levels.
Two novel mutations in the lipoprotein lipase gene in a family with marked hypertriglyceridemia in heterozygous carriers. Potential interaction with the polymorphic marker D1S104 on chromosome 1q21-q23.
Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride.
Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome.
Upregulation of fatty acid synthase gene expression in experimental chronic renal failure.
Variants of Lipid-Related Genes in Adult Japanese Patients with Severe Hypertriglyceridemia.
Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency.
Whole-Exome Sequencing Reveals GPIHBP1 Mutations in A Case of Infantile Colitis with Severe Hypertriglyceridemia.
Zeolite Nanoparticles for Selective Sorption of Plasma Proteins.
[A case of polymyositis associated with hypertriglyceridemia due to decline of lipoprotein lipase activity]
[Disorders of lipid metabolism in insulin resistance]
[Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism]
[Effects of intravenous glucose loads on endogenous and post-heparin lipoprotein lipase activity in plasma of normal subjects, patients with primary endogenous hypertriglyceridemia and diabetics]
[Genetic basis of primary hypertriglyceridemia].
[High-density lipoprotein subfractions and sex hormones in the blood plasma of men 40 to 59]
[High-density-lipoprotein and renal insufficiency (author's transl)]
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
[Hypertriglyceridemia in a deficiency of lipoprotein lipase and hepatic lipase]
[Hypertriglyceridemia-induced pancreatitis].
[Lipoprotein lipase, diabetes mellitus and hypertriglyceridemia]
[Lipoprotein lipase--physiological and pathophysiological roles of this gene variant in Croatian population]
[Management of hypertriglyceridemia in children].
[New kidney, but a sick heart. Why many patients with renal failure and kidney transplant patients die of cardiovascular disease]
[On the behavior of the endogenous lipoprotein lipase activity in plasma during an intravenous lipid infusion in normal persons and patients with hypertriglyceridemia]
[On the etiology of diabetic hyperlipidemia from the aspects of the metabolism of ApoHDL (author's transl)]
[Pathophysiology and therapy of lipid metabolism disorders in kidney diseases]
[POEMS cured by radical treatment of plasmacytoma]
[Serum lipoprotein lipase activity in diabetes mellitus. II. Hypertriglyceridemia and lipoprotein lipase activity]
[Severe hypertriglyceridemia : Diagnostics and new treatment principles].
[Studies on hypertriglyceridemia in liver diseases by means of measurements of hepatic triglyceride lipase and plasma lipoprotein lipase activity in the heparinized plasma]
[TOTAL PARENTERAL NUTRITION IN A PREGNANT PATIENT WITH ACUTE PANCREATITIS AND LIPOPROTEIN LIPASE DEFICIENCY].
Hypertrophy, Left Ventricular
The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.
Hypoalbuminemia
Endothelial bound lipoprotein lipase (LpL) depletion in hypoalbuminemia results from decreased endothelial binding, not decreased secretion.
Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis.
Hypoalphalipoproteinemias
Genetic polymorphisms and mutations of the lipoprotein lipase gene in Japanese schoolchildren with hypoalphalipoproteinemia.
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
[High-density lipoprotein subfractions and sex hormones in the blood plasma of men 40 to 59]
Hypobetalipoproteinemias
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Lipoprotein lipase and hepatic lipase activity after heparin administration in abetalipoproteinemia and hypobetalipoproteinemia.
The molecular genetics of pediatric lipid disorders: recent progress and future research directions.
Hypoglycemia
Carbohydrate and lipid abnormalities in infants of diabetic mothers.
Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency. Islet LPL regulates insulin secretion.
Hypogonadism
Increase in hepatic lipase activity after testosterone substitution in men with hypogonadism of pituitary origin.
Hypokinesia
Effect of hypokinesia on lipoprotein lipase activity in skeletal muscles of rat.
Hypophosphatemia
Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men.
Hypothyroidism
Amiodarone-induced changes in lipid metabolism.
Brain lipoprotein lipase is responsive to nutritional and hormonal modulation.
Brown adipocytes differentiated in vitro can express the gene for the uncoupling protein thermogenin: effects of hypothyroidism and norepinephrine.
Dyslipoproteinaemia in hypothyroidism of pituitary origin: effects of L-thyroxine substitution on lipoprotein lipase, hepatic lipase, and on plasma lipoproteins.
Effects of hypothyroidism on the metabolism of lipid emulsion models of triacylglycerol-rich lipoproteins in rats.
Expression of lipoprotein lipase in rat muscle: regulation by feeding and hypothyroidism.
High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction--effects of treatment.
Influence of nutritional state on lipoprotein lipase activities in the hypothyroid rat.
Lipoprotein lipase-mediated sequestration of long-chain polyunsaturated triacylglycerols in serum LDL from normal and hypothyroid rats.
Reduced thermogenesis in muscle and disturbed lipoprotein metabolism in relation to thyroid function in haemodialysis patients.
Regulation of myocardial lipoprotein lipase activity by diabetes and thyroid hormones.
Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations.
Reversal of decreased hepatic lipase and lipoprotein lipase activities after treatment of hypothyroidism.
Reversal of decreased human adipose tissue lipoprotein lipase and hypertriglyceridemia after treatment of hypothyroidism.
Thyroid Hormone Effects on Whole-Body Energy Homeostasis and Tissue-Specific Fatty Acid Uptake in Vivo.
Translational regulation of lipoprotein lipase by thyroid hormone is via a cytoplasmic repressor that interacts with the 3' untranslated region.
[Heparin and lipoprotein lipase activity of the blood in primary hypothyroidism]
Infections
Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells.
Adipose tissue lipoprotein lipase activity in Plasmodium chabaudi and Plasmodium vinckei rodent malaria.
Changes in fat metabolism of black-bone chickens during early stages of infection with Newcastle disease virus.
Changes in serum lipoprotein pattern induced by acute infections.
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host.
Lipoprotein lipase activity in surgical patients: influence of trauma and infection.
Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins.
Lipoprotein lipase and hydrofluoric acid deactivate both bacterial lipoproteins and lipoteichoic acids, but platelet-activating factor-acetylhydrolase degrades only lipoteichoic acids.
Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry.
Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation.
Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.
Lipoproteins and acute phase response during acute infection. Interrelationships between C-reactive protein and serum amyloid-A protein and lipoproteins.
Striated muscle gene therapy for the treatment of lipoprotein lipase deficiency.
The role of cachectin/TNF in the pathogenesis of tuberculosis.
Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition.
Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
Influenza, Human
Hepatic steatosis during convalescence from influenza B infection in ferrets with postprandial hyperinsulinemia.
Insulin Resistance
Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome.
Alterations in lipoprotein lipase in insulin resistance.
Analysis of candidate genes in Polish families with obesity.
Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase.
Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice.
Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids.
Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice.
Artemisia Iwayomogi Extract Attenuates High-Fat Diet-Induced Hypertriglyceridemia in Mice: Potential Involvement of the Adiponectin-AMPK Pathway and Very Low Density Lipoprotein Assembly in the Liver.
Association of adiponectin with serum preheparin lipoprotein lipase mass in women independent of fat mass and distribution, insulin resistance, and inflammation.
Association of lipoprotein lipase gene variation with the physiological components of the insulin-resistance syndrome in the population of the San Luis Valley, Colorado.
Association of polymorphism genes LPL , ADRB2 , AGT and AGTR1 with risk of hyperinsulinism and insulin resistance in the Kazakh population.
Associations between lipoprotein lipase gene polymorphisms and insulin resistance in coronary heart disease.
Associations for lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene and coronary artery disease in an Indian population.
Associations of Lower-Body Fat Mass with Favorable Profile of Lipoproteins and Adipokines in Healthy, Slim Women in Early Adulthood.
C-peptide but not insulin concentrations are related to the serum lipoprotein levels during insulin treatment of non-insulin-dependent diabetes mellitus (NIDDM) patients.
Cardiorespiratory and metabolic characteristics of detraining in humans.
Catalytically inactive lipoprotein lipase overexpression increases insulin sensitivity in mice.
Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus.
Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886.
Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes.
Crocetin improves the insulin resistance induced by high-fat diet in rats.
Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance.
Defining the Regulated Secreted Proteome of Rodent Adipocytes upon the Induction of Insulin Resistance.
Delayed postprandial metabolism of triglyceride-rich lipoproteins in obese young men compared to lean young men.
Dietary iron overload induces visceral adipose tissue insulin resistance.
Diets high in carbohydrate may not be appropriate for rs328 G carriers with the metabolic syndrome.
Different Expression of Duodenal Genes Related to Insulin Resistance Between Nonobese Women and Those with Severe Obesity.
Diurnal variation in lipoprotein lipase activity.
Effect of dietary macronutrient composition on tissue-specific lipoprotein lipase activity and insulin action in normal-weight subjects.
Effects of exercise training on abdominal obesity and related metabolic complications.
Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus.
Effects of lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene variants on metabolic syndrome traits.
Effects of prepartum 2,4-thiazolidinedione on insulin sensitivity, plasma concentrations of tumor necrosis factor-? and leptin, and adipose tissue gene expression.
Epigenetic regulation of lipoprotein lipase gene via BRD4, which is potentially associated with adipocyte differentiation and insulin resistance.
Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism.
Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance.
Fasting decreases free fatty acid turnover in mice overexpressing skeletal muscle lipoprotein lipase.
Fibrate therapy in the management of diabetic dyslipidemia: there is no ACCORD to be found.
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes.
Glucose and insulin stimulate heparin-releasable lipoprotein lipase activity in mouse islets and INS-1 cells. A potential link between insulin resistance and beta-cell dysfunction.
Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats.
Hepatitis C virus infection: molecular pathways to metabolic syndrome.
High lipoprotein lipase activity increases insulin sensitivity in transgenic rabbits.
Human skeletal muscle PPARalpha expression correlates with fat metabolism gene expression but not BMI or insulin sensitivity.
Hyperlipidemia of chronic renal failure.
Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspects.
Increased VLDL-TG Fatty Acid Storage in Skeletal Muscle in Men With Type 2 Diabetes.
Influence of Dietary Chitosan Feeding Duration on Glucose and Lipid Metabolism in a Diabetic Rat Model.
Influence of gender, obesity, and muscle lipase activity on intramyocellular lipids in sedentary individuals.
Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men.
Insulin action in uremia.
Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner.
Insulin resistance and lipid metabolism.
Insulin Sensitivity Is Associated with Lipoprotein Lipase (LPL) and Catenin Delta 2 (CTNND2) DNA Methylation in Peripheral White Blood Cells in Non-Diabetic Young Women.
Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency.
Laparoscopic Sleeve Gastrectomy Significantly Increases Serum Lipoprotein Lipase Level in Obese Patients.
Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM.
Lipolytic enzymes, metablic syndrome and atherosclerosis (revisiting and revising a 40 years old study).
Lipoprotein lipase (LPL) mass in preheparin serum reflects insulin sensitivity.
Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity.
Lipoprotein lipase at onset of obesity induced in rats by a high-fat diet.
Lipoprotein lipase is a gene for insulin resistance in Mexican Americans.
Lipoprotein lipase links vitamin D, insulin resistance, and type 2 diabetes: a cross-sectional epidemiological study.
Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism.
Long-term weight cycling in female Wistar rats: effects on metabolism.
Medium-chain oil reduces fat mass and down-regulates expression of adipogenic genes in rats.
Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients.
Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men.
Metabolic responses to exercise. Effects of endurance training and implications for diabetes.
Mini review: physical activity and fitness and its relations to cardiovascular disease risk factors in children.
Muscle fiber composition and capillarization in relation to metabolic alterations in hypertensive men.
NO-1886 ameliorates glycogen metabolism in insulin-resistant HepG2 cells by GSK-3? signalling.
NO-1886 suppresses diet-induced insulin resistance and cholesterol accumulation through STAT5-dependent upregulation of IGF-1 and CYP7A1.
Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase.
Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women.
Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance.
Overexpression of lipoprotein lipase improves insulin resistance induced by a high-fat diet in transgenic rabbits.
Overexpression of muscle lipoprotein lipase and insulin sensitivity.
Peroxisome proliferator-activated receptor-? agonists have opposing effects on insulin resistance in high fat fed rats and mice due to different metabolic responses in muscle.
Physical activity and blood lipids and lipoproteins in dialysis patients.
Physiological concentrations of insulin and T3 stimulate 3T3-L1 adipocyte acyl-CoA synthetase gene transcription.
Pioglitazone decreases plasma angiotensin II concentration in type 2 diabetes.
PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance.
Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
Postprandial modulation of lipoprotein lipase in rats with insulin resistance.
Pre-heparin plasma lipoprotein lipase mass: correlation with intra-abdominal visceral fat accumulation.
Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents.
Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome.
Preventive effect of diabegon, a polyherbal preparation, during progression of diabetes induced by high-fructose feeding in rats.
Regulation of adipose tissue lipoprotein lipase in young and old rats.
Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia.
Relationship between a lipoprotein lipase gene polymorphism in placental tissue and insulin resistance in patients with gestational diabetes mellitus.
Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase.
Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.
Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia.
Role of insulin resistance in decreasing lipoprotein lipase activity in tumor-bearing rats.
Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
Sarpogrelate hydrochloride decreases cardio-ankle vascular index accompanied by increased serum lipoprotein lipase mass in type 2 diabetic patients.
ShRNA-mediated gene silencing of lipoprotein lipase improves insulin sensitivity in L6 skeletal muscle cells.
Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues.
Subcutaneous Abdominal Adipose Tissue Subcompartments: Potential Role in Rosiglitazone Effects.
Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects.
Testosterone and regional fat distribution.
The 3' untranslated region of the lipoprotein lipase gene: haplotype structure and association with post-heparin plasma lipase activity.
The actions of a novel lipoprotein lipase activator, NO-1886, in hypertriglyceridemic fructose-fed rats.
The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
The apoB-to-PCSK9 ratio: A new index for metabolic risk in humans.
The Association of a Rare Variant of -93, -53 Promoter Gene Polymorphisms of Lipoprotein Lipase gene with Obesity and Insulin Resistance.
The atherosclerotic process and its exacerbation by diabetes.
The effect of short-term alpha-glucosidase inhibition on carbohydrate and lipid metabolism in type II (noninsulin-dependent) diabetics.
The effects of 20 days bed rest on serum lipids and lipoprotein concentrations in healthy young subjects.
The heterozygous N291S mutation in the lipoprotein lipase gene impairs whole-body insulin sensitivity and affects a distinct set of plasma metabolites in humans.
The influence of insulin infusion on the metabolism of amyloid ? peptides in plasma.
The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet.
The major inflammatory mediator interleukin-6 and obesity.
The rise of the plasma lipid concentration elicited by dietary sodium chloride restriction in Wistar rats is due to an impairment of the plasma triacylglycerol removal rate.
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance.
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men.
Waging war on modern chronic diseases: primary prevention through exercise biology.
Whole-body insulin resistance and energy expenditure indices, serum lipids, and skeletal muscle metabolome in a state of lipoprotein lipase overexpression.
[A new attempt with lipoprotein lipase agonists in the treatment of nonalcoholic steatohepatitis].
[Clinical significance of preheparin serum lipoprotein lipase mass in normocholesterolemic patients with coronary artery disease]
[Dyslipidemia in insulin resistance and its improvement by troglitazone]
[Dyslipidemia in metabolic syndrome]
[Dyslipidemia, increased lipolysis, and depleted heparin system in insulin resistance].
[Dyslipidemia]
[The polycystic ovary syndrome and insulin resistance]
Intellectual Disability
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Intracranial Hemorrhage, Hypertensive
HindIII Polymorphism in the Lipoprotein Lipase Gene and Hypertensive Intracerebral Hemorrhage in the Chinese Han Population.
Iron Deficiencies
Iron deficiency hyperlipidemia in 18-day-old rat pups: effects of milk lipids, lipoprotein lipase, and triglyceride synthesis.
Iron Overload
Rapid responses of adipocytes to iron overload increase serum TG level by decreasing adiponectin.
Ischemic Stroke
Associations of apolipoprotein E exon 4 and lipoprotein lipase S447X polymorphisms with acute ischemic stroke and myocardial infarction.
Cholesteryl ester transfer protein TaqI B and lipoprotein lipase Ser447Ter gene polymorphisms are not associated with ischaemic stroke in Greek patients.
Genetic variation in MDR1, LPL and eNOS genes and the response to atorvastatin treatment in ischemic stroke.
Investigation of the Interaction Between the Ser447Term Polymorphism of Lipoprotein Lipase and the Stroke-Related Risk Factors in Ischemic Stroke.
Lipoprotein lipase gene polymorphisms in ischaemic stroke and carotid stenosis.
Lipoprotein lipase Ser447Ter polymorphism associated with the risk of ischemic stroke: A meta-analysis.
Polymorphism of apolipoprotein E (APOE) and lipoprotein lipase (LPL) genes and ischaemic stroke in individuals of Yakut ethnicity.
Predictive role of polymorphisms in interleukin-5 receptor alpha-subunit, lipoprotein lipase, integrin A2 and nitric oxide synthase genes on ischemic stroke in type 2 diabetes-An 8-year prospective cohort analysis of 1327 Chinese patients.
The association of lipid metabolism relative gene polymorphisms and ischemic stroke in Han and Uighur population of Xinjiang.
The HindIII and PvuII polymorphisms of lipoprotein lipase (LPL) gene reduce the risk of ischemic stroke (IS): A meta-analysis.
Jaundice, Neonatal
Breast milk jaundice; the role of lipoprotein lipase and the free fatty acids.
Lipolytic activity in milk from mothers of unjaundiced infants.
[Lipoprotein lipase activity in human milk; inhibition in vitro of the glucuro-conjugation of bilirubin (author's transl)]
Ketosis
1,3,5,8-Tetrahydroxyxanthone regulates ANGPTL3-LPL pathway to lessen the ketosis in mice.
Gram-negative bacteria sepsis in the rat and tissue lipolytic activity on LCT and MCT/LCT-based commercial parenteral emulsions.
Lipid metabolism in the fetus and the newborn.
Metabolic syndrome and low-carbohydrate ketogenic diets in the medical school biochemistry curriculum.
Momilactone B Inhibits Ketosis In Vitro by Regulating the ANGPTL3-LPL Pathway and Inhibiting HMGCS2.
Plasma lipoproteins and lipoprotein lipase in young diabetics with and without ketonuria.
Relationship of organ lipoprotein lipase activity and ketonuria to hypertriglyceridemia in starved and streptozocin-induced diabetic rats.
Severe hypertriglyceridaemia in diabetic ketoacidosis: clinical and genetic study.
Kidney Diseases
Lipoprotein lipase in the kidney: activity varies widely among animal species.
Uremic toxins and lipases in haemodialysis: a process of repeated metabolic starvation.
Kidney Failure, Chronic
Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure.
Effect of protein and peptide fractions from the peritoneal dialysate of patients with chronic renal failure on the lipoprotein lipase activity.
Impaired lipoprotein lipase activation by uraemic and post-transplant sera.
Impaired metabolism of high density lipoprotein in uremic patients.
Influence of haemodialysis on lipase activity.
Lipid profiles and lipase activities in children and adolescents with chronic renal failure treated conservatively or with hemodialysis or transplantation.
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.
Normalization of lipoprotein lipase and hepatic lipase by gemfibrozil results in correction of lipoprotein abnormalities in chronic renal failure.
Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure.
Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure.
Study on the inhibitory effect of uremic plasma on lipoprotein lipase.
Upregulation of fatty acid synthase gene expression in experimental chronic renal failure.
[Apolipoprotein C-II and C-III anomalies in normolipemic and hyperlipemic patients with chronic kidney failure]
Kwashiorkor
Dietary effects in the early recovery phase of kwashiorkor. Plasma levels of triglycerides, FFA, D-beta-hydroxybutyrate, glycerol, postheparin lipoprotein lipase (LPL), glucose and insulin.
Studies on hepatic and extrahepatic lipoprotein lipases in protein-calorie malnutrition.
Lecithin Cholesterol Acyltransferase Deficiency
Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph.
Familial lecithin:cholesterol acyltransferase deficiency. Further studies on plasma lipoproteins and plasma postheparin lipase activity of a patient with normal renal function.
Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency.
Lipid compositions of plasma major lipoproteins and lipoprotein lipase activity in hypolipidemic and hyperlipidemic siblings with familial LCAT deficiency.
Leishmaniasis, Visceral
Lipoprotein lipase and PPAR alpha gene polymorphisms, increased very-low-density lipoprotein levels, and decreased high-density lipoprotein levels as risk markers for the development of visceral leishmaniasis by Leishmania infantum.
Leukemia
Cells of a human monocytic leukemia cell line (THP-1) synthesize and secrete apolipoprotein E and lipoprotein lipase.
DNA sequence of lipoprotein lipase cDNA cloned from human monocytic leukemia THP-1 cells.
Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes.
Lipoprotein lipase gene expression in THP-1 cells.
Malignant fibrous histiocytoma-pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study.
Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein.
Transcriptional activation of the lipoprotein lipase gene in macrophages by dexamethasone.
Leukemia, Lymphocytic, Chronic, B-Cell
Correction: Lipoprotein Lipase SNPs rs13702 and rs301 Correlate with Clinical Outcome in Chronic Lymphocytic Leukemia Patients.
Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression.
Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia.
Expression level of lipoprotein lipase in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.
EXPRESSION OF LIPOPROTEIN LIPASE AND c-MYC ONCOGENE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AFFECTED BY THE CHORNOBYL ACCIDENT.
High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia.
Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia.
Lipoprotein lipase as a predictor for survival in chronic lymphocytic leukemia.
Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia.
Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia: New Insights into Leukemic Progression.
Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia.
Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications.
Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity.
Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia.
Lipoprotein lipase SNPs rs13702 and rs301 correlate with clinical outcome in chronic lymphocytic leukemia patients.
Methylation status regulates lipoprotein lipase expression in chronic lymphocytic leukemia.
PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia.
Prognostic value of lipoprotein lipase expression among egyptian B-chronic lymphocytic leukemia patients.
Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells.
The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.
[Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors]
Leukemia, Lymphoid
Prognostic value of lipoprotein lipase expression among egyptian B-chronic lymphocytic leukemia patients.
Leydig Cell Tumor
Lipid metabolism in cachectic tumor-bearing rats at different stages of tumor growth.
Suppression of carcass weight loss in cachexia in rats bearing Leydig cell tumor by the novel compound NO-1886, a lipoprotein lipase activator.
Liddle Syndrome
Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II-receptor gene and the renin loci in man.
Lipid Metabolism Disorders
Effects of Portulaca Oleracea Extract on Acute Alcoholic Liver Injury of Rats.
Rare novel LPL mutations are associated with neonatal onset lipoprotein lipase (LPL) deficiency in two cases.
Lipidoses
Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity.
Effect of rumen-protected choline supplementation on liver and adipose gene expression during the transition period in dairy cattle.
Lipodystrophy
Advanced Lipoprotein Analysis Shows Atherogenic Lipid Profile That Improves After Metreleptin in Patients with Lipodystrophy.
Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin.
The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.
Lipodystrophy, Familial Partial
The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.
Lipoma
Are the metabolic characteristics of congenital intraspinal lipoma cells identical to, or different from normal adipocytes?
Correlation of morphologic and biochemical observations in human lipomas.
Glycosylation of lipoprotein lipase in human subcutaneous lipomas.
Lipoprotein lipase activity in normal human adipose tissue and its absence in human lipomas.
Lipoprotein lipase and hormone-sensitive lipase activities in human subcutaneous lipomas: comparison with normal subcutaneous adipose tissue.
[Lipoprotein lipase activity in lipomas]
Lipomatosis
Metabolic abnormalities in multiple symmetric lipomatosis: elevated lipoprotein lipase activity in adipose tissue with hyperalphalipoproteinemia.
Lipomatosis, Multiple Symmetrical
Metabolic abnormalities in multiple symmetric lipomatosis: elevated lipoprotein lipase activity in adipose tissue with hyperalphalipoproteinemia.
lipoprotein lipase deficiency
11-year Follow-up in Biliopancreatic Diversion for Recurrent Pancreatitis Due to Lipoprotein Lipase Deficiency.
A 19 year follow-up of a woman with lipoprotein lipase deficiency treated with biliopancreatic diversion.
A Chinese patient with recurrent pancreatitis during pregnancy induced by hypertriglyceridemia associated with compound heterozygosity (Glu242Lys and Leu252VaL) in the lipoprotein lipase gene.
A compound heterozygote for lipoprotein lipase deficiency, Val69-->Leu and Gly188-->Glu: correlation between in vitro LPL activity and clinical expression.
A family-based study of hyperinsulinemia and hypertriglyceridemia in heterozygous lipoprotein lipase deficiency.
A G----C change at the donor splice site of intron 1 causes lipoprotein lipase deficiency in a southern-Italian family.
A Japanese patient with lipoprotein lipase deficiency homozygous for the Gly188Glu mutation prevalent worldwide.
A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency.
A missense (Asp250----Asn) mutation in the lipoprotein lipase gene in two unrelated families with familial lipoprotein lipase deficiency.
A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries.
A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians.
A new Italian case of lipoprotein lipase deficiency: a Leu365- > Val change resulting in loss of enzyme activity.
A new mutation in the human lipoprotein lipase gene causing familial hyperchylomicronaemia.
A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency.
A novel substitution at the translation initiator codon (ATG-->ATC) of the lipoprotein lipase gene is mainly responsible for lipoprotein lipase deficiency in a patient with severe hypertriglyceridemia and recurrent pancreatitis.
A pathophysiologic approach to managing hyperlipemia.
A sweet heart: Increased cardiac glucose uptake in patients with lipoprotein lipase deficiency.
Absence of serum-stimulated lipase activity and altered lipid content in milk from a patient with type I hyperlipoproteinaemia.
Accumulation of large VLDL in cyclophosphamide treated rabbits. Relationship with lipoprotein lipase deficiency.
Acquired lipoprotein lipase deficiency associated with chronic urticaria. A new etiology for type I hyperlipoproteinemia.
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.
Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity.
Adipose cell size and distribution in familial lipoprotein lipase deficiency.
Adipose Specific Lipoprotein Lipase Deficiency More Profoundly Affects Brown Than White Fat Biology.
Adipose tissue fatty acid composition in humans with lipoprotein lipase deficiency.
Alipogene tiparvovec for the treatment of lipoprotein lipase deficiency.
Alipogene tiparvovec, an adeno-associated virus encoding the Ser(447)X variant of the human lipoprotein lipase gene for the treatment of patients with lipoprotein lipase deficiency.
Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency.
Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency.
Alterations in erythrocyte membrane lipid composition and fluidity in primary lipoprotein lipase deficiency.
Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency.
Amino acid substitution (Ile194----Thr) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands. Support for a multicentric origin.
An essential receptor for adeno-associated virus infection.
An incomplete form of familial lipoprotein lipase deficiency presenting with type I hyperlipoproteinemia.
ApoE enhances lipid uptake by macrophages in lipoprotein lipase deficiency during pregnancy.
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiency.
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.
Bio F1B hamster: a unique animal model with reduced lipoprotein lipase activity to investigate nutrient mediated regulation of lipoprotein metabolism.
Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro.
C-II anapolipoproteinemia and severe hypertriglyceridemia. Report of a rare case with absence of C-II apolipoprotein isoforms and review of the literature.
Capecitabine-induced severe hypertriglyceridemia: report of two cases.
Cardiovascular Gene Therapy: Past, Present, and Future.
Case series of type III hyperlipoproteinemia in children.
Catalytic triad residue mutation (Asp156----Gly) causing familial lipoprotein lipase deficiency. Co-inheritance with a nonsense mutation (Ser447----Ter) in a Turkish family.
Cell therapy could be a potential way to improve lipoprotein lipase deficiency.
Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias.
Cognitive impairment and polidistrectual atherosclerotic disease in chylomicronemia syndrome: A case report.
Comparison of plasmapheresis with medical apheresis in terms of efficacy and cost in the acute treatment of hypertriglyceridemia in children with lipoprotein lipase deficiency.
Complete paternal isodisomy for chromosome 8 unmasked by lipoprotein lipase deficiency.
Compound heterozygosity of Leu252Val and Leu252Arg causing lipoprotein lipase deficiency in a chinese patient with hypertriglyceridemia.
Compound heterozygote for lipoprotein lipase deficiency: Ser----Thr244 and transition in 3' splice site of intron 2 (AG----AA) in the lipoprotein lipase gene.
Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph.
Congenital lipoprotein lipase deficiency and hyperlipemia in the young puppy.
Congenital lipoprotein lipase deficiency in hyperlipemic kitten siblings.
Correction of Feline Lipoprotein Lipase Deficiency with Adeno-Associated Virus Serotype 1-Mediated Gene Transfer of the Lipoprotein Lipase S447X Beneficial Mutation.
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation.
Cost-Effectiveness Analysis of Glybera for The Treatment of Lipoprotein Lipase Deficiency.
Critical review of non-statin treatments for dyslipoproteinemia.
Deceptive hyperbilirubinaemia in a newborn with familial lipoprotein lipase deficiency.
Defective enzyme protein in lipoprotein lipase deficiency.
Demystifying the management of hypertriglyceridaemia.
Detailed analysis of lipolytic enzymes in a Japanese woman of familial lipoprotein lipase deficiency - Effects of pemafibrate treatment.
Detection and characterization of the heterozygote state for lipoprotein lipase deficiency.
Detection of a new compound heterozygote (del G916/G1401A) for lipoprotein lipase deficiency and a comparative haplotype analysis of the mutant lipoprotein lipase gene from Japanese patients.
Detection of mutations in the apolipoprotein CII gene by denaturing gradient gel electrophoresis. Identification of the splice site variant apolipoprotein CII-Hamburg in a patient with severe hypertriglyceridemia.
Developing immunologically inert adeno-associated virus (AAV) vectors for gene therapy: possibilities and limitations.
Development and Optimization of AAV hFIX Particles by Transient Transfection in an iCELLis(®) Fixed-Bed Bioreactor.
Diet-induced atherosclerosis in the domestic cat.
Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome.
Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism.
Dissociation between plasma triglyceride concentration and tissue lipoprotein lipase deficiency in insulin-deficient rats.
Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Effects of exercise and fat ingestion on high density lipoprotein production by peripheral tissues.
Effects of heparin infusion on plasma lipoproteins in subjects with lipoprotein lipase deficiency. Evidence for a role of hepatic endothelial lipase in the metabolism of high-density lipoprotein subfractions in man.
Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice.
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL(S447X)) gene therapy for lipoprotein lipase deficiency: an open-label trial.
Eruptive Xanthomas in Lipoprotein Lipase Deficiency.
Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
Evaluation of an HPLC method for LDL-cholesterol determination in patients with various lipoprotein abnormalities in comparison with beta-quantification.
Exchange transfusions for extreme hypertriglyceridemia in a 7-week-old infant with multi-organ failure.
Extreme hypertriglyceridemia, pseudohyponatremia, and pseudoacidosis in a neonate with lipoprotein lipase deficiency due to segmental uniparental disomy.
Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity.
Familial chylomicronemia syndrome.
Familial chylomicronemia syndrome: a case report.
Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
Familial dyslipidaemic hypertension and other multiple metabolic syndromes.
Familial lipoprotein lipase deficiency caused by known (G188E) and novel (W394X) LPL gene mutations.
Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study.
Familial lipoprotein lipase deficiency: a case of compound heterozygosity of a novel duplication (R44Kfs*4) and a common mutation (N291S) in the lipoprotein lipase gene.
Familial lipoprotein lipase deficiency: abnormal lipoproteins and defective metabolism of low density lipoproteins in cultured human skin fibroblasts.
Frameshift mutation in exon 3 of the lipoprotein lipase gene causes a premature stop codon and lipoprotein lipase deficiency.
Gene polymorphism identified by PvuII in familial lipoprotein lipase deficiency.
Gene therapy for dyslipidemia: clinical prospects.
Gene therapy for genetic lipid disorders: lipoprotein lipase deficiency as a paradigm.
Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice.
Gene therapy for lipoprotein lipase deficiency.
Gene Therapy for Lipoprotein Lipase Deficiency: Working Toward Clinical Application.
Gene therapy for lipoprotein lipase deficiency: working toward clinical application.
Gene Therapy in Lipoprotein Lipase Deficiency: Case Report on the First Patient Treated with Alipogene Tiparvovec Under Daily Practice Conditions.
Gene therapy on demand: site specific regulation of gene therapy.
Gene-based therapies in lipidology: current status and future challenges.
Genealogy and regional distribution of lipoprotein lipase deficiency in French-Canadians of Quebec.
Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies.
Generation of analytic plasma lipoprotein profiles using two prepacked superose 6B columns.
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
Genetic epidemiology of lipoprotein lipase deficiency in Saguenay-Lac-St-Jean (Québec, Canada).
Gestational hyperlipidemia and acute pancreatitis with underlying partial lipoprotein lipase deficiency and apolipoprotein E3/E2 genotype.
Glucose-stimulated insulin response in non-diabetic patients with lipoprotein lipase deficiency and hypertriglyceridemia.
HDL metabolic activities in a boy with lipoprotein lipase deficiency and his family.
Hemolysis in primary lipoprotein lipase deficiency.
Heterogeneity of primary lipoprotein lipase deficiency.
Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency.
Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.
Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease.
High frequency of lipoprotein lipase deficiency in the Quebec population.
Homozygous deletion of exon 9 causes lipoprotein lipase deficiency: possible intron-Alu recombination.
Homozygous LPL p.Gly188Glu Mutation in a Mexican Girl With Lipoprotein Lipase Deficiency.
Human lipoprotein lipase deficiency: does chronic dyslipidemia lead to increased oxidative stress and mitochondrial DNA damage in blood cells?
Hyperchylomicronaemia due to lipoprotein lipase deficiency as a cause of false-positive newborn screening for biotinidase deficiency.
Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency.
Hyperlipidemia Resulting in Abnormal Density and Signal Intensity of Blood in a Neonate with Lipoprotein Lipase Deficiency.
Hyperlipoproteinemia and multifocal neurologic dysfunction in systemic lupus erythematosus.
Hyperlipoproteinemias: Part I. Lipoprotein classification and abnormalities.
Hypertriglyceridemia and insulin resistance.
Hypertriglyceridemia associated with thrombocytopenia and lipoprotein lipase deficiency.
Hypertriglyceridemia-induced pancreatitis created by oral estrogen and in vitro fertilization ovulation induction.
IDL, VLDL, chylomicrons and atherosclerosis.
Immune Responses to Intramuscular Administration of Alipogene Tiparvovec (AAV1-LPL(S447X)) in a Phase II Clinical Trial of Lipoprotein Lipase Deficiency Gene Therapy.
Improved visual function with dietary intervention in a child with lipemia retinalis.
In vitro remodelling of plasma lipoproteins in whole plasma by lipoprotein lipase in primary and secondary hypertriglyceridaemia.
Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis.
Initial diagnosis of lipoprotein lipase deficiency in a 75-year-old man.
Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency.
Irradiation-induced free cholesterol accumulation in very-low-density lipoproteins. Role of lipoprotein lipase deficiency.
Issues Affecting Quality of Life and Disease Burden in Lipoprotein Lipase Deficiency (Lpld) - First Step Towards a Pro Measure in Lpld.
Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency.
Lipaemia in lipoprotein lipase deficiency.
Lipaemia retinalis in a 29-day-old infant with type 1 hyperlipoproteinaemia.
Lipase deficiencies.
Lipemia retinalis: case report and review of the literature.
Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency.
Lipid and lipoprotein analysis of cats with lipoprotein lipase deficiency.
Lipid-lowering agents.
Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat.
Lipoprotein lipase and atherosclerosis.
Lipoprotein Lipase Deficiency (R243H) in a Type 2 Diabetes Patient with Multiple Arterial Aneurysms.
Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice.
Lipoprotein lipase deficiency and transient diabetes mellitus in a neonate.
Lipoprotein Lipase Deficiency Arising in Type V Dyslipidemia.
Lipoprotein lipase deficiency due to a 3' splice site mutation in intron 6 of the lipoprotein lipase gene.
Lipoprotein lipase deficiency due to long-term heparinization presenting as severe hypertriglyceridaemia in pregnancy.
Lipoprotein Lipase Deficiency Impairs Bone Marrow Myelopoiesis and Reduces Circulating Monocyte Levels.
Lipoprotein Lipase Deficiency in an Infant With Chylomicronemia, Hepatomegaly, and Lipemia Retinalis.
Lipoprotein lipase deficiency in an infant.
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.
Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein (ASP) plasma levels.
Lipoprotein lipase deficiency leads to ?-synuclein aggregation and ubiquitin C-terminal hydrolase L1 reduction.
Lipoprotein lipase deficiency presenting with neonatal perianal abscesses.
Lipoprotein lipase deficiency resulting from a nonsense mutation in exon 3 of the lipoprotein lipase gene.
Lipoprotein lipase deficiency with pancreatitis in mink: biochemical characterization and pathology.
Lipoprotein lipase deficiency with visceral xanthomas.
Lipoprotein lipase deficiency.
Lipoprotein Lipase Deficiency.
Lipoprotein lipase deficiency: benefits and limitations of a novel therapeutic surgical approach.
Lipoprotein lipase deficiency: clinical, biochemical and molecular characteristics in three patients with novel mutations in the LPL gene.
Lipoprotein Lipase Deficiency: Diet is the Key!
Lipoprotein lipase secretion by human monocyte-derived macrophages.
Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation.
Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis.
Management of patients with severe hypertriglyceridaemia during pregnancy: report of two cases with familial lipoprotein lipase deficiency.
Management of severe hypertriglyceridemia due to lipoprotein lipase deficiency in children
Management strategy and novel ophthalmological findings in neonatal severe hypertriglyceridemia: a case report and literature review.
Marked changes of lipid levels during puberty in a patient with lipoprotein lipase deficiency.
Maternal expression of functional lipoprotein lipase and effects on body fat mass and body condition scores of mature cats with lipoprotein lipase deficiency.
Mechanisms of atherogenesis: endothelial hypoxia proposed as the major initiator.
Medium- and long-chain triglycerides labeled with 13C: a comparison of oxidation after oral or parenteral administration in humans.
Metabolic surgery for the treatment of hypertriglyceridemia-related pancreatitis due to familial lipoprotein lipase deficiency.
Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia.
Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.
Molecular basis of lipoprotein lipase deficiency in two Austrian families with type I hyperlipoproteinemia.
Molecular genetics of apoC-II and lipoprotein lipase deficiency.
Molecular genetics of human lipoprotein lipase deficiency.
Neonatal pancreatitis associated with familial lipoprotein lipase deficiency.
Neuronal Lipoprotein Lipase Deficiency Alters Neuronal Function and Hepatic Metabolism.
New lipid-lowering drugs: an update.
Novel compound heterozygous mutations for lipoprotein lipase deficiency. A G-to-T transversion at the first position of exon 5 causing G154V missense mutation and a 5' splice site mutation of intron 8.
Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review.
Novel therapeutics in hypertriglyceridemia.
Occurrence of idiopathic, familial hyperchylomicronaemia in a cat.
Occurrence of multiple aberrantly spliced mRNAs upon a donor splice site mutation that causes familial lipoprotein lipase deficiency.
Partial gene duplication involving exon-Alu interchange results in lipoprotein lipase deficiency.
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.
Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transfer.
Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.
Phenotypic heterogeneity in the extended pedigree of a proband with lipoprotein lipase deficiency.
Phospholipid and cholesteryl ester transfer are increased in lipoprotein lipase deficiency.
Plasma apolipoprotein CII levels in hypertriglyceridemia.
Postheparin plasma lipoprotein lipase activity in heterozygotes of familial lipoprotein lipase deficiency.
Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia.
Potential of AAV vectors in the treatment of metabolic disease.
Potential of essential fatty acid deficiency with extremely low fat diet in lipoprotein lipase deficiency during pregnancy: A case report.
Pregnancy-induced hyperlipoproteinemia: review of the literature.
Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene.
Prevalence, geographical distribution and genealogical investigations of mutation 188 of lipoprotein lipase gene in the French Canadian population of Québec.
Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiency.
Prevention of recurrent pancreatitis in familial lipoprotein lipase deficiency with high-dose antioxidant therapy.
Primary hypertriglyceridemia in children and adolescents.
Primary lipoprotein lipase deficiency.
Primary type 1 hyperlipoproteinemia: significance of lipoprotein lipase and hepatic triglyceride lipase activity in heterozygotes of patients with familial lipoprotein lipase deficiency.
Progress and challenges in viral vector manufacturing.
Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.
Quantification and genotyping of lipoprotein lipase in patients with diabetic lipaemia.
Reduced cholesteryl ester transfer in plasma of patients with lipoprotein lipase deficiency.
Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency.
Risk factors for coronary artery disease: a study comparing hypercholesterolaemia and hypertriglyceridaemia in angiographically characterized patients.
Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera®).
Scientifically-based strategies for nutrition of the high-risk low birth weight infant.
Serum HDL-C values: An extremely useful marker for differentiating homozygous lipoprotein lipase deficiency from severe hypertriglyceridemia with other causes in Japan: A meta-analysis based on literatures on Japanese homozygous lipoprotein lipase deficiency.
Severe acute necrotizing pancreatitis associated with lipoprotein lipase deficiency in childhood.
Severe hypercholesterolemia in a double heterozygote for lipoprotein lipase deficiency (LPL(Arita)) and apolipoprotein epsilon4: a report of a family with LPL(Arita).
Severe hypertriglyceridaemia and pancreatitis in a patient with lipoprotein lipase deficiency based on mutations in lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) genes.
Severe hypertriglyceridaemia as a result of familial chylomicronaemia: the Cape Town experience.
Severe hypertriglyceridemia associated with pancytopenia and lipoprotein lipase deficiency.
Severe Hypertriglyceridemia in a Newborn with Monogenic Lipoprotein Lipase Deficiency: An Unconventional Therapeutic Approach with Exchange Transfusion.
Severe hypertriglyceridemia in Japan: Differences in causes and therapeutic responses.
Severe hypertriglyceridemia, large lipoproteins and protection against atherosclerosis.
Severe hypertriglyceridemia-related acute pancreatitis.
Severe, gestational, non-familial, non-genetic hypertriglyceridemia.
Siblings with hepatosplenomegaly and lipoprotein lipase deficiency.
Striated muscle gene therapy for the treatment of lipoprotein lipase deficiency.
The burden of familial chylomicronemia syndrome in Canadian patients.
The effect of gestational age on intralipid tolerance in newborn infants.
The genotypic and phenotypic spectrum of PIGA deficiency.
The impact of lipoprotein lipase deficiency on health-related quality of life: a detailed, structured, qualitative study.
The molecular genetics of pediatric lipid disorders: recent progress and future research directions.
The pathology of an inherited hyperlipoproteinaemia of cats.
The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
The rapidly evolving state of gene therapy.
The role of lecithin: cholesterol acyltransferase in high density lipoprotein3/high density lipoprotein2 interconversion.
The role of patient registries for rare genetic lipid disorders.
The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency.
The ultrastructural pathology of five lipoprotein lipase-deficient cats.
Tocopherol content of adipose tissue from vitamin E-deficient humans.
Transient lipoprotein lipase deficiency with hyperchylomicronemia.
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
Type I hyperlipidaemia caused by lipoprotein lipase deficiency in a nurseling: the role of the clinical laboratory in processing biological samples and contributing to the diagnosis and therapeutic follow-up of patients.
Use of plasma lipoprotein lipase activity without heparin injection for detection of homozygous and heterozygous lipoprotein lipase deficiency.
Whole exome sequencing for non-selective pediatric patients with hyperlipidemia.
Xanthoma of bone associated with lipoprotein lipase deficiency.
[A case of neonatal lipoprotein lipase deficiency caused by novel compound heterozygous variants of LPL gene].
[A gene analysis of familial lipoprotein lipase deficiency in China]
[Chylomicronemia syndrome in 45 years old man]
[Chylomicronemia syndrome]
[Clearing factor deficiency in coronary atherosclerosis.]
[Familial hyperchylomicronemia with a new mutation of the lipoprotein lipase gene]
[Familial lipoprotein lipase deficiency]
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
[Lipoprotein lipase deficiencies]
[Lipoprotein lipase deficiency due to lipoprotein lipase gene mutations (current overview)]
[Lipoprotein lipase deficiency in 2 young patients (hyperlipoproteinemia type I)]
[Lipoprotein lipase deficiency, familial]
[Lipoprotein lipase deficiency. A familial study]
[Lipoprotein lipase deficiency. Apropos of 2 cases]
[Lipoprotein lipase: a multifunctional enzyme in lipoprotein metabolism]
[Management of hypertriglyceridemia in children].
[Molecular genetics and lipoprotein lipase deficiency]
[Neonatal hyperlipemia due to lipoprotein lipase deficiency]
[Oral contraceptive-induced pancreatitis in the hyperchylomicronemia syndrome]
[Primary lipoprotein lipase deficiency. Study in Quebec]
[Primary lipoprotein lipase deficiency: clinical and genetic aspects]
Liver Cirrhosis
Angiopoietin-like protein 4 deficiency augments liver fibrosis in liver diseases such as nonalcoholic steatohepatitis in mice through enhanced free cholesterol accumulation in hepatic stellate cells.
Lipoprotein Lipase Up-regulation in Hepatic Stellate Cells Exacerbates Liver Fibrosis in Nonalcoholic Steatohepatitis in Mice.
[Free fatty acids and the activities of postheparinesterase and lipoprotein lipase in liver cirrhosis]
[On lipoprotein lipase activity, serum lipids and the effect of heparin on the blood sugar level in atrophic liver cirrhosis and chronic hepatitis]
[Plasma unesterified fatty acids and lipoprotein lipase activity in liver cirrhosis]
Liver Cirrhosis, Biliary
Lipoprotein pattern and plasma lipoprotein lipase activities in patients with primary biliary cirrhosis. Relationship with increase of HDL2 fraction in Lp-X-positive and Lp-X-negative subjects.
Liver Diseases
A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors.
Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Changes in postheparin lipolytic activity in liver diseases.
Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease.
Hepatic triglyceride lipase deficiency in liver disease.
Lipoprotein lipase activity in liver disease.
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
Prevention Mechanism of 2,3,5,4'-Tetrahydroxy-stilbene-2-O-?-D-glucoside on Lipid Accumulation in Steatosis Hepatic L-02 Cell.
Secondary hypertriglyceridaemia in patients with parenchymal liver disease.
The genotypic and phenotypic spectrum of PIGA deficiency.
Triglyceride lipase activity in postheparin plasma and plasma lipoproteins in liver disease.
[Postheparin esterase and clearing factor in liver diseases.]
[Studies on hypertriglyceridemia in liver diseases by means of measurements of hepatic triglyceride lipase and plasma lipoprotein lipase activity in the heparinized plasma]
Lung Diseases
Assessment of lipoprotein lipase activity in patients with atherosclerosis and nonspecific pulmonary diseases.
Lung Neoplasms
Increased Fatty Acid Synthase Activity in Non-small Cell Lung Cancer Tissue Is a Weaker Predictor of Shorter Patient Survival than Increased Lipoprotein Lipase Activity.
Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival.
Lipolytic and lipoprotein lipase (LPL)-inhibiting activities produced by a human lung cancer cell line responsible for cachexia induction.
Lipoprotein lipase activity and gene expression in lung cancer and in adjacent noncancer lung tissue.
Lipoprotein lipase activity and prediction for survival in lung cancer.
Lipoprotein lipase in non-small cell lung cancer tissue is highly expressed in a subpopulation of tumor-associated macrophages.
Reply: Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival.
Stimulation of decreased lipoprotein lipase activity in the tumor-bearing state by the antihyperlipidemic drug bezafibrate.
Lupus Erythematosus, Systemic
Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease.
Elevated apolipoprotein-B levels in corticosteroid-treated patients with systemic lupus erythematosus.
Lupus Nephritis
Serological correlations with nephritis in systemic lupus erythematosus.
Lymphohistiocytosis, Hemophagocytic
Lipoprotein alterations and plasma lipoprotein lipase reduction in familial hemophagocytic lymphohistiocytosis.
Lymphoma
Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity.
Radiation-driven lipid accumulation and dendritic cell dysfunction in cancer.
Magnesium Deficiency
Effect of magnesium deficiency on post-heparin lipase activity and tissue lipoprotein lipase in the rat.
Malabsorption Syndromes
[Alimentary lipemia and postheparin activity of lipoprotein lipase in children with malabsorption syndrome]
Malaria
Adipose tissue lipoprotein lipase activity in Plasmodium chabaudi and Plasmodium vinckei rodent malaria.
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Malnutrition
Effects of pre- and early postnatal protein malnutrition on carcass composition and lipoprotein lipase activity in male rats.
Lipoprotein lipase disturbances induced by uremia and hemodialysis.
Malnutrition causing neonatal dyslipidemia.
Maternal undernutrition leads to elevated hepatic triglycerides in male rat offspring due to increased expression of lipoprotein lipase.
Rat plasma VLDL composition and concentration and hepatic lipase and lipoprotein lipase activities are impaired during two types of protein malnutrition and unaffected by balanced refeeding.
Refeeding meal-fed rats increases lipoprotein lipase activity and deposition of dietary [14C]lipid in white adipose tissue and decreases oxidation to 14CO2. The role of undernutrition.
The effect of maternal malnutrition on the progeny in the rat. Studies in vitro of adipose tissue lipogenesis and lipoprotein lipase activity following fructose feeding.
[Fat in the parenteral feeding of malnourished patients]
Maple Syrup Urine Disease
The genotypic and phenotypic spectrum of PIGA deficiency.
Mastitis
Factors affecting the distribution of lipoprotein lipase activity between serum and casein micelles in bovine milk.
Lipoprotein lipase activity of milk from cows with prolonged subclinical mastitis.
The relationship between the levels of free fatty acids, lipoprotein lipase, carboxylesterase, N-acetyl-beta-D-glucosaminidase, somatic cell count and other mastitis indices in bovine milk.
Melanoma
Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor.
Enhanced Fatty Acid Scavenging and Glycerophospholipid Metabolism Accompany Melanocyte Neoplasia Progression in Zebrafish.
Suppression of lipoprotein lipase in 3T3-L1 cells by a mediator produced by SEKI melanoma, a cachexia-inducing human melanoma cell line.
Melanoma, Experimental
Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKI.
Mesothelioma
Lipolysis of polyenoic fatty acid esters of human chylomicrons by lipoprotein lipase.
Metabolic Diseases
Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases.
Potential of AAV vectors in the treatment of metabolic disease.
Variations in DNA elucidate molecular networks that cause disease.
Metabolic Syndrome
Adipose Tissue LPL Methylation is Associated with Triglyceride Concentrations in the Metabolic Syndrome.
Age Stratification in Genetic Variation of Lipoprotein Lipase in Metabolic Syndrome Javanese Ethnics of Indonesia.
Association of Metabolic Syndrome with Serum Adipokines in Community-Living Elderly Japanese Women: Independent Association with Plasminogen Activator-Inhibitor-1.
Catalytically inactive lipoprotein lipase overexpression increases insulin sensitivity in mice.
Clinical determination of the severity of metabolic syndrome: preheparin lipoprotein lipase mass as a new marker of metabolic syndrome.
Corrigendum to "Gender-related relation between metabolic syndrome and S447X and HindIII polymorphisms of lipoprotein lipase gene in northern Iran" [Gene 706 (2019) 13-18].
Diets high in carbohydrate may not be appropriate for rs328 G carriers with the metabolic syndrome.
Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome.
Effect of Glycine on Adipocyte Hypertrophy in a Metabolic Syndrome Rat Model.
Effects of lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene variants on metabolic syndrome traits.
Endothelial lipase and the metabolic syndrome.
Gender-related relation between metabolic syndrome and S447X and HindIII polymorphisms of lipoprotein lipase gene in northern Iran.
Genetic variations at the lipoprotein lipase gene influence plasma lipid concentrations and interact with plasma n-6 polyunsaturated fatty acids to modulate lipid metabolism.
Genetics of the metabolic syndrome.
Interaction of genetic risk factors confers increased risk for metabolic syndrome: the role of peroxisome proliferator-activated receptor ?.
Lipid Profiles and Associated Gene Polymorphisms in Young Asian Indian Patients with Acute Myocardial Infarction and the Metabolic Syndrome.
Lipoprotein Lipase Inhibitor, Nordihydroguaiaretic Acid, Aggravates Metabolic Phenotypes and Alters HDL Particle Size in the Western Diet-Fed db/db Mice.
Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the Metabolic Syndrome.
Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion.
Plasma apolipoprotein CI and CIII levels are associated with increased plasma triglyceride levels and decreased fat mass in men with the metabolic syndrome.
Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking.
Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome.
Reduced LPL and subcutaneous lipid storage capacity are associated with metabolic syndrome in postmenopausal women with obesity.
Relationship between serum preheparin lipoprotein lipase mass, plasma glucose and metabolic syndrome in older subjects.
Relationship Between Two Common Lipoprotein Lipase Variants and the Metabolic Syndrome and Its Individual Components.
The association of lipoprotein lipase PvuII polymorphism and niacin intake in the prevalence of metabolic syndrome: a KMSRI-Seoul study.
The gene-diet interaction, LPL PvuII and HindIII and carbohydrate, on the criteria of metabolic syndrome: KMSRI-Seoul Study.
The heterozygous N291S mutation in the lipoprotein lipase gene impairs whole-body insulin sensitivity and affects a distinct set of plasma metabolites in humans.
The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome.
The S447X variant of lipoprotein lipase gene is associated with metabolic syndrome and lipid levels among Turks.
[Association of lipoprotein lipase gene Hind III and S447X polymorphisms in metabolic syndrome patients among Kazakh and Han ethnics from Xinjiang.]
[Polymorphisms of lipoprotein lipase gene and their participation in metabolic processes].
[Remnant lipoprotein cholesterol level measured by homogeneous assay reflects the quantity of intermediate-density lipoprotein]
[The association of S447X and Hind III polymorphism in the lipoprotein lipase gene with dyslipidemia of the metabolic syndrome in patients with essential hypertension]
Metabolism, Inborn Errors
Severe hypertriglyceridemia-related acute pancreatitis.
Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis.
Migraine Disorders
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Multiple Sclerosis
[Behavior of lipoprotein lipase in multiple sclerosis and other neurologic diseases]
[Lipoprotein lipase in the blood and cerebrospinal fluid of patients with multiple sclerosis]
Muscular Atrophy, Spinal
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.
Muscular Diseases
Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice.
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Myocardial Infarction
Alterations in plasma proteins and lipoproteins in acute myocardial infarction: effects on activation of lipoprotein lipase.
Association between preheparin serum lipoprotein lipase mass and acute myocardial infarction in Japanese men.
Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM Study.
Association of lipoprotein lipase and apolipoprotein C-III genes polymorphism with acute myocardial infarction in diabetic patients.
Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes The genetics, outcomes, and lipids in type 2 diabetes (GOLD) study.
Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden.
Associations of apolipoprotein E exon 4 and lipoprotein lipase S447X polymorphisms with acute ischemic stroke and myocardial infarction.
Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
Decreased lipoprotein lipase activity and increased postprandial concentrations of triglyceride-rich lipoproteins in offspring of elderly survivors of myocardial infarction.
Genetic variants of the lipoprotein lipase gene and myocardial infarction in the Central Valley of Costa Rica.
Human lipoprotein lipase HindIII polymorphism in young patients with myocardial infarction.
Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction.
Interaction of the lipoprotein lipase asparagine 291-->serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults.
Lipoprotein lipase gene HindIII polymorphism and risk of myocardial infarction in South Indian population.
Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population.
Lipoprotein Lipase Gene Polymorphisms Are Associated with Myocardial Infarction Risk: A Meta-Analysis.
Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde.
Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS).
Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins.
Polymorphisms of the human lipoprotein lipase gene: possible association with lipid levels in patients with coronary heart disease in Beijing area.
Relationship between two AMI risk factors: low serum lipoprotein lipase mass and hypoadiponectinemia.
[Connection of HindIII-polymorphism in the lipoprotein lipase gene with myocardial infarct and life span in elderly ischemic heart disease patients]
[Connection of HindIII-polymorphism of the lipoprotein lipase gene with risk of developing myocardial infarct]
[Coronary heart disease in patients with primary type V hyperlipoproteinemia (author's transl)]
[HindIII polymorphism of lipoprotein lipase gene and risk of myocardial infarction]
[Lipoprotein lipase activity and the effect of heparin on blood sugar level and blood lipids in patients with acute myocardial infarct]
[Lipoprotein lipase activity following heparin infusion. II. Patients with healed myocardial infarct]
[Myocardial infarct. Lipoprotein lipase in the myocardium and the infarct]
[Myocardial infarct: an acute dysmetabolic disease]
Myocardial Ischemia
A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovascular disease in women but not in men.
A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.
An application of the patient rule-induction method for evaluating the contribution of the Apolipoprotein E and Lipoprotein Lipase genes to predicting ischemic heart disease.
Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.
Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease.
Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis.
Lipoprotein lipase Ser447Ter polymorphism associated with the risk of ischemic stroke: A meta-analysis.
Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen city heart study.
Myocardial ischemia and lipoprotein lipase activity.
Myocardial lipoproteins lipase activity during acute myocardial ischemia in dogs.
Reduced adipose tissue lipoprotein lipase responses, postprandial lipemia, and low high-density lipoprotein-2 subspecies levels in older athletes with silent myocardial ischemia.
Relationship between common lipoprotein lipase gene sequence variants, hyperinsulinemia, and risk of ischemic heart disease: A population-based study.
[Change in the functional state of the sympathetic-adrenal system and the activity of lipoprotein lipase in patients with ischemic heart disease under the effect of refinded carbohydrates included in diets of different caloric value]
[Connection of HindIII-polymorphism in the lipoprotein lipase gene with myocardial infarct and life span in elderly ischemic heart disease patients]
[HindIII DNA-polymorphism of lipoprotein lipase gene in elderly patients with ischemic heart disease]
[Lipoprotein lipase activity of ischemic heart disease patients with different types of hyperlipoproteinemia on the basis of fat loading]
Myotoxicity
Hyperlipidaemia alone and in combination with acidosis can increase the incidence and severity of statin-induced myotoxicity.
Neoplasms
?-Estradiol Enhanced Secretion of Lipoprotein Lipase from Mouse Mammary Tumor FM3A Cells.
A proof of principle clinical trial to determine whether conjugated linoleic acid modulates the lipogenic pathway in human breast cancer tissue.
A sib-pair analysis study of 15 candidate genes in French families with morbid obesity: indication for linkage with islet 1 locus on chromosome 5q.
Abnormal substrate metabolism and nutritional strategies in cancer management.
Abnormality of hepatic triglyceride metabolism in ApcMin/+ mice with colon cancer cachexia.
Activity and tissue-specific expression of lipases and tumor-necrosis factor alpha in lean and obese cats.
Aloe-emodin inhibits adipocyte differentiation and maturation during in vitro human mesenchymal stem cell adipogenesis.
Alterations in plasma lipoproteins and heparin-releasable lipase activities in mice bearing the GRSL ascites tumor.
Analysis of candidate genes in Polish families with obesity.
ANGPTL3 is part of the machinery causing dyslipidemia majorily via LPL inhibition in mastitis mice.
Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model.
Antiadipogenic Effects of Loganic Acid in 3T3-L1 Preadipocytes and Ovariectomized Mice.
Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor.
Augmentation of tumor necrosis factor-alpha-induced suppression of lipoprotein lipase by nitric oxide donors in cultured brown adipocytes.
Bacterial lipopolysaccharide reduces macrophage lipoprotein lipase levels: an effect that is independent of tumor necrosis factor.
Bacterial lipopolysaccharide suppresses the expression of lipoprotein lipase in murine macrophages: a process independent of tumor necrosis factor or interleukin 1.
Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes.
Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity.
CAMK1 Phosphoinositide Signal-Mediated Protein Sorting and Transport Network in Human Hepatocellular Carcinoma (HCC) by Biocomputation.
Cancer cachexia.
Cardiac lipoprotein lipase: effects of lipopolysaccharide and tumor necrosis factor.
Cellular Glycolysis and The Differential Survival of Lung Fibroblast and Lung Carcinoma Cell Lines.
Changes in activity of lipoprotein lipase, plasma free fatty acids and triglycerides with weight loss in a cachexia model.
Changes in lipoprotein lipase activity (LPLA) in tumor cells and tissues in mice bearing Ehrlich ascites tumor.
Changes in the activities of lipoprotein lipase and the lipogenic enzymes in tumor-bearing rats.
Characterization of differentiation factor/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes.
Conjugated linoleic acids reduce body fat in healthy postmenopausal women.
Control of lipoprotein lipase secretion in mouse macrophages.
Correlation of morphologic and biochemical observations in human lipomas.
Cytokine production in five tumor cell lines with activity to induce cancer cachexia syndrome in nude mice.
Depot-related gene expression in human subcutaneous and omental adipocytes.
Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice. Modulation of macrophage secretory activities.
Differential effects of lipoprotein lipase on tumor necrosis factor-alpha and interferon-gamma-mediated gene expression in human endothelial cells.
Differential modulation of intracellular energetics in A549 and MRC-5 cells.
Differentiation of human monocytes to monocyte-derived macrophages is associated with increased lipoprotein lipase-induced tumor necrosis factor-alpha expression and production: a process involving cell surface proteoglycans and protein kinase C.
Effect of cortisol on cell proliferation and the expression of lipoprotein lipase and vascular endothelial growth factor in a human osteosarcoma cell line.
Effect of endotoxin and cytokines on lipoprotein lipase activity in mice.
Effect of the lipid-lowering agent bezafibrate on tumour growth rate in vivo.
Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia.
Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat.
Effects of intravenous infusion of trans-10, cis-12 18:2 on mammary lipid metabolism in lactating dairy cows.
Effects of prepartum 2,4-thiazolidinedione on insulin sensitivity, plasma concentrations of tumor necrosis factor-? and leptin, and adipose tissue gene expression.
Effects of tumor necrosis factor (TNF) on lipolytic activities of rat heart.
Elevated expression of the genes encoding TNF-alpha and thromboxane synthase in leucocytes from patients with systemic sclerosis.
Endocrine effects of cytokines.
Enhanced Fatty Acid Scavenging and Glycerophospholipid Metabolism Accompany Melanocyte Neoplasia Progression in Zebrafish.
Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans.
Evidence of endoplasmic reticulum stress and liver inflammation in the American mink Neovison vison with benign hepatic steatosis.
Exogenous supplement of N-acetylneuraminic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice.
Expression of the apolipoprotein E gene in a human macrophage-like cell line, THP-1.
Genetic and epigenetic inactivation of LPL gene in human prostate cancer.
Genetic variation in APOJ, LPL, and TNFRSF10B affects the plasma fatty acid distribution in Alaskan Eskimos.
Genome scale metabolic models as tools for drug design and personalized medicine.
Hepatic triglyceride lipase and lipoprotein lipase activities in post-heparin plasma of patients with various cancers.
Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
Hypertriglyceridemia associated with tumor necrosis factor-alpha in hamster cheek-pouch carcinogenesis.
Impact of body weight gain on hepatic metabolism and hepatic inflammatory cytokines in comparison of Shetland pony geldings and Warmblood horse geldings.
Increased expression of the mRNA for hormone-sensitive lipase in adipose tissue of cancer patients.
Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival.
Induction of adipocyte-specific gene expression is correlated with mammary tumor regression by the retinoid X receptor-ligand LGD1069 (targretin).
Induction of tumor necrosis factor alpha gene expression by lipoprotein lipase requires protein kinase C activation.
Induction of tumor necrosis factor alpha gene expression by lipoprotein lipase.
Influence of Dietary Chitosan Feeding Duration on Glucose and Lipid Metabolism in a Diabetic Rat Model.
Inhibitory effect of tumor necrosis factor on gene expression of hormone sensitive lipase in 3T3-L1 adipocytes.
Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.
Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia.
Labilizing affect of lipoprotein lipase on lysosomes of tumor cells.
Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes.
Lipid and lipoprotein metabolism in familial combined hyperlipidaemia during treatment of sporadic phaeochromocytoma: a case study.
Lipid emulsions of palmitoylrhizoxin: effects of composition on lipolysis and biodistribution.
Lipid metabolism during the initiation of lactation in the rat. The effects of starvation and tumour growth.
Lipid metabolism in cachectic tumor-bearing rats at different stages of tumor growth.
Lipid metabolism in rats bearing the Yoshida AH-130 ascites hepatoma.
Lipid metabolism in tumour-bearing mice: studies with knockout mice for tumour necrosis factor receptor 1 protein.
Lipolytic and lipoprotein lipase (LPL)-inhibiting activities produced by a human lung cancer cell line responsible for cachexia induction.
Lipoprotein lipase and endothelial lipase in human testis and in germ cell neoplasms.
Lipoprotein lipase as a candidate target for cancer prevention/therapy.
Lipoprotein lipase in heart cell cultures is suppressed by bacterial lipopolysaccharide: an effect mediated by production of tumor necrosis factor.
Lipoprotein lipase links dietary fat to solid tumor cell proliferation.
Lipoprotein lipase synergizes with interferon gamma to induce macrophage nitric oxide synthetase mRNA expression and nitric oxide production.
Liraglutide Increases the Catabolism of Apolipoprotein B100-Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression.
Lysosome labilizers potentiate the antitumor effects of tumor necrosis factor-alpha.
Modified lipoprotein lipase activities, rates of lipogenesis, and lipolysis as factors leading to lipid depletion in C57BL mice bearing the preputial gland tumor, ESR-586.
Modulation of lipoprotein lipase activity in mouse peritoneal macrophages by recombinant human tumor necrosis factor.
Molecular characterisation of tumour necrosis factor alpha and its potential connection with lipoprotein lipase and peroxisome proliferator-activated receptors in blunt snout bream (Megalobrama amblycephala).
Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo.
Nitric oxide mediates down regulation of lipoprotein lipase activity induced by tumor necrosis factor-alpha in brown adipocytes.
Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats.
Plasma clearance of exogenous lipids in patients with malignant disease.
Plasma interleukin-6 is not a mediator of changes in lipoprotein lipase activity in cancer patients.
Platyphylloside Isolated From Betula platyphylla Inhibit Adipocyte Differentiation and Induce Lipolysis Via Regulating Adipokines Including PPAR? in 3T3-L1 Cells.
Polyunsaturated fatty acids augment tumoricidal action of 5-fluorouracil on gastric cancer cells by their action on vascular endothelial growth factor, tumor necrosis factor-? and lipid metabolism related factors.
Potential role of TNFalpha and lipoprotein lipase as candidate genes for obesity.
Preliminary assessment of differential expression of candidate genes associated with atherosclerosis.
Production and characterization of monoclonal antibodies against recombinant human tumor necrosis factor/cachectin.
Properties of lipoprotein lipase extracted from livers of normal rats and livers and tumors of rats bearing Walker carcinosarcoma 256.
Protein kinase C mediates tumor necrosis factor-alpha-induced inhibition of obese gene expression and leptin secretion in brown adipocytes.
Rapid downregulation of adipose tissue lipoprotein lipase activity on food deprivation: evidence that TNF-alpha is involved.
Recessive inheritance of obesity in familial non-insulin-dependent diabetes mellitus, and lack of linkage to nine candidate genes.
Recombinant human tumor necrosis factor does not inhibit lipoprotein lipase in primary cultures of isolated human adipocytes.
Recombinant human tumour necrosis factor-alpha suppresses synthesis, activity and secretion of lipoprotein lipase in cultures of a human osteosarcoma cell line.
Reduced meal frequency alleviates high-fat diet-induced lipid accumulation and inflammation in adipose tissue of pigs under the circumstance of fixed feed allowance.
Reduced plasma lipoprotein lipase activity in patients with malignancy-associated weight loss.
Regulation of lipid metabolism and peroxisome proliferator-activated receptors in rainbow trout adipose tissue by lipolytic and antilipolytic endocrine factors.
Regulation of lipoprotein lipase activity and mRNA content in rat epididymal adipose tissue in vitro by recombinant tumour necrosis factor.
Regulation of lipoprotein lipase mRNA content in 3T3-L1 cells by tumour necrosis factor.
Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factor--the primary regulatory role of the hormone in 3T3-L1 adipocytes.
Regulation of lipoprotein lipase synthesis in 3T3-L1 adipocytes by cachectin. Further proof for identity with tumour necrosis factor.
Relationship of classical and non-classical risk factors with genetic variants relevant to coronary heart disease.
Release of lipoprotein lipase from Ehrlich ascites tumor produced by an association with a rapid increase in cyclic AMP content.
Sequential alterations in tissue lipoprotein lipase, triglyceride secretion rates, and serum tumor necrosis factor alpha during Escherichia coli bacteremic sepsis in relation to the development of hypertriglyceridemia.
Sequential changes in the activities of lipoprotein lipase and lipogenic enzymes during tumor growth in rats.
Short communication: Effect of heat stress during the dry period on gene expression in mammary tissue and peripheral blood mononuclear cells.
Single nucleotide polymorphisms in obesity-related genes and all-cause and cause-specific mortality: a prospective cohort study.
Sodium acetate, propionate, and butyrate reduce fat accumulation in mice via modulating appetite and relevant genes.
Stimulation of decreased lipoprotein lipase activity in the tumor-bearing state by the antihyperlipidemic drug bezafibrate.
Stimulatory release of lipoprotein lipase activity with activation of protein tyrosine kinase produced by low molecular weight dextran sulfate in Ehrlich ascites tumor cells.
Structure-activity relationship of heparan sulphate.
Suppression of carcass weight loss in cachexia in rats bearing Leydig cell tumor by the novel compound NO-1886, a lipoprotein lipase activator.
Synergism between interferon gamma and tumour necrosis factor alpha in the regulation of lipoprotein lipase in the macrophage J774.2 cell line.
The effect of tumor necrosis factor alpha on the activity of lipoprotein lipase in adipose tissue.
The effects of a biological response modifier, OK-432, on tumor-induced alterations in the host metabolism.
The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.
The stimulation of tumor necrosis factor and inhibition of glucose transport and lipoprotein lipase in adipose cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Tissue-specific effects of rapid tumour growth on lipid metabolism in the rat during lactation and on litter removal.
Tissue-specific regulation of guinea pig lipoprotein lipase; effects of nutritional state and of tumor necrosis factor on mRNA levels in adipose tissue, heart and liver.
Transcriptional regulatory networks in human lung adenocarcinoma.
Tumor growth and lipid metabolism during lactation in the rat.
Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition.
Tumor necrosis factor induced release of endothelial cell lipoprotein lipase.
Tumor necrosis factor mediates hypertriglyceridemia during thermal injury in mice genetically susceptible to lipopolysaccharides.
Tumor necrosis factor-alpha eliminates binding of NF-Y and an octamer-binding protein to the lipoprotein lipase promoter in 3T3-L1 adipocytes.
Tumor necrosis factor-increased hepatic very-low-density lipoprotein production and increased serum triglyceride levels in diabetic rats.
Tumor necrosis factor-mediated biological activities involve a G-protein-dependent mechanism.
Tumor-induced alterations in tissue lipoprotein lipase activity and mRNA levels.
Ubá mango juices intake decreases adiposity and inflammation in high-fat diet-induced obese Wistar rats.
Wasting in cancer.
[Adipose tissue as an endocrine organ].
[Reduced plasma lipoprotein lipase activity in patients with various cancers: preliminary report]
[Stimulation of tissue lipoprotein lipase activity in cancer cachectic rats: preliminary report]
Neoplasms, Germ Cell and Embryonal
Lipoprotein lipase and endothelial lipase in human testis and in germ cell neoplasms.
Nephritis
Serological correlations with nephritis in systemic lupus erythematosus.
Nephrosis
Changes in biological activity and immunoreactive mass of lipoprotein lipase in congenital nephrosis: relationship to hypertriglyceridaemia.
Gene expression of lipoprotein lipase in experimental nephrosis.
Lipoprotein lipase in clinical and experimental nephrosis.
Lipoprotein metabolism in the nephrotic syndrome.
Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
Nephrosis, Lipoid
[The clearing factor and the inhibiting factor during lipoid nephrosis.]
Nephrotic Syndrome
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome.
Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity.
Characterization of glycosaminoglycans in urine from patients with nephrotic syndrome and control subjects, and their effects on lipoprotein lipase.
Effect of the lipoprotein lipase activator NO-1886 on adriamycin-induced nephrotic syndrome in rats.
Endothelial chylomicron binding is altered by interaction with high-density lipoprotein in Heymann's nephritis.
Glycosaminoglycans and chylomicron metabolism in control and nephrotic rats.
Inhibition of lipoprotein lipase by plasma from children with the steroid responsive nephrotic syndrome.
Lipoprotein lipase activator deficiency in very low density lipoproteins in rat nephrotic syndrome.
Plasma lipoprotein lipase in children with idiopathic nephrotic syndrome.
Post-heparin hepatic and lipoprotein lipase activities in nephrotic syndrome.
Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome.
[Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome]
[In vitro inhibition of lipoprotein lipase by a monoclonal immunoglobulin in a case of nephrotic syndrome with hyperlipemia caused by auto-antibodies]
[Lipoprotein lipase activity in the nephrotic syndrome.]
[Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome]
[Study of plasma levels of free fatty acids and lipoprotein lipase activity in patients with nephrotic syndrome caused by intrinsic renal disease]
Neurodegenerative Diseases
Association Studies of Specific Cholesterol Related Genes (APOE, LPL, and CETP) with Lipid Profile and Memory Function: A Correlative Study Among Rural and Tribal Population of Dharmapuri District, India.
Non-alcoholic Fatty Liver Disease
A novel index including SNPs for the screening of nonalcoholic fatty liver disease among elder Chinese: A population-based study.
A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors.
Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease.
Lipoprotein Lipase Up-regulation in Hepatic Stellate Cells Exacerbates Liver Fibrosis in Nonalcoholic Steatohepatitis in Mice.
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
Prevention Mechanism of 2,3,5,4'-Tetrahydroxy-stilbene-2-O-?-D-glucoside on Lipid Accumulation in Steatosis Hepatic L-02 Cell.
Obesity
Activity of lipoprotein lipase and effect of heparin on blood lipids in exogenous obesity.
Adipose tissue and the insulin resistance syndrome.
Adipose tissue lipoprotein lipase and glycerol release in fasted Zucker (fa/fa) rats.
Apolipoprotein A5 and Lipoprotein Lipase Interact to Modulate Anthropometric Measures in Hispanics of Caribbean Origin.
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice.
Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Association between peroxisome proliferator-activated receptor, UCP3 and lipoprotein lipase gene polymorphisms and obesity in Chinese adolescents.
Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population.
Association of sets of alleles of genes encoding beta3-adrenoreceptor, uncoupling protein 1 and lipoprotein lipase with increased risk of metabolic complications in obesity.
Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families.
Characterization of lipase activities in obese Pima indians. Decreases with weight reduction.
Cyanidin-3-O-?-glucoside improves obesity and triglyceride metabolism in KK-Ay mice by regulating lipoprotein lipase activity
Cyanidin-3-O-?-glucoside improves obesity and triglyceride metabolism in KK-Ay mice by regulating lipoprotein lipase activity.
Deficiency of lipoprotein lipase in neurons modifies the regulation of energy balance and leads to obesity.
Determinants of fasting hypertriglyceridemia in ventromedial hypothalamic obesity in rats.
Determinants of HDL particle size in patients with the null (P207L) or defective (D9N) mutation in the lipoprotein lipase gene: the Québec LipD Study.
Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity.
Developmental changes in adipose and muscle lipoprotein lipase activity in the atherosclerosis-prone JCR:LA-corpulent rat.
Diet composition and lipoprotein lipase (EC 3.1.1.34) activity in human obesity.
Dietary triglycerides as signaling molecules that influence reward and motivation.
Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia.
Effect of eggplant (Solanum melongena) on the metabolic syndrome: A review.
Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue.
Effect of Glycine on Adipocyte Hypertrophy in a Metabolic Syndrome Rat Model.
Effect of obesity on HDL and LDL particle sizes in carriers of the null P207L or defective D9N mutation in the lipoprotein lipase gene: the Québec LipD Study.
Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: Studies using genetically engineered mouse models.
Effect of pu-erh tea on body fat and lipid profiles in rats with diet-induced obesity.
Effect of sucrose overfeeding on brown adipose tissue lipogenesis and lipoprotein lipase activity in rats.
Effects of estradiol and progesterone on food intake, body weight, and carcass adiposity in weanling rats.
Effects of weight loss and weight maintenance on the serum lipids, lipoprotein lipase and hepatic triglyceride lipase activities in obese rats.
Effects of Weight Loss on Lipid Transfer Proteins in Morbidly Obese Women.
Effects of weight reduction on plasma lipoproteins and adipose tissue metabolism in obese subjects.
Elevated adipose tissue lipoprotein lipase in the pathogenesis of obesity in the Prader-Willi syndrome.
Epididymal fat depot lipoprotein lipase activity is lower in animals with high endogenous fat preferences.
Erratum to "Association between peroxisome proliferator-activated receptor, UCP3 and lipoprotein lipase gene polymorphisms and obesity in Chinese adolescents" [Obes Res Clin Pract 2017;11(January-February1):27-33].
Exercise and detraining: effect on food intake, adiposity and lipogenesis in Osborne-Mendel rats made obese by a high fat diet.
Familial dyslipidaemic hypertension and other multiple metabolic syndromes.
Fasting and postprandial adipose tissue LPL and HSL in obesity and type 2 diabetes.
Formula Diet is Effective for the Reduction and Differentiation of Visceral Adipose Tissue in Zucker Fatty Rats.
Gender-related relation between metabolic syndrome and S447X and HindIII polymorphisms of lipoprotein lipase gene in northern Iran.
Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesity.
Human adipose tissue lipoprotein lipase: comparison of assay methods and expressions of activity.
Impact of walking on adipose tissue lipoprotein lipase activity and expression in pre- and postmenopausal women.
Impaired regulation of adipose tissue lipoprotein lipase in obesity.
Increased adipose-tissue lipoprotein-lipase activity in moderately obese men after weight reduction.
Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity.
Increased VLDL-TG Fatty Acid Storage in Skeletal Muscle in Men With Type 2 Diabetes.
Increasing adipocyte lipoprotein lipase improves glucose metabolism in high fat diet-induced obesity.
Influence of lipoprotein lipase gene Ser447Stop and beta1-adrenergic receptor gene Arg389Gly polymorphisms and their interaction on obesity from childhood to adulthood: the Bogalusa Heart Study.
Inhibitory effects of grape seed extract on lipases.
Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity.
Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese.
Lipoprotein lipase activator NO-1886 (ibrolipim) accelerates the mRNA expression of fatty acid oxidation-related enzymes in rat liver.
Lipoprotein lipase activities in adipose tissues and muscle in the obese Zucker rat.
Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity.
Lipoprotein lipase activity in adipose tissue and in postheparin plasma in human obesity.
Lipoprotein lipase activity of adipose tissue, skeletal muscle and post-heparin plasma in primary endogenous hypertriglyceridaemia: relation to lipoprotein pattern and to obesity.
Lipoprotein lipase at onset of obesity induced in rats by a high-fat diet.
Lipoprotein lipase in human adipose tissue, obesity and serum triglyceride.
Lipoprotein Lipase Maintains Microglial Innate Immunity in Obesity.
Lipoprotein lipase of adipose tissue and skeletal muscle in human obesity: response to glucose and to semistarvation.
Lipoprotein lipase variants interact with polyunsaturated fatty acids for obesity traits in women: replication in two populations.
Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases.
LIPOPROTEIN LIPASE: FROM GENE TO OBESITY.
Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism.
Long-term effects on adiposity after preweaning nutritional manipulations in the gastrostomy-reared rat.
Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota.
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.
Metabolism of the mouse made obese by a high-fat diet.
Mice with altered brain lipoprotein metabolism display maladaptive responses to environmental challenges that may predispose to weight gain.
Mutations at the lipoprotein lipase gene locus in subjects with diabetes mellitus, obesity and lipaemia.
NO-1886 (ibrolipim), a lipoprotein lipase activator, increases the expression of uncoupling protein 3 in skeletal muscle and suppresses fat accumulation in high-fat diet-induced obesity in rats.
Nutrient regulation of post-heparin lipoprotein lipase activity in obese subjects.
Obesity and metabolic efficiency.
Obesity development in neuron-specific lipoprotein lipase deficient mice is not responsive to increased dietary fat content or change in fat composition.
Orlistat response to missense mutations in lipoprotein lipase.
Overexpression of human lipoprotein lipase increases hormone-sensitive lipase activity in adipose tissue of mice.
Overexpression of lipoprotein lipase improves insulin resistance induced by a high-fat diet in transgenic rabbits.
Overexpression of lipoprotein lipase in transgenic Watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity.
Physical activity and plasma lipoprotein lipid concentrations in men.
Plasma triglyceride clearing in obese children.
Postheparin plasma lipase activities in obesity: failure to increase with adipose organ enlargement.
Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
POTENTIAL ADMINISTRATION OF LIPOIC ACID AND COENZYME Q AGAINST ADIPOGENSIS: TARGET FOR WEIGHT REDUCTION.
Potential role of TNFalpha and lipoprotein lipase as candidate genes for obesity.
Predictors of adipose tissue lipoprotein lipase in middle-aged and older men: relationship to leptin and obesity, but not cardiovascular fitness.
Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase.
Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery.
Recessive inheritance of obesity in familial non-insulin-dependent diabetes mellitus, and lack of linkage to nine candidate genes.
Regulation of adipose tissue lipoprotein lipase in young and old rats.
Regulation of lipoprotein lipase activity in the sand rat: effect of nutritional state and cAMP modulation.
Relationships between the amount of weight loss and post-heparin lipoprotein lipase activity in patients with type II diabetes.
Relationships in women between body mass index and the intravascular metabolism of chylomicron-like emulsions.
Relationships of PPARgamma and PPARgamma2 mRNA levels to obesity, diabetes and hyperinsulinaemia in rhesus monkeys.
Reversal of high-fat diet-induced obesity in female rats.
Sex differences in obesity development in pair-fed neuronal lipoprotein lipase deficient mice.
The Association of a Rare Variant of -93, -53 Promoter Gene Polymorphisms of Lipoprotein Lipase gene with Obesity and Insulin Resistance.
The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.
The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet.
The lipoprotein lipase S447X and cholesteryl ester transfer protein rs5882 polymorphisms and their relationship with lipid profile in human serum of obese individuals.
The modulating effect of Persea americana fruit extract on the level of expression of fatty acid synthase complex, lipoprotein lipase, fibroblast growth factor-21 and leptin--A biochemical study in rats subjected to experimental hyperlipidemia and obesity.
The relationship between the basal lipolytic and lipoprotein lipase activities in human adipose tissue.
Time course of changes in serum glucose, insulin, lipids and tissue lipase activities in macrosomic offspring of rats with streptozotocin-induced diabetes.
Tissue-specific lipoprotein lipase: relationships to body composition and body fat distribution in normal weight humans.
Trangenic and knockout rodents: novel insights into mechanisms of body weight regulation.
Variations in DNA elucidate molecular networks that cause disease.
Visceral obesity and diabetes.
Whole-body insulin resistance and energy expenditure indices, serum lipids, and skeletal muscle metabolome in a state of lipoprotein lipase overexpression.
[Activity of lipoprotein lipase and the effect of heparin on the blood lipids pattern in exogenous obesity]
[Effect of electroacupuncture on metabolism of lipids in rats of obesity induced by sodium glutamate]
[Effect of lipoprotein lipase gene polymorphism on plasma lipid levels,BMI and subcutaneous fat distribution in simple obesity children]
[Lipoprotein lipase gene mutations and the risk of cardiovascular diseases in children with obesity.]
[Lipoprotein lipase gene polymorphism in non-insulin-dependent diabetics: preliminary study]
[Studies of lipoprotein lipase activity and adipocyte characteristics in the human: effect of obesity and diabetes (author's transl)]
[The role of gut microbiota in the pathogenesis of obesity].
Obesity, Abdominal
Association of the lipoprotein lipase gene T+495G polymorphism with central obesity and serum lipids in a twin study.
Differential expression of lipoprotein lipase gene in tissues of the rat model with visceral obesity and postprandial hyperlipidemia.
Formula Diet is Effective for the Reduction and Differentiation of Visceral Adipose Tissue in Zucker Fatty Rats.
Genetic susceptibility to visceral obesity and related clinical implications.
Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency.
Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Québec Family Study.
Lipoprotein lipase gene S447X polymorphism modulates the relation between central obesity and serum lipids, a twin study.
Modulation of adipocyte lipoprotein lipase expression as a strategy for preventing or treating visceral obesity.
Muscle and adipose tissue morphology and metabolism in Cushing's syndrome.
The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity.
[The polycystic ovary syndrome and insulin resistance]
Obesity, Morbid
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy.
Lack of pronounced changes in the expression of fatty acid handling proteins in adipose tissue and plasma of morbidly obese humans.
Optic Atrophy
LncRNAs expression signatures of human brain arteriovenous malformation revealed by microarray.
Osteoporosis
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Osteosarcoma
Effect of cortisol on cell proliferation and the expression of lipoprotein lipase and vascular endothelial growth factor in a human osteosarcoma cell line.
Recombinant human tumour necrosis factor-alpha suppresses synthesis, activity and secretion of lipoprotein lipase in cultures of a human osteosarcoma cell line.
Overweight
Effect of Insulin Infusion on Spillover of Meal-Derived Fatty Acids.
Effects of fasting on lipoprotein lipase activity in different depots of white and brown adipose tissues in diet-induced overweight rats.
Hind III polymorphism of the lipoprotein lipase gene and plasma lipid response to low calorie diet.
Lipoprotein lipase gene variation is associated with adipose tissue lipoprotein lipase activity, and lipoprotein lipid and glucose concentrations in overweight postmenopausal women.
Reduced LPL and subcutaneous lipid storage capacity are associated with metabolic syndrome in postmenopausal women with obesity.
Relation of lipoprotein lipase activity in adipose tissue to adipocyte volume and its influence in hypertriglyceridemia pathogenesis.
Serum lipoprotein and lipoprotein lipase in overweight, type II diabetics during and after supplemented fasting.
Pancreatitis
11-year Follow-up in Biliopancreatic Diversion for Recurrent Pancreatitis Due to Lipoprotein Lipase Deficiency.
A case of adolescent hyperlipoproteinemia with xanthoma and acute pancreatitis, associated with decreased activities of lipoprotein lipase and hepatic triglyceride lipase.
A case of non-alcoholic steatohepatitis complicated with severe acute pancreatitis induced by decreased lipoprotein lipase and hepatic triglyceride lipase activity levels in a young Japanese woman.
A Chinese patient with recurrent pancreatitis during pregnancy induced by hypertriglyceridemia associated with compound heterozygosity (Glu242Lys and Leu252VaL) in the lipoprotein lipase gene.
A compound heterozygote for lipoprotein lipase deficiency, Val69-->Leu and Gly188-->Glu: correlation between in vitro LPL activity and clinical expression.
A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency.
A novel Glu421Lys substitution in the lipoprotein lipase gene in pregnancy-induced hypertriglyceridemic pancreatitis.
A novel lipoprotein lipase gene missense mutation in Chinese patients with severe hypertriglyceridemia and pancreatitis.
A novel substitution at the translation initiator codon (ATG-->ATC) of the lipoprotein lipase gene is mainly responsible for lipoprotein lipase deficiency in a patient with severe hypertriglyceridemia and recurrent pancreatitis.
A serum metabolomic investigation on lipoprotein lipase-deficient mice with hyperlipidemic pancreatitis using gas chromatography/mass spectrometry.
Acute and chronic pancreatitis in patients with inborn errors of metabolism.
Acute hypertriglyceridaemic pancreatitis in a pregnant Indian: a new lipoprotein lipase gene mutation.
Acute hypertriglyceridemic pancreatitis during pregnancy due to homozygous lipoprotein lipase gene mutation.
Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency.
Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency.
ApoE enhances lipid uptake by macrophages in lipoprotein lipase deficiency during pregnancy.
Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiency.
Association of the HindIII Lipoprotein Lipase Gene Polymorphism with the Development of the Non-Biliary Acute Pancreatitis: a Pilot Study.
Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study.
Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia.
Composition of free fatty acid and triglyceride fractions in human necrotic pancreatic tissue.
Compound but non-linked heterozygous p.W14X and p.L279 V LPL gene mutations in a Chinese patient with long-term severe hypertriglyceridemia and recurrent acute pancreatitis.
Compound heterozygosity of Leu252Val and Leu252Arg causing lipoprotein lipase deficiency in a chinese patient with hypertriglyceridemia.
Correction of Feline Lipoprotein Lipase Deficiency with Adeno-Associated Virus Serotype 1-Mediated Gene Transfer of the Lipoprotein Lipase S447X Beneficial Mutation.
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation.
Diagnosis and treatment of severe hypertriglyceridemia.
Diagnostic evaluation of acute pancreatitis in two patients with hypertriglyceridemia.
Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome.
Effects of two therapeutic dietary regimens on primary chylomicronemia in paediatric age: a retrospective data analysis.
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL(S447X)) gene therapy for lipoprotein lipase deficiency: an open-label trial.
Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells.
Excessive hypertriglyceridemia and pancreatitis in pregnancy. Association with deficiency of lipoprotein lipase.
Familial chylomicronemia and multifactorial chylomicronemia.
Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.
Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice.
Gene therapy for lipoprotein lipase deficiency.
Gene Therapy for Lipoprotein Lipase Deficiency: Working Toward Clinical Application.
Gene therapy for lipoprotein lipase deficiency: working toward clinical application.
Gene Therapy in Lipoprotein Lipase Deficiency: Case Report on the First Patient Treated with Alipogene Tiparvovec Under Daily Practice Conditions.
Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis.
Genetic Variants Associated With Increased Plasma Levels of Triglycerides, via Effects on the Lipoprotein Lipase Pathway, Increase Risk of Acute Pancreatitis.
Gestational hyperlipidemia and acute pancreatitis with underlying partial lipoprotein lipase deficiency and apolipoprotein E3/E2 genotype.
Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease.
Homozygosity for two point mutations in the lipoprotein lipase (LPL) gene in a patient with familial LPL deficiency: LPL(Asp9-->Asn, Tyr262-->His).
Hyperlipemia in acute pancreatitis. Metabolic studies in a patient and demonstration of abnormal lipoprotein-triglyceride complexes resistant to the action of lipoprotein lipase.
Hyperlipidemia and pancreatitis during pregnancy in two sisters with a mutation in the lipoprotein lipase gene.
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia.
Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis.
Initial diagnosis of lipoprotein lipase deficiency in a 75-year-old man.
Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis.
Lipoprotein lipase deficiency with pancreatitis in mink: biochemical characterization and pathology.
Lipoprotein lipase deficiency with visceral xanthomas.
Lipoprotein Lipase Deficiency.
Lipoprotein lipase deficiency: clinical, biochemical and molecular characteristics in three patients with novel mutations in the LPL gene.
Lipoprotein lipase gene analyses in one Turkish family and three different Chinese families with severe hypertriglyceridaemia: One novel and several established mutations.
Lipoprotein lipase gene-deficient mice with hypertriglyceridaemia associated with acute pancreatitis.
Lipoprotein lipase inhibition in rabbits with experimental pancreatitis.
Lipoprotein Lipase Mutation S447X Associated With Pancreatic Calcification and Steatorrhea in Hyperlipidemic Pancreatitis.
Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation.
Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis.
Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis.
Management of severe hypertriglyceridemia due to lipoprotein lipase deficiency in children
Metabolic surgery for the treatment of hypertriglyceridemia-related pancreatitis due to familial lipoprotein lipase deficiency.
Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes.
Mutations in the lipoprotein lipase gene as a cause of hypertriglyceridemia and pancreatitis in Taiwan.
Neonatal hyperlipidemia with pancreatitis: Novel gene mutation of lipoprotein lipase.
Neonatal pancreatitis associated with familial lipoprotein lipase deficiency.
Pancreatitis associated with hyperlipoproteinaemia type I in mink (Mustela vison): earliest detectable changes occur in mitochondria of exocrine cells.
Pancreatitis in a child with lipemia due to novel lipoprotein lipase mutations.
Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.
Potential of essential fatty acid deficiency with extremely low fat diet in lipoprotein lipase deficiency during pregnancy: A case report.
Prevention of recurrent pancreatitis in familial lipoprotein lipase deficiency with high-dose antioxidant therapy.
Pseudodominance of lipoprotein lipase (LPL) deficiency due to a nonsense mutation (Tyr302>Term) in exon 6 of LPL gene in an Italian family from Sardinia (LPL(Olbia)).
Recurrent pancreatitis and chylomicronemia in an extended Dutch kindred is caused by a Gly154-->Ser substitution in lipoprotein lipase.
Relationships of lipoprotein lipase and hyperlipemia in pancreatitis.
Severe acute necrotizing pancreatitis associated with lipoprotein lipase deficiency in childhood.
Severe Familial Hypertriglyceridemia: Successful Treatment With Insulin and a Modified Meal Plan.
Severe hypertriglyceridaemia and pancreatitis in a patient with lipoprotein lipase deficiency based on mutations in lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) genes.
Severe hypertriglyceridaemia as a result of familial chylomicronaemia: the Cape Town experience.
Severe hypertriglyceridemia due to two novel loss-of-function lipoprotein lipase gene mutations (C310R/E396V) in a Chinese family associated with recurrent acute pancreatitis.
Severe Hypertriglyceridemia in a Newborn with Monogenic Lipoprotein Lipase Deficiency: An Unconventional Therapeutic Approach with Exchange Transfusion.
Severe hypertriglyceridemia with plasma inhibitory factor(s) on lipoprotein lipase activity in a patient with a common Ser(447)-Ter LPL mutation.
Striated muscle gene therapy for the treatment of lipoprotein lipase deficiency.
Targeting APOC3 in the familial chylomicronemia syndrome.
The role of free fatty acids, pancreatic lipase and Ca+ signalling in injury of isolated acinar cells and pancreatitis model in lipoprotein lipase-deficient mice.
The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency.
Therapeutic plasma exchange for the management of severe gestational hypertriglyceridaemic pancreatitis due to lipoprotein lipase mutation.
Therapeutic response to medium-chain triglycerides and omega-3 fatty acids in a patient with the familial chylomicronemia syndrome.
Transient lipoprotein lipase deficiency with hyperchylomicronemia.
Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjogren's syndrome.
Type I hyperlipoproteinemia due to a novel loss of function mutation of lipoprotein lipase, Cys(239)-->Trp, associated with recurrent severe pancreatitis.
Very low-density lipoprotein apolipoprotein B-100 turnover in glycogen storage disease type Ia (von Gierke disease).
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.
[Heparin and insulin in the treatment of acute hypertriglyceridemia-induced pancreatitis]
[LDL-Apheresis for the treatment of hyperchylomicronemia-induced pancreatitis]
[Lipoprotein lipase activity and PHLA inhibitors level in acute pancreatitis (author's transl)]
[Lipoprotein lipase--physiological and pathophysiological roles of this gene variant in Croatian population]
[Lipoprotein lipase: a multifunctional enzyme in lipoprotein metabolism]
[Modifications of lipoprotein lipase in pancreatitis]
[Molecular genetics and lipoprotein lipase deficiency]
[Pancreatitis in pregnant women]
[Primary lipoprotein lipase deficiency. Study in Quebec]
[Primary lipoprotein lipase deficiency: clinical and genetic aspects]
[TOTAL PARENTERAL NUTRITION IN A PREGNANT PATIENT WITH ACUTE PANCREATITIS AND LIPOPROTEIN LIPASE DEFICIENCY].
Pancreatitis, Acute Necrotizing
Severe acute necrotizing pancreatitis associated with lipoprotein lipase deficiency in childhood.
Pancreatitis, Alcoholic
LIPOPROTEIN LIPASE INHIBITION IN THE HYPERLIPEMIA OF ACUTE ALCOHOLIC PANCREATITIS.
Pancreatitis, Chronic
Lipoprotein Lipase Mutation S447X Associated With Pancreatic Calcification and Steatorrhea in Hyperlipidemic Pancreatitis.
Pancytopenia
Severe hypertriglyceridemia associated with pancytopenia and lipoprotein lipase deficiency.
Pediatric Obesity
APOE, CETP and LPL genes show strong association with lipid levels in Greek children.
Lipoprotein lipase gene polymorphisms and risks of childhood obesity in Chinese preschool children.
Peptic Ulcer
[Lipoprotein lipase activity and the effect of blood serum on the lipolytic activity of fatty tissue in patients with peptic ulcer]
Perinatal Death
Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
Peripheral Nervous System Diseases
Insulin-induced upregulation of lipoprotein lipase in Schwann cells during diabetic peripheral neuropathy.
Peritonitis
Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic, Escherichia coli bacteremic, and polymicrobial septic rats.
Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota.
Persistent Infection
Characterization of differentiation factor/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes.
Responses of adipose and muscle lipoprotein lipase to chronic infection and subsequent acute lipopolysaccharide challenge.
phosphatidylcholine-sterol o-acyltransferase deficiency
Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph.
Familial lecithin:cholesterol acyltransferase deficiency. Further studies on plasma lipoproteins and plasma postheparin lipase activity of a patient with normal renal function.
Gene therapy for dyslipidemia: clinical prospects.
Pituitary ACTH Hypersecretion
Salt resistant lipase activity in human adrenal gland is increased in Cushing's disease.
Plasmacytoma
Interleukin-11 and its receptor.
Pneumonia
[Blood lipoprotein lipase, non-esterified and unsaturated fatty acids in pneumonia]
Polycystic Ovary Syndrome
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
Polymyositis
[A case of polymyositis associated with hypertriglyceridemia due to decline of lipoprotein lipase activity]
Prader-Willi Syndrome
Elevated adipose tissue lipoprotein lipase in the pathogenesis of obesity in the Prader-Willi syndrome.
Malignant fibrous histiocytoma-pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study.
Pre-Eclampsia
Association between the levels of CGI-58 and lipoprotein lipase in the placenta of patients with preeclampsia.
Association of Four Missense SNPs with Preeclampsia in Saudi Women.
Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene.
Functional variants of the lipoprotein lipase gene and the risk of preeclampsia among non-Hispanic Caucasian women.
Lipolytic activity in the placentas of chronically deprived fetuses.
Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia.
Triglycerides and apoproteins in toxemia of pregnancy.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Novel compounds that target lipoprotein lipase and mediate growth arrest in acute lymphoblastic leukemia.
The rapidly evolving state of gene therapy.
Prehypertension
Familial dyslipidaemic hypertension and other multiple metabolic syndromes.
Prolactinoma
Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma.
Prostatic Neoplasms
Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a Japanese population.
PAGE4 is a cytoplasmic protein that is expressed in normal prostate and in prostate cancers.
Transcriptional regulatory networks in human lung adenocarcinoma.
[Relationship between chromosome 8 alterations and Gleason score in prostatic adenocarcinoma]
Protein Deficiency
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Evaluation of an HPLC method for LDL-cholesterol determination in patients with various lipoprotein abnormalities in comparison with beta-quantification.
Protein-Energy Malnutrition
Lipoprotein lipase activity in marasmic type of protein-calorie malnutrition.
Proteinuria
Endothelial bound lipoprotein lipase (LpL) depletion in hypoalbuminemia results from decreased endothelial binding, not decreased secretion.
Proteinuria and lipoprotein lipase activity in Miniature Schnauzer dogs with and without hypertriglyceridemia.
Sex dimorphism in serum lecithin: cholesterol acyltransferase and lipoprotein lipase activities in adult sickle cell anaemia patients with proteinuria.
Psoriasis
[A case of psoriasis vulgaris whose lipoprotein lipase activity decreased during treatment with etretinate]
Renal Insufficiency
Atorvastatin Improves Hepatic Lipid Metabolism and Protects Renal Damage in Adenine-Induced Chronic Kidney Disease in Sprague-Dawley Rats.
Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertriglyceridemia in renal failure.
Hyperlipidemia in renal failure: studies of plasma lipoproteins, hepatic triglyceride production, and tissue lipoprotein lipase in a chronically uremic rat moedl.
Pathogenesis of dyslipoproteinemia in renal insufficiency: the role of lipoprotein lipase and hepatic lipase.
[Effects of Shenshuai Yangzhen capsule on lipid metabolism disorder in rats with chronic renal failure]
[New kidney, but a sick heart. Why many patients with renal failure and kidney transplant patients die of cardiovascular disease]
[Relative concentration of VLDL C-apolipoproteins in the hyperlipoproteinaemia of haemodialysis-treated chronic renal failure (author's transl)]
Renal Insufficiency, Chronic
Dysregulation of hepatic fatty acid metabolism in chronic kidney disease.
Hypercholesterolemia in rats with chronic renal insufficiency not aggravated by recombinant human growth hormone.
Lipid profiles and lipase activities in children and adolescents with chronic renal failure treated conservatively or with hemodialysis or transplantation.
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.
Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency.
[Reduction of post-heparin lipoprotein lipase activity by acidotic blood pH]
Respiratory Insufficiency
Respiratory failure in acute pancreatitis: the role of free fatty acids.
Retinal Degeneration
Exploring Excitotoxicity and Regulation of a Constitutively Active TRP Ca2+ Channel in Drosophila.
Retinal Diseases
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.
Retinoblastoma
Understanding mutations and protein stability through tripeptides.
Rhabdomyosarcoma
Increased fat oxidation and regulation of metabolic genes with ultraendurance exercise.
Rheumatic Diseases
Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
[Activity of the clearing factor (lipoproteinase) in the blood plasma of children with rheumatism.]
[Clearing factor in rheumatic diseases.]
Rheumatic Heart Disease
[Clearing factor in Bouillaud's disease.]
Rickets
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Sarcoma
Existence of lipoprotein lipase in human sarcomas and carcinomas.
The synthesis and activity of lipoprotein lipase in the subcutaneous adipose tissue of patients with musculoskeletal sarcomas.
Sepsis
Alterations in lipogenic enzymes and lipoprotein lipase activity during gram-negative sepsis in the rat.
Gram-negative bacteria sepsis in the rat and tissue lipolytic activity on LCT and MCT/LCT-based commercial parenteral emulsions.
Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic, Escherichia coli bacteremic, and polymicrobial septic rats.
Insulin stimulates lipoprotein lipase activity and synthesis in adipocytes from septic rats.
Lipoprotein lipase activity in surgical patients: influence of trauma and infection.
Monokines and the metabolic pathophysiology of septic shock.
Sepsis-induced regulation of lipoprotein lipase expression in rat adipose tissue and soleus muscle.
Sequential alterations in tissue lipoprotein lipase, triglyceride secretion rates, and serum tumor necrosis factor alpha during Escherichia coli bacteremic sepsis in relation to the development of hypertriglyceridemia.
Severe Combined Immunodeficiency
The rapidly evolving state of gene therapy.
Shock, Septic
Postheparin plasma lipoprotein and hepatic lipases in preterm neonates.
Synergism between lipopolysaccharide and interferon gamma in the regulation of lipoprotein lipase in macrophages.
Sialic Acid Storage Disease
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Sialorrhea
Dyslipidaemia in a boy with recurrent abdominal pain, hypersalivation and decreased lipoprotein lipase activity.
Silicosis
[The clearing factor and several other indices of lipid metabolism in silicosis and silico-tuberculosis]
[The lungs and lipid metabolism. Behavior of the lipoprotein lipase, electrophoretic lipoproteins and total blood cholesterol in emphysema and pulmonary silicosis.]
Sjogren's Syndrome
Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjogren's syndrome.
Sleep Apnea Syndromes
Chronic Intermittent Hypoxia Induces Atherosclerosis via Activation of Adipose Angiopoietin-like 4.
[Association between serum lipoprotein lipase level and dyslipidemia in patients with obstructive sleep apnea syndrome].
Sleep Apnea, Obstructive
Decreased lipoprotein lipase in obstructive sleep apnea syndrome.
Effects of acute hypoxia on human adipose tissue lipoprotein lipase activity and lipolysis.
[Association between serum lipoprotein lipase level and dyslipidemia in patients with obstructive sleep apnea syndrome].
Spasms, Infantile
The genotypic and phenotypic spectrum of PIGA deficiency.
ST Elevation Myocardial Infarction
Proteomic Discovery and Validation of the Confounding Effect of Heparin Administration on the Analysis of Candidate Cardiovascular Biomarkers.
Starvation
Carbohydrate-lipid interactions during gestation and their control by insulin.
Cardiac lipoprotein lipase activities in relation to glucose utilization during progressive starvation.
Changes in lipoprotein lipase activities in adipose tissue, heart and skeletal muscle during continuous or interrupted feeding.
Changes with starvation in the rat of the lipoprotein lipase activity and hydrolysis of triacylglycerols from triacylglycerol-rich lipoproteins in adipose tissue preparations.
Effect of nutritional status on swine adipose tissue lipolytic activities.
Effect of starvation on activities and mRNA expression of lipoprotein lipase and hormone-sensitive lipase in tilapia (Oreochromis niloticus x O. areus).
Effect of starvation on lipoprotein lipase activity in different tissues during gestation in the rat.
Effect of starvation on lipoprotein lipase activity in the liver of developing rats.
Effects of fasting on lipoprotein lipase activity in different depots of white and brown adipose tissues in diet-induced overweight rats.
Effects of Starvation on Lipid Metabolism and Gluconeogenesis in Yak.
Lipid metabolism during the initiation of lactation in the rat. The effects of starvation and tumour growth.
Lipid metabolism in the obese Zucker rat. Disposal of an oral [14C]triolein load and lipoprotein lipase activity.
Lipoprotein lipase activity in the liver of starved pregnant rats.
Lipoprotein lipase and hepatic lipase in Wistar and Sprague-Dawley rat tissues. Differences in the effects of gender and fasting.
Mechanisms of decreased lipoprotein lipase activity in adipocytes of starved rats depend on duration of starvation.
Nutrition in the critically ill patient: part I. Essential physiology and pathophysiology.
Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy.
Starvation enhances lipoprotein lipase activity in the liver of the newborn rat.
The activities of lipoprotein lipase and of enzymes involved in triacylglycerol synthesis in rat adipose tissue. Effects of starvation, dietary modification and of corticotropin injection.
The effect of fasting on the utilization of chylomicron triglyceride fatty acids in relation to clearing factor lipase (lipoprotein lipase) releasable by heparin in the perfused rat heart.
The effect of nutritional state on the lipoprotein lipase activity of isolated fat cells.
The effect of short-term starvation on the lipoprotein lipase activity of adipose tissue and cardiac muscle during postnatal development of the rat.
The effects of starvation and of cold stress on clearing factor lipase activity and triglyceride fatty acid utilization in rat heart.
The influence of starvation and refeeding on the lipoprotein lipase activity of skeletal muscle and adipose tissue of lean and obese Zucker rats.
The lipoprotein lipase of white adipose tissue. Studies on the intracellular distribution of the adipocyte-associated enzyme.
The relationship between the basal lipolytic and lipoprotein lipase activities in human adipose tissue.
Status Epilepticus
[Lipoprotein lipase expression in the hippocampus and its effects on vitamin E levels in rats with epilepsy]
Steatorrhea
Lipoprotein Lipase Mutation S447X Associated With Pancreatic Calcification and Steatorrhea in Hyperlipidemic Pancreatitis.
Stomach Neoplasms
Cholesterol import and steroidogenesis are biosignatures for gastric cancer patient survival.
Polyunsaturated fatty acids augment tumoricidal action of 5-fluorouracil on gastric cancer cells by their action on vascular endothelial growth factor, tumor necrosis factor-? and lipid metabolism related factors.
[Blood lipase activity in cancer patients]
Stroke
Association between HindIII (rs320) variant in the lipoprotein lipase gene and the presence of coronary artery disease and stroke among the Saudi population.
Association between Lipoprotein Lipase Polymorphism and the Risk of Stroke: A Meta-analysis.
Frequency and allelic association of common variants in the lipoprotein lipase gene in different ethnic groups: the Wandsworth Heart and Stroke Study.
Genetic variation in MDR1, LPL and eNOS genes and the response to atorvastatin treatment in ischemic stroke.
Investigation of the Interaction Between the Ser447Term Polymorphism of Lipoprotein Lipase and the Stroke-Related Risk Factors in Ischemic Stroke.
Lipoprotein lipase gene polymorphisms as risk factors for stroke: a computational and meta-analysis.
LPL polymorphism predicts stroke risk in men.
Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
MicroRNA-410 regulated lipoprotein lipase variant rs13702 is associated with stroke incidence and modulated by diet in the randomized controlled PREDIMED trial.
Polymorphisms of the lipoprotein lipase gene as genetic markers for stroke in colombian population: a case control study.
The lipoprotein lipase Ser447Ter mutation and risk of stroke in the Chinese.
[Activity of lipoprotein lipase in families of patients with different types of stroke]
Tangier Disease
A discrepancy between in vivo and in vitro lipoprotein lipase activity in a patient with Tangier disease.
Erythrocyte membrane alterations and plasma lipids in patients with chylomicronemia and in Tangier disease.
Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia.
Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
Thalassemia
Erythrocyte membrane alterations and plasma lipids in patients with chylomicronemia and in Tangier disease.
Thrombocytopenia
Hypertriglyceridemia associated with thrombocytopenia and lipoprotein lipase deficiency.
Thyroid Diseases
Post heparin plasma lipoprotein lipase activity in thyroid disease.
Toxemia
Triglycerides and apoproteins in toxemia of pregnancy.
triacylglycerol lipase deficiency
Accumulation of large VLDL in cyclophosphamide treated rabbits. Relationship with lipoprotein lipase deficiency.
Acute dyslipoproteinemia induced by interleukin-2: lecithin:cholesteryl acyltransferase, lipoprotein lipase, and hepatic lipase deficiencies.
Adrenal and liver in normal and cld/cld mice synthesize and secrete hepatic lipase, but the lipase is inactive in cld/cld mice.
Combined lipase deficiency (cld/cld) in mice affects differently post-translational processing of lipoprotein lipase, hepatic lipase and pancreatic lipase.
Combined lipase deficiency (cld/cld) in mice. Demonstration that an inactive form of lipoprotein lipase is synthesized.
Differential effect of combined lipase deficiency (cld/cld) on human hepatic lipase and lipoprotein lipase secretion.
Effect of combined lipase deficiency (cld/cld) on hepatic and lipoprotein lipase activities in liver and plasma of newborn mice.
Effect of the combined lipase deficiency mutation (cld/cld) on ultrastructure of tissues in mice. Diaphragm, heart, brown adipose tissue, lung, and liver.
Expression of lipoprotein lipase gene in combined lipase deficiency.
Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure.
High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.
Irradiation-induced free cholesterol accumulation in very-low-density lipoproteins. Role of lipoprotein lipase deficiency.
Lipase deficiencies.
Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency.
Lipoprotein lipase and hepatic lipase deficiencies associated with impaired chylomicron clearance in D-(+) galactosamine hepatitis.
Lipoprotein lipase mRNA in neonatal and adult mouse tissues: comparison of normal and combined lipase deficiency (cld) mice assessed by in situ hybridization.
Molecular cloning of mouse hepatic triacylglycerol lipase: gene expression in combined lipase-deficient (cld/cld) mice.
Naturally occurring mutations in mice affecting lipid transport and metabolism.
Plasma lipoproteins in familial hepatic lipase deficiency.
Synthesis of inactive nonsecretable high mannose-type lipoprotein lipase by cultured brown adipocytes of combined lipase-deficient cld/cld mice.
Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome.
Triple Negative Breast Neoplasms
Lipoprotein lipase hydrolysis products induce pro-inflammatory cytokine expression in triple-negative breast cancer cells.
Tuberculosis
[Lipoprotein lipase activity in cattle with tuberculosis]
Tuberculosis, Pulmonary
[Lipoprotein lipase activity of the blood in patients with pulmonary tuberculosis]
Uremia
Hypertriglyceridemia and lipoprotein lipase activity in experimental uremia.
Increased lipase inhibition in uremia: identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma.
Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia.
Lipoprotein lipase disturbances induced by uremia and hemodialysis.
Metabolic studies of adipose tissue in acute uremia.
Selective deficiency of hepatic triglyceride lipase in uremic patients.
Urinary Bladder Neoplasms
Transcriptional regulatory networks in human lung adenocarcinoma.
Vascular Diseases
DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus.
Fatty acid metabolism and vascular disease.
Genetic polymorphism of heparan sulfate proteoglycan (perlecan, HSPG2), lipid profiles and coronary artery disease in the Australian population.
Genetics of the lipoprotein lipase gene and hypertriglyceridaemia.
Lipoprotein lipase (LPL) gene variation and progression of carotid artery plaque.
Polymorphisms of the lipoprotein lipase gene are associated with atherosclerotic cerebral infarction in the Chinese.
Recent advances in factors that alter lipid metabolism in chronic renal failure.
[Determination of total plasma lipoprotein lipase in patients with vascular diseases and hyperlipemia]
[Rapid effect of glucuronyl glucosamine glycan sulfate on the blood levels of HDL-cholesterol in vascular diseases]
[Studies on neutral fat, lipoproteins and lipoprotein lipase in relation to vascular disease in young Indian diabetics]
Venous Thromboembolism
Polymorphism in the beta2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: a multilocus, population-based, prospective genetic analysis.
Venous Thrombosis
Triglyceride dependence of factor VII coagulant activity in deep venous thrombosis.
[Effects of a natural mucopolysaccharide-fibrinolytic complex on venous thrombosis and on the clearing factor]
Virus Diseases
Changes in serum lipoprotein pattern induced by acute infections.
Lipoproteins and acute phase response during acute infection. Interrelationships between C-reactive protein and serum amyloid-A protein and lipoproteins.
Vitamin E Deficiency
Dietary vitamin E deficiency inhibits fat metabolism, antioxidant capacity, and immune regulation of inflammatory response in genetically improved farmed tilapia (GIFT, Oreochromis niloticus) fingerlings following Streptococcus iniae infection.
von Hippel-Lindau Disease
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Whooping Cough
Tumor necrosis factor-mediated biological activities involve a G-protein-dependent mechanism.
Xanthomatosis
A case of adolescent hyperlipoproteinemia with xanthoma and acute pancreatitis, associated with decreased activities of lipoprotein lipase and hepatic triglyceride lipase.
A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency.
An Infant with Milky Serum and a Rare Mutation.
ApoE enhances lipid uptake by macrophages in lipoprotein lipase deficiency during pregnancy.
C-II anapolipoproteinemia and severe hypertriglyceridemia. Report of a rare case with absence of C-II apolipoprotein isoforms and review of the literature.
Eruptive Xanthomas in Lipoprotein Lipase Deficiency.
Lipoprotein lipase deficiency with visceral xanthomas.
Lipoprotein lipase deficiency: clinical, biochemical and molecular characteristics in three patients with novel mutations in the LPL gene.
Mutations in the lipoprotein lipase gene as a cause of hypertriglyceridemia and pancreatitis in Taiwan.
Xanthoma of bone associated with lipoprotein lipase deficiency.
[Familial hyperchylomicronemia with a new mutation of the lipoprotein lipase gene]
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
[Primary lipoprotein lipase deficiency: clinical and genetic aspects]